2017 Centre Overview · 2018-08-28 · Deputy: A/Prof Mark Walterfang DEPRESSION AND ANXIETY NEUROSCIENCE A/Prof. Ben Harrison Deputy: A/Prof Chris Davey SOCIAL AFFECTIVE NEURODEVELOPMENT

2017 Centre Overview

Foreword 3

Melbourne Neuropsychiatry Centre 4About Us 4Organisational Chart 5Research Stream Profiles 6Psychosis and Developmental Neuropsychiatry

6

Clinical Neuropsychiatry 8Depression & Anxiety Neuroscience

10

Social and Affective NeuroDevelopment

11

Systems Neuropsychiatry 12Gene-Environment Neuropsychiatry

13

Performance Indicators 14Research Output & Impact 14Funding 15Supervision & Teaching 16Knowledge Transfer 16Acknowledgements 17Publications 2012-present 18

Contents

Overview | Melbourne Neuropsychiatry Centre 3

Professor Ian Everall BSc, MB ChB (Hons), PhD, DSc, FRCPsych, FRCPath, FRANZCP Cato Professor of Psychiatry, Royal Melbourne Hospital and Head of Department of Psychiatry, The University of Melbourne.

The Melbourne Neuropsychiatry Centre (MNC) was officially launched in 2004 as a joint centre of The University of Melbourne and Melbourne Health. Since its inception, MNC has been tremendously successful in bringing together an outstanding team of research active clinical academics, clinicians, and scientists from various disciplines, as well as professional staff, to advance our knowledge and treatment of neuropsychiatric conditions.

The clinical-research interface is at the heart of MNC and is reflective of the strong partnership that exists between the Department of Psychiatry at The University of Melbourne and the NorthWestern Mental Health Program of Melbourne Health. Professors Christos Pantelis and Dennis Velakoulis have attracted a highly talented group of people that has led to new discoveries in schizophrenia and other psychoses, mood and anxiety disorders, and disorders of brain development and brain degeneration. The Centre’s work is internationally recognised and is already contributing to better outcomes for the patients they treat. These successes have been possible through the generous support from Melbourne Health (NorthWestern Mental Health), The University of Melbourne, the Department of Health and Human Services, and the Florey Institute for Neurosciences and Mental Health.

Over the past five years, in particular, the Centre has recorded a remarkable level of achievement. It has been awarded 7 highly competitive NHMRC Fellowships, including a Senior Principal Research Fellowship (Prof Pantelis) and 4 recent Career Development Fellowships (CDFs; Drs. Zalesky, Harrison, Whittle, Bousman). Importantly, in 2016, The University of Melbourne submitted 41 applications for CDFs, and 3 of the 8 CDFs awarded at the university were at MNC. This is a fabulous effort. The Centre’s level of research output and impact over the past five years has also been impressive. They have recorded 600 research publications since 2012, with their average publication citation rate performing well above the University average. Their citations are equally impressive, with Prof Pantelis being listed in Thomson Reuter’s top 1% of the most highly cited in his field each year since 2014.

MNC represents a shining example of a research centre that delivers outcomes at an international level and which raises the profile of my Department and the university. I am delighted to support MNC as a key centre in the Department of Psychiatry, focussed on delivering the best outcomes for patients with severe mental disorders and disorders of neurodevelopment. It has been a pleasure to be part of the centre’s Management Committee, and to work closely with a number of researchers from MNC. While my new role going forward will be as Dean at the Institute of Psychiatry in London, my ongoing collaboration with Prof Pantelis, Prof Velakoulis and their teams will continue going forward, with a number of collaborative efforts already established or planned. I will continue to follow the work of this impressive centre, which continues to lead the field in many areas of mental health research.

Prof Ian Everall

30 May 2017

Foreword

4 Melbourne Neuropsychiatry Centre | Overview

About UsMelbourne Neuropsychiatry Centre (MNC) was established in 2004 with the appointment of Christos Pantelis as Foundation Professor in Neuropsychiatry at The University of Melbourne. Since that time, MNC has established its reputation as one of the most productive psychiatric research Centres in Australia. The team at MNC currently consists of 11 salaried academic staff, 6 professional staff. At any given time MNC supports over 30 individuals who work with the research streams at the Alan Gilbert Building as stipend funded PhD students, Masters and Honours students, and international research fellows.

MNC has maintained a core research focus on understanding the neurobiology of psychosis and other neurodevelopment disorders (incl. autism spectrum disorders), following on from its seminal work identifying progressive changes at transition to a psychotic illness (Pantelis et al, Lancet, 2003). It has also developed core overlapping research interests in the area of epilepsy and neurodegenerative disorders (Velakoulis et al.); depression and anxiety (Harrison et al., Whittle et al.); advanced brain network science (Zalesky et al.) and psychiatric genetics and genomics (Bousman et al.).

MNC is a joint Centre of The University of Melbourne and Melbourne Health. It brings together clinical and research teams at Sunshine and Royal Melbourne Hospitals, with a dedicated brain imaging archive and analysis laboratory located at the University’s Parkville campus.

Melbourne Neuropsychiatry Centre

Parkville (UoM) / RMH (NWMH) Sunshine Hospital (NWMH & UoM)

Research Operations Neuroimaging Laboratory Adult Mental Health

Rehabilitation Unit (AMHRU, NWMH)Prof Christos Pantelis

Deputy: Dr Naveen Thomas

WCHRE (UoM)Prof Christos Pantelis &

A/Prof. Ben HarrisonDr. Chad BousmanPSYCHOSIS AND

DEVELOPMENTAL NEUROPSYCHIATRYProf. Christos PantelisDeputy: Dr Vanessa Cropley

CLINICAL \NEUROPSYCHIATRYProf. Dennis Velakoulis Deputy: A/Prof Mark Walterfang

DEPRESSION AND ANXIETY NEUROSCIENCEA/Prof. Ben Harrison Deputy: A/Prof Chris Davey

SOCIAL AFFECTIVE NEURODEVELOPMENTA/Prof. Sarah Whittle Deputy: Dr Julian Simmons

SYSTEMS NEUROPSYCHIATRYDr. Andrew Zalesky

GENE-ENVIRONMENT NEUROPSYCHIATRYDr. Chad Bousman

Barbara StachlewskiPA to Scientific Director

Yvonne SteimleBusiness Manager (EFT 0.6)

Chester KangLab Manager & Analyst (EFT 0.5)

Organisational ChartScientific Director: Prof Christos PantelisClinical Director: Prof Dennis Velakoulis

Deputy Scientific Director: A/Prof Ben Harrison


Psychosis and Developmental Neuropsychiatry Stream leader: Prof. Christos Pantelis, MB BS, MD (Melb), Hon MD (Athens),

MRCPsych, FRANZCP

Deputy: Dr Vanessa Cropley

The stream’s goal is to understand the neurobiological basis of disorders emerging in childhood and adolescence, including psychotic disorders. They are located at MNC Parkville and MNC Sunshine. Primary local collaborators include the Centre for Neural Engineering; The Florey Institute of Neuroscience and Mental Health; Orygen – The National Centre of Excellence in Youth Mental Health; and Monash Institute of Pharmaceutical Sciences (MIPS). Over the past 5 years they have published over 140 peer-reviewed research articles (19368 citations). Highlights include:

1. Schizophrenia Working Group of the Psychiatric Genomics Consortium. (2014). Biological insights from 108 schizophrenia-associated genetic loci. Nature 511 (7510), 421-427. CITATIONS = 1377.

2. Fornito et al. (2012). Schizophrenia, neuroimaging and connectomics. Neuroimage 62 (4), 2296-2314. CITATIONS =327.

3. Bora et al. (2012). Gray matter abnormalities in major depressive disorder: a meta-analysis of voxel based morphometry studies. Journal of Affective Disorders 138 (1), 9-18. CITATIONS =307.

4. Yücel et al. (2012). The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample. Schizophrenia Bulletin 38 (2), 316-330. CITATIONS = 174.

5. Skafidis, Testa, Zantomio, Chana, Everall, Pantelis (2014). Predicting the diagnosis of autism spectrum disorder using gene pathway analysis. Molecular Psychiatry 19, 504-510. CITATIONS = 73.

Stream leader profileAppointment: Prof. Pantelis holds current appointments as NHMRC Senior Principal Research Fellow (since 2010), Foundation Professor of Neuropsychiatry and Scientific Director, MNC (2004–), Honorary Adjunct Professor, Centre for Neural Engineering (CfNE; 2015-), Honorary Senior Research Fellow, Bedfordshire Centre For Mental Health Research in Association with the University of Cambridge (UK; 2013–), Honorary Professorial Fellow, Florey Institute for Neuroscience & Mental Health (2004–), Principal Specialist, Adult Mental Health Rehabilitation Unit (AMRHU), Western Hospital Sunshine, North Western Mental Health Program, Melbourne Health (2000–).

Funding: Prof. Pantelis and his team have received >$45M in competitive research funding, including 22 NHMRC/ARC grants since 1994, incl: 4 current project grants;

3 current international collaborative EU-NHMRC grants; national NHMRC Enabling Grant that established the Australian Schizophrenia Research Bank (ASRB; international resource; leading to a paper in Nature Neuroscience); 2 NHMRC Program Grants (2005-2013: $17.4M), focusing on emerging mental illness; Mental Health CRC ($23M direct funding; total >$70 M) examining biomarkers in neurodegeneration and psychosis. His NHMRC SPRF (held since 2010) was recently renewed (2016-20; $926,980).

Publications: Prof. Pantelis has 500+ publications, incl. 3 books. His work has been cited 32,811 times (h-index 98) with 26 papers cited more than 300 times. His seminal Lancet paper (Pantelis et al. 2003) describing progressive brain changes at psychosis onset has received 1117 citations. Chris has been consistently one of the most highly cited researchers in The University of Melbourne. In 2016, Prof Pantelis was one of 17 UoM researchers named on the Clarivate Analytics ‘Highly Cited Researchers’ list, which identifies scientists whose research — the top 1% — has had significant global impact within their respective fields (he has been in this list since 2014).

Profile: Prof. Pantelis’ work has been recognised with awards from the USA (NARSAD) and Germany (Justus Liebig University), among many others. In 2015, he was conferred a Doctor Honoris Causa (Honourary Doctorate) from the National and Kapodistrian University of Athens. He has delivered the prestigious UoM Beattie Smith Lecture (2012) and Danks Oration (2015). In 2013, he was invited to participate and speak at an NIMH workshop by the former Director of NIMH (Tom Insel), including a subsequent international working party on early psychosis. He gave the opening plenary of the (WFSBP) World Federations of Societies of Biological Psychiatry in 2015, and recent keynote talks at Universities in Cambridge, Germany, Switzerland and Netherlands.

Research Stream Profiles


He participates on 10 journal editorial boards and peer reviews for various medical, psychiatric and neuroscience journals and national/international grant bodies; recently appointed as Associate Editor to Psychological Medicine (2016-). He is also on the NHMRC Academy and involved in NHMRC peer review and Fellowships panels (incl. 2016/17); past board member of the Schizophrenia Research Institute (SRI, NSW), Mental Illness Fellowship (MIF, Vic); on SACs of Neurosciences Victoria, IMHRI (NSW), and Biogrid; member (inter)national research committees; Chair of Department of Psychiatry Research Committee (2011-2013). He has been elected to the Schizophrenia International Research Society (SIRS) Nominating Committee (2012-2018) and has been part of the SIRS conference organising committee and various organizing committees for national and international conferences (incl. 2015 & 2018 WFSBP, Athens & Copenhagen, respectively). In 2016, he and his wife, Kimberley, established the ‘Nicholas & Dimitra Pantelis Travelling Scholarship’ to support early career schizophrenia researchers.

Supervision: Prof. Pantelis has supervised/mentored >100 doctoral, postdoc and research staff (32 doctoral [11 current], >30 International Fellows), 6 becoming Professors (3 since 2010) and 8 A/Profs (4 since 2013). Since 2009, MNC researchers under his mentorship have been awarded >33 competitive fellowships (incl. 14 NHMRC/2 ARC/5 NARSAD).


Clinical NeuropsychiatryStream leader: Prof. Dennis Velakoulis,

MBBS, Dip Crim, FRANZCP, MMed, DMed Sci

The stream is a multidisciplinary team including consultant neuropsychiatrists, neuropsychologists, occupational therapists, social workers, behavioural neurologists, training psychiatrists, resident medical officers and mental health and general medical nursing. They are based at the Neuropsychiatry Unit (NPU), John Cade Building, Royal Melbourne Hospital (MNC Royal Melbourne). The NPU is a state-wide specialist mental health service that offers neuropsychiatric assessment and advice to psychiatric, neurological and other medical and mental health services. The unit offers inpatient, outpatient, off-site and telemedicine assessments to other services across the state and the region. The unit has strong links to research in cognitive and clinical neuropsychiatry and training within the North-Western Mental Health Region and beyond. It is involved in a range of world-leading research endeavours, innovative educational programmes, and training of mental health clinicians to meet the future specialised mental health needs of the community. Over the past 5 years, they have published 90+ peer-reviewed research articles – highlights include:

1. Dazan et al. (2012). Volumetric abnormalities predating the onset of schizophrenia and affective psychoses: An MRI study in subjects at ultrahigh risk of psychosis Schizophrenia Bulletin 38, 1083-1091. CITATIONS = 456.

2. Linberg et al. (2012). Hippocampal shape analysis in Alzheimer’s disease and frontotemporal lobar degeneration subtypes. Journal of Alzheimers Disease 30, 355-365. CITATIONS = 38.

3. Chen, Z., Lusicic, A., O’Brien, T. J., Velakoulis, D., Adams, S. J., & Kwan, P. (2016). Psychotic disorders induced by antiepileptic drugs in people with epilepsy. Brain, 139(Pt 10), 2668-2678. doi:10.1093/brain/aww196. CITATIONS = 2.

4. Bora et al. (2015). Theory of mind in behavioural-variant frontotemporal dementia and Alzheimer’s disease: A meta-analysis. Journal of Neurology Neurosurgery and Psychiatry 86, 714-719. CITATIONS = 25.

5. Solowij et al. (2013). Alteration to hippocampal shape in cannabis users with and without schizophrenia. Schizophrenia Research. 143, 179-184. CITATIONS = 18.

Stream leader profileAppointment: Prof. Velakoulis is appointed as Clinical Director of MNC (2005-), Director of the Neuropsychiatry Unit (NPU), Royal Melbourne Hospital (2001-) and Professor, Department of Psychiatry, The University of Melbourne (2012-). Following graduation from The University of Melbourne in Medicine, Prof. Velakoulis completed a Diploma of Criminology before successfully completing his Fellowship for the RANZCP and a Masters of Medicine in Psychiatry in neuroimaging. He received a Doctor

of Medical Science degree in 2012. Prof. Velakoulis has maintained a full-time clinical role since 1997. He has held a 0.2 EFT academic position since 2006.

Funding: Prof. Velakoulis has been a chief investigator (CI) on more than 10 NHMRC grants (Total funding > $5M) and lead CI on two of these grants. He has also been a CI on non-NHMRC grants totaling over $4 million dollars. The breadth of these grants across psychiatry, neurology, human and animal studies reflects his collaborations with neuroscientists within and outside psychiatry.

Publications: Prof. Velakoulis has published 260+ peer reviewer articles, including publications in the highest ranked medical (Lancet – second author), neurological (Lancet Neurology –first author x 1, last author x 1, Brain) and all 6 of the highest ranked psychiatric journals. Of his publications, 13 (8%) papers have been published in journals with impact factor > 12.0 (8 as first, second or senior author) and 51 (30%) papers in journals with impact factor > 5.0. His h-index is 52 with 25 papers cited more than 100 times and 54 papers cited between 50 and 99 times (total 9090 citations).

Profile: Prof. Velakoulis has presented 60+ talks and workshops related to research and clinical activities, both nationally and internationally. He has assessed competitive grants and fellowships for major funding bodies, including the NHMRC. He has been an examiner for the Royal Australian and New Zealand College of Psychiatrists (RANZCP); Chair of the North Western Mental Health Research (2000-03) and ECT Committees (2005-10); Deputy Chair, Section of Neuropsychiatry, RANZCP (2006-10); Chair, Section of Neuropsychiatry, RANZCP (2010-current); and Deputy Chair, Victorian Psychosurgery Review Board.



Supervision: Prof. Velakoulis has supervised 17 University of Melbourne students (6 PhD, 11 Advanced Medical Sciences Medical students). The completed PhD and AMS projects have attained high grades with the completed PhD (A/Prof. Mark Walterfang) awarded for the Chancellor’s and Dean’s Prizes. Over the last fifteen years he has also developed a Neuropsychiatry service with a reputation for delivering teaching and education to clinicians and students across multiple disciplines and across geographic areas. This teaching is provided to medical specialists and trainees (psychiatry, neurology, geriatrics), nursing staff, allied health staff (neuropsychology, psychology, occupational therapy, speech therapy, art therapy) and students (medical, nursing, allied health) from multiple universities (The University of Melbourne, Monash University, Victoria University).

Neuropsychiatry is the study of the brain in people

suffering mental illness


Depression & Anxiety Neuroscience

Stream leader: A/Prof. Ben Harrison, PhD.

This stream’s aim is to develop experimental models based on affective neuroscience for treatment-oriented research and discovery in mood and anxiety disorders. They are located at MNC Parkville and MNC Sunshine. Primary local collaborators include: Orygen – The National Centre of Excellence in Youth Mental Health (Youth Mood Clinic) and Western Health Medical Imaging (Sunshine Hospital). Their work is primarily funded by NHMRC project grants and fellowships. Over the past 5 years they have published 70+ peer-reviewed research articles (3770 GS citations) – highlights include:

1. Davey CG, Pujol J, Breakspear M, Harrison BJ. A brain model of disturbed self appraisal in depression. The American Journal of Psychiatry. In Press.

2. Fullana, M.A., Harrison, B.J., et al. 2016. Neural signatures of human fear conditioning: an updated and extended meta-analysis of fMRI studies. Molecular Psychiatry 21, 500-508. CITATIONS = 45.

3. Schmaal, L., et al. 2016. Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group. Molecular Psychiatry. In Press. CITATIONS = 20.

4. Harrison, B.J., et al. 2013. Brain corticostriatal systems and the major clinical symptom dimensions of obsessive-compulsive disorder. Biological Psychiatry 73, 321-328. CITATIONS = 96.

5. Fornito, A., Harrison, B.J., Zalesky, A., Simons, J.S., 2012. Competitive and cooperative dynamics of large-scale brain functional networks supporting recollection. Proc Natl Acad Sci U S A 109, 12788-12793. CITATIONS = 194.

Stream leader profileAppointment: A/Prof. Harrison is a research psychologist and neuroscientist who has specialised in the study of mood and anxiety disorders with neuroimaging. He is appointed as Associate Professor and Deputy Scientific Director of MNC. He received his PhD in 2006 and has been funded by NHMRC Fellowships since this time (1 ECF, 2 x CDFs). He currently holds a Clinical Career Development Fellowship (Level 2; 2017-21). He is also appointed as Honorary Principal Research Fellow at Orygen – The National Centre of Excellence in Youth Mental Health.

Funding: A/Prof. Harrison has been involved in securing $8M+ in competitive funding. Nationally, he has led/currently leads 2 NHMRC Project Grants and has performed/currently perform as a Chief Investigator on 3 others. He has also received 4 sole or joint Principal Investigator Grants from competitive schemes of The University of Melbourne, the Clive & Vera Ramaciotti Foundation (Perpetual Trustees) and Myer Family Foundation. Internationally,

he has been a named chief/principal investigator on 10 competitively funded research projects.

Publications: A/Prof. Harrison has published 120 peer-review research articles to date (h-index 40, 4940 citations). Career publication highlights include 1st author articles in PNAS (234 citations), Molecular Psychiatry (47 citations in 12 months) and JAMA Psychiatry (317 citations). 17 of his publications have been cited 100+ times.

Profile: A/Prof. Harrison has been an invited Keynote speaker at national and international conferences and co-chaired numerous workshops and symposia. In 2016, he gave the Plenary lecture at the Annual Winter Conference on Brain Research (New Zealand). He has assessed competitive grants and fellowships for major funding bodies, including the NHMRC, Welcome Trust (UK), ANR (France), ZonMw (Netherlands), and Carlos III Institute (Spain). He has served on NHMRC Project Grant Review Panels. In 2017, he was appointed to the NHMRC Assigner’s Academy for Mental Health/Psychiatry. He has also served on the Grant Review Panel of the Society for Mental Health Research (SMHR), which allocates funding to early career researchers from the ABC’s “Mental As” campaign. A/Prof Harrison has been a member of the MNC Executive Committee since 2011; and was appointed its Deputy Scientific Director in 2017. He currently also Chairs the Research Subcommittee of the Department of Psychiatry.

Supervision: A/Prof. Harrison has supervised 3 post-doctoral, 5 PhD, 2 Masters and 5 Honours students to completion and hosted several international research fellows, including 2 international Endeavour Awardees and 3 stipend-funded clinical research trainees. Of his completed PhD students: one has received an NHMRC Early Career Fellowship; one a post-doctoral fellowship at King’s College London; and one a Spanish Government Early Career Fellowship.



Social and Affective NeuroDevelopment

Stream leader: A/Prof. Sarah Whittle, PhD.

The stream brings together neuroimaging and neuroendocrinology expertise, with an aim to characterise neurodevelopmental risk and resilience factors for common mental health problems in children and adolescents, particularly mental disorders such as depression and anxiety. They are located at MNC Parkville. Primary local collaborators include: Melbourne School of Psychological Sciences – The University of Melbourne, and the Murdoch Childrens Research Institute. Their work is primarily funded by ARC discovery grants, and NHMRC project grants and fellowships. Over the past 5 years they have published 80 peer-reviewed research articles (2182 GS citations) – highlights include:

1. Whittle, S., Vijayakumar, N., Simmons, J.G., Dennison, M., Schwartz, O., Pantelis, C., Sheeber, L., Byrne, M.L., Allen, N.B. The effect of neighborhood socioeconomic disadvantage on brain development, and the moderating role of positive parenting. JAMA Psychiatry. In Press.

2. Richmond, Johnson, Seal, Allen and Whittle. (2016). Development of brain networks and relevance of environmental and genetic factors:

A systematic review. Neuroscience & Biobehavioral Reviews 71, 215-239. CITATIONS = 3.

3. Whittle et al. (2014). Structural brain development and depression onset during adolescence: a longitudinal, prospective study. The American Journal of Psychiatry 171(5): 564-571. CITATIONS = 53.

4. Whittle et al. (2013). Childhood maltreatment and psychopathology affect brain development during adolescence. Journal of the American Academy of Child and Adolescent Psychiatry I52: 940-952. CITATIONS = 53.

5. Cheetham et al. (2012). Orbitofrontal Volumes in Early Adolescence Predict Initiation of Cannabis Use: A 4-Year Longitudinal and Prospective Study. Biological Psychiatry 71(8): 684-92. CITATIONS = 91.

Stream leader profileAppointment: A/Prof. Whittle completed her PhD in 2007, and was awarded an ARC postdoctoral fellowship in 2008 to establish her research focus on neurodevelopment and mental health at Orygen, The National Centre of Excellence in Youth Mental Health. She was awarded an NHMRC CDF (Level 1) in 2012, which she took up at the MNC. She was promoted to Associate Professor in 2015 and was recently awarded an NHMRC CDF (Level 2; 2017-21). She has an honorary appointment in the Melbourne School of Psychological Sciences.

Funding: A/Prof. Whittle has been involved in attracting a total of over $6M successful grant funding. Of note, she has current CIA roles on one NHMRC project and one ARC discovery grant, and had a CIA role on a NARSAD grant from the US (2014-2015). She has had (or holds) CI roles on a further 7 NHMRC/ARC grants, and an AI role on one NHMRC grant, and has received funding from other sources including the Victorian Government, The University of Melbourne and the Murdoch Childrens Research Institute.

Publications: A/Prof. Whittle has published 95 journal articles/book chapters from 2006-2017 in general (e.g., PNAS) and specialty (e.g., American Journal of Psychiatry, JAMA Psychiatry, Trends in Cognitive Sciences) journals. Over 30 percent of A/Prof. Whittle’s publications are either in press or published in 2016/2017, illustrating an exponential increase in her research output. She has 2674 paper citations and a h-Index of 28.

Profile: A/Prof. Whittle has been invited to speak at >30 national or international conferences. She was invited (and funded) to present at the Inaugural Brain Development Methodology workshop (April, 2016, USA) as an expert in the field. A/Prof. Whittle was a member of the NHMRC Research Translation Faculty 2012-2015. She has completed numerous manuscript reviews for international peer review journals and grant reviews for the NHMRC, ARC and Heart Foundation, and was appointed to the Editorial Board of Psychological Medicine in 2017. She was the founder and is currently the Treasurer of the Australasian Society for Social and Affective Neuroscience. She was on the organising committee for the Society’s annual meetings in 2014 and 2017. She has received the Research Australia Discovery Award (2009) for research that has demonstrated importance/impact. A/Prof. Whittle has been a member of two Human Research & Ethics Committees (2009-11: Orygen Youth Health; 2009-current: Melbourne Health). She has been a member of the MNC Executive Committee since 2011, and the Department of Psychiatry Community Engagement/Knowledge Transfer committee since 2016.

Supervision: A/Prof. Whittle has supervised 16 doctoral students to completion (2 Advanced medical science students, 6 Honours, 5 PhD, 5 Masters). All 5 completed PhD students are either currently in postdoctoral research roles (2 international, 1 national) or are working clinically. She currently supervises 11 graduate students and is a mentor to three postdoctoral research fellows.


Systems NeuropsychiatryStream leader: Dr. Andrew Zalesky, PhD.

The Systems Neuropsychiatry Stream aims to understand how different parts of the human brain interact with each other to produce complex behaviour and why these astoundingly complex interactions breakdown in individuals with serious mental illness. They model the brain in both health and disease using networks of interconnected neural elements that interact in time and space across a hierarchy of scales. They develop new methodologies to perform statistical inference on brain networks and undertake research into computational models that describe the emergence and progression of network pathology over the course of disease. Their aim is to discover new ways to prevent, treat and cure mental illness. The stream brings together a diverse range of expertise from basic science, engineering and psychiatry in order to tackle these aims using innovative, interdisciplinary approaches. They are located at MNC Parkville and their work is primarily funded by NHMRC and ARC Project Grants. Over the past 5 years they have published 60+ peer-reviewed research articles (4607 GS citations) – highlights include:

1. Fornito A, Zalesky A, Bullmore E. (2016). Fundamentals of Brain

Network Analysis, Academic Press (Elsevier). 450+ page authored textbook. Resides in top-10% most read neuroscience books published by Elsevier in 2016.

2. Zalesky A et al., (2014). Time-resolved resting-state brain networks. Proc Natl Acad Sci U S A 111, 10341-10346. CITATIONS = 168.

3. Zalesky A et al., (2012). Effects of long term cannabis use on axonal fibre connectivity. Brain 135, 2245-2255. CITATIONS = 167.

4. Fornito A, Zalesky A, Breakspear M. (2015). The connectomics of brain disorders. Nature Reviews Neuroscience 16, 159-172. CITATIONS = 201.

5. Zalesky A et al., (2015). Delayed development of brain connectivity in adolescents with schizophrenia and their unaffected siblings. JAMA Psychiatry 72; 900-908. CITATIONS = 8.

Stream leader profileAppointment: Dr. Zalesky is a Senior Research Fellow at The University of Melbourne and holds a joint appointment in the Departments of Psychiatry and Electrical & Electronic Engineering. He completed his PhD in Electrical Engineering at UoM in 2007 and has been based at Melbourne Neuropsychiatry Centre since this time. He co-established Systems Neuropsychiatry in 2013 and now leads this research stream. Editorial appointments: Network Neuroscience (Assoc Editor), Brain Topography (Assoc Editor). He has served as guest editor for numerous journals, including Neuroimage and IEEE JTSP.

Funding: Dr. Zalesky has been awarded NHMRC Project Grants (×3, including CIA); ARC Discovery Projects (×2, including CIA). He has been continuously supported by ARC, NHMRC and other competitive fellowships since PhD completion, including 2014-17 NHMRC Career Development Fellowship; 2012 Inaugural Melbourne Neuroscience Institute Fellowship; 2009-11 ARC Postdoctoral Fellow; 2008 ARC Linkage International Fellowship; 2007

American-Australian Association Sir Keith Murdoch Fellowship.

Publications: Dr. Zalesky has co-authored 100+ papers in 10 years of postdoctoral research, which have cumulatively received 5000+ citations. 10 papers cited 100+ times. His 2010 “nodes paper” has become a classic in the field of connectomics, cited 500+ times in 5 years. In the last 5 years, he has published papers in PNAS (1st author), Brain (1st), JAMA Psychiatry (1st), American Journal of Psychiatry (1st), Biological Psychiatry (1st) and Nature Reviews Neuroscience (2nd).

Profile: Dr. Zalesky is internationally recognised for developing the network-based statistic, one of the most widely used methods for performing statistical inference on brain networks. His method is implemented in well-known software and its use is reported in 60+ published psychiatry papers. His contributions to neuropsychiatry include mapping of the schizophrenia connectome and development of advanced methods for analysing neuroimaging data. He coauthored ‘Fundamentals of Brain Network Analysis’, one of the best-selling Elsevier neuroscience titles published in 2016. Awards: 2016 Aubery Lewis Award for research excellence and leadership in biological psychiatry. 2014 Young Tall Poppy Award for excellence in science communication. 2011 Ziskind-Somerfeld finalist for most highly cited paper in Biological Psychiatry.

Supervision: Dr. Zalesky co-established and now leads Systems Neuropsychiatry, a multidisciplinary research team comprising 2 postdocs and 7 PhD/Masters students. In last 5 years, 7 postdocs/psychiatrists from abroad have chosen to bring their brain imaging data to Melbourne to learn how to analyse it with methods he has developed. He leads several initiatives in connectomics training, including 2017 Australian Connectome Summer School and teaching at bioinformatics schools in Malaysia (2017), Switzerland (2016) and Netherlands (2015).



Gene-Environment Neuropsychiatry

Stream leader: Dr. Chad Bousman, MPH, PhD

The stream’s objective is to advance precision psychiatry via the interrogation of gene by environment (including drug) interactions relevant to the onset, course, and treatment of schizophrenia and depression. They are located at MNC-Parkville but include members located within the Melbourne Brain Centre and Royal Melbourne Hospital. The work is primarily funded by the CRC in Mental Health, NHMRC fellowships, and philanthropic grants (e.g. LEW Carty Foundation). In the past 5 years, they have been highly productive and the stream is being recognised as emerging leaders in the field – highlights include:

1. Liu, Bousman et al. (2017). Pathway-wide association study identifies five shared pathways associated with schizophrenia in three ancestral distinct populations. Translational Psychiatry 7(2), e1037.

2. Bousman et al. (2017). Polygenic phenotypic plasticity moderates the effects of severe childhood abuse on depressive symptom severity in adulthood: A 5-year prospective cohort study. The World Journal of Biological Psychiatry, 18(1): 75-81. CITATIONS = 4.

3. Bousman and Hopwood. (2016). Commercial pharmacogenetic-based decision support tools in psychiatry. The Lancet Psychiatry, 3(6): 585-90. CTIATIONS = 9.

4. Bousman et al. (2013). Effects of NRG1 and DAOA genetic variation on transition to psychosis in individuals at ultra-high risk for psychosis. Translational Psychiatry, 3(4), e251. CITATIONS = 20.

5. Singh, Bousman, et al. (2012). ABCB1 Polymorphism Predicts Escitalopram Dose Needed for Remission in Major Depression. Translational Psychiatry, 2(11), e198. CITATIONS = 51.

Stream leader profileAppointment: Dr. Bousman received his Master in Public Health in 2003 from San Diego State University and a PhD in genetic epidemiology from the University of California-San Diego in 2009. He is currently appointed as Senior Research Fellow and NHMRC Career Development Fellow (Level 1, 2017-21). He also holds Honorary Research Fellow appointments within the Department of General Practice and Florey Institute of Neuroscience and Mental Health at The University of Melbourne.

Funding: Dr. Bousman has been a lead investigator on 8 competitively awarded international and national research applications securing over $1M (AUD). In addition, he has contributed to obtaining over $3M in funds as a co-investigator on international (eg. NIH) and national (eg. NHMRC, Abbott) research projects. Dr. Bousman is a past recipient of a NARSAD Young Investigator Award (2014-2016) and the prestigious Ronald Phillip Griffith Fellowship (2013-2016) from the FMDHS. He was a past recipient of one of only 10 inaugural McKenzie Post-Doctoral Fellowships (2010-2013) that were established to attract outstanding postdoctoral students to The University of Melbourne.

Publications: Dr. Bousman is an emerging leader in the field of psychiatric genetics and pharmacogenetics (peer-review publications=67; h-index = 17; i10-index=28; citations = 838). His psychiatric genetics work, has identified promising genetic biomarkers for transition to psychosis among individuals defined as ultra high risk for psychosis as well as genetic

pathways linked to schizophrenia. His pharmacogenetics work, has identified genetic markers associated with antidepressant response, which recently aided the development of a commercial pharmacogentic-based decision support tool for antidepressant dosing (CNSDose®). In addition, Dr. Bousman was recently made a member of the Clinical Pharmacogenetics Implementation Consortium, an international group of scientists, clinicians, and industry partners with the goal of translating pharmacogenetic tests into clinical practice.

Profile: Dr. Bousman has been invited to speak at 7 international meetings and received sponsored travel to speak at the American College of Neuropsychopharmacology and the International College of Neuropsychopharmacology meetings. He represented Australia in the 2012 Australia-China Young Researchers Exchange Program sponsored by the Australian Department of Industry, Innovation, Science, Research and Tertiary Education and the Chinese Ministry of Science and Technology. He also has received a Young Investigator Travel Award from the USA National Institute on Drug Abuse to attend the World Congress on Psychiatric Genetics. He is an Associate Editor for Frontiers in Psychiatry. Dr. Bousman is the coordinator of the Honours and RHD programs and serves on three committees (Education, Knowledge Partnerships, Research-sub) within the Department of Psychiatry.

Supervision: Dr. Bousman currently supervises 6 PhD students, 1 MD student, and oversees a research stream comprised of 6 students and/or research assistants. He has provided research mentoring to 24 undergraduate and 7 PhD students. He has successfully supervised 2 undergraduate, 1 Masters, 3 PhD, and 1 MD students. He has co-published articles or abstracts with 60% of the students that he has mentored/supervised. All students have successfully completed their degree or are currently in good standing.


Research output & impact Since its inception, MNC has published 1000+ peer-reviewed journal articles (25,200 total citations). Over half of these publications (550+) have occurred in the last 5 years – with the Centre maintaining a strong upward trajectory in its growth

of publication output. The ‘impact plot’ below illustrates the growth of research citations for Centre-affiliated peer-reviewed articles to have occurred since 2004. Currently, the Centre averages 24 citations per article, which is well

above the University average. A full list of the Centre’s research publications (2012-current) can be found in the appendix and on its website:

www.psychiatry.unimelb.edu.au/mnc

Performance Indicators

Fig. 1: Growth of citations for MNC-affiliated peer-reviewed publications to have occurred since the Centre’s inception in 2004.

Years

Cita

tions

5000

4000

3000

2000

1000

0

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

APR

IL 2

017

1000+ publications since Centre launch (2004)100+ publications per year over past 5 years25,200+ total citations, Centre h-index = 7524 average citations per paper (UoM average is 18)


FundingThe total amount of research funding that has been directly administered by the Centre (UoM) over the reporting period (2012-current) is $7.3M, with an average yearly administration of $1.37M. The vast majority of this funding represents the administration of NHMRC project grants and fellowships.

In 2016, the Centre was awarded 3 highly competitive NHMRC career development fellowships ($1.4M, 2017-21: Harrison, Whittle, Bousman), adding to the SPRF awarded to Prof. Pantelis in 2015 ($926K, 2016-20). The Centre also administers three additional NHMRC fellowships, with renewal applications currently submitted to NHMRC.

Annualised breakdown of MNC research funding

2012 2013 2014 2015 2016 (Jan-Apr) 2017

Total Income $1,272,664.74 $938,670.40 $1,103,396.11 $1,318,000.65 $1,466,693.60 $1,230,284.93


Supervision & TeachingSince 2012, the Centre has averaged 2.4 PhD completions per year with an overall timely completion rate of 86%. MNC currently provides primary supervision for 35% (n=14) of the 39 PhD students enrolled within the Department of Psychiatry, with co-supervision for many others. MNC additionally provides co-supervision to students within the Melbourne School of Engineering and the School of Psychological Sciences. In addition to PhD supervision, on average, MNC provided primary supervision to one Melbourne Medical School Scholarly Selective student and two Honors students per year. At completion of their degrees, a majority of our students have been successful in obtaining prestigious post-doctoral funding or clinical placements both nationally and internationally.

Prof. Pantelis supervises trainees in psychiatry and is involved in teaching psychiatry to medical students. He is also a Course Coordinator for the M. Med. (Psychiatry) for The University of Melbourne. This position involves supervision and the teaching of research skills to trainees in psychiatry as part of their final (dissertation) year in psychiatry. Dr Bousman is involved in teaching psychiatric genetics within the Master of Psychiatry course at The University of Melbourne. A/Prof Whittle has developed and conducted 1 to 6 guest lectures per year (from 2007 to 2016) for second and third year undergraduate subjects in the Melbourne School of Psychological Sciences, The University of Melbourne.

Knowledge transferOver the past five years, the Centre’s research has featured prominently in radio, television, print and online media (Reuters, New York Times, BBC, ABC TV News, Channel 10 “The Project”; ABC

Radio-National, ABC Radio 891 Adelaide, CSIRO, 3RRR, Triple J, SYN radio, The Age, Sydney Morning Herald, The Weekend Australian, Catalyst, The Guardian, The UOM Pursuit, The UOM Up Close, The Conversation, Australian Rotary Health Hat Day Blog, ABC News, ABC Science, Cosmos, US News & World Report, Mooney Valley Weekly, Neos Kosmos (Greek National News), SBS Greek radio, & more).

Prof. Pantelis travels frequently nationally and internationally to represent the Centre and The University. Since 2012, he has participated in almost 100 speaking engagements at major conferences, workshops and Institutes. The Centre’s other stream leaders have also participated in 100+ speaking engagements over the past 5 years, including several invited Keynote and Plenary presentations.

Prof Pantelis has provided regular lectures on the neurobiology of schizophrenia across the country, including webinars to for on-line courses in psychiatry.

The Centre has also established a profile of broader community engagement. For example, Dr. Zalesky has been a guest speaker at school science days organised by Quantum Victoria in 2015 aimed at raising mental health awareness. Dr. Bousman is a participating scientist in the Scientists in Schools Program, an Australian Government Initiative run by CSIRO. He also serves as a mentor for year 11 students enrolled in the Elizabeth Blackburn School of Sciences at the University High School in Melbourne. MNC provides week-long work experience placements for high-school students interested in neuropsychiatry and related fields.

MNC has formed close public links with the Greek community in Melbourne as well as Athens and established the first Greek-Australian travelling fellowship in Neuropsychiatry in 2016. The inaugural fellow, Stefanos Dimitrakopoulos, arrived in August 2016. As part of the fellowship launch MNC held a free Public Lecture titled ‘Psychological Impact of the Economic Crisis on the Greek Population’ given by Prof Nikos Stefanis (National & Kapodistrian University of Athens) and Ms Rika Zoula-Vayianni (26 Nov 2015).

Performance Indicators


Acknowledgements

The Centre gratefully acknowledges continued funding support from The Department of Psychiatry, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne and Melbourne Health (North Western Mental Health Programme). The Centre acknowledges competitive funding support from the Australian NHMRC and ARC, to which it has a consistent track record of funding success.

In December 2015, The Centre established the first Greek-Australian Travelling Fellowship in Neuropsychiatry – a collaborative initiative between Melbourne Health and The University of Melbourne. The Centre thanks Servier Laboratories Australia and

their European office for funding the first of these fellowships for a 6-month period. We gratefully acknowledge the support of those who contributed philanthropic funding to this fellowship via the Melbourne Health crowd-funding initiative, which can be found here:

https://doyourownthing.everydayhero.com/au/greek-australian-travelling-fellowship

Lastly, the Centre acknowledges all past members, students, visiting fellows and research participants who have contributed enormously to its research vision, productivity and culture. They are all part of the extended MNC family.

Each day brings us closer to new

discoveries about the neuroscience of mental illness


NHMRC Fellowships2017-2020 Career Development Fellowship (CDF Level 2) to Ben Harrison. Title: Depression and Anxiety Neuroscience.

$470,144.

2017-2020 Career Development Fellowship (CDF Level 2) to Sarah Whittle. Title: Neurodevelopmental risk factors for depression from childhood to early adulthood. $470,144.

2017-2020 Career Development Fellowship (CDF Level 1) to Chad Bousman. Title: Pharmacogenetics of antidepressant response and remission: toward genotype-guided prescribing in major depressive disorder. $425,048.

2016-2020 Senior Principal Research Fellowship renewed (SPRF; ID: 1105825) to Christos Pantelis. “Neurobiological ‘risk’ and ‘resilience’ biomarkers of severe mental illness”. $926,980.

2015-2018 Early Career Fellowships (Overseas): CJ Martin Biomedical ECF to Bridget Callaghan. Title: Human neural development in the absence of species-expected stimuli. $309,436

2015-2018 Early Career Fellowship to Tamsyn Van Reenen. Title: Characterising facial emotion processing networks in bipolar disorder. $309,436.

2014-2017 NHMRC Career Development Fellowship (CDF) to Andrew Zalesky. Title: Mapping the connectome in schizophrenia. $397,724.

NHMRC Project Grants 2016-2019 ID: 1103252. Resilient brain networks in patients with schizophrenia and their unaffected siblings. CIs: Andrew

Zalesky, Christos Pantelis, Dennis Velakoulis. AIs: Chad Bousman, Ian Everall. $422,936.

2015-2019: ID: 1082668. Pubertal timing, brain development and mental health in adolescence CIs: Sarah Whittle, Nick Allen, George Patton, Marc Seal, Julian Simmons, P Dudgeon $755,015.

2014-2017 ID: 1065742. Investigating neuroinflammation and its relationship with progressive brain structural loss in schizophrenia. CIs: Vanessa Cropley, Christos Pantelis, Bernhard Baune, James Olver, G Paul Amminger. $505,940.

2014-2016 ID: 1067040. Erythrocyte Membrane Fatty Acid Concentrations and Myelin Integrity in Young People at Ultra-High Risk of Psychosis. CIs: Paul Amminger, Chris Pantelis, Tom Whitford, Sarah Whittle, Alex Fornito, Daniel Hermen $390,879.

2014-2017 ID: 1064643. Neural predictors of treatment response in youth depression. CIs: Ben Harrison, Chris Davey, Murat Yucel, Sarah Whittle, Alex Fornito, Jesus Pujol. $498,820.

2014-2016 ID: 063383. Kava for the treatment of generalized anxiety disorder. CIs: Jerome Sarris, Con Stough, Andrew Scholey, Chad Bousman. $658,539.

2013-2017 ID: 10250504. CIs: Alex Fornito, Chad Bousman, Andrew Zalesky, Ben Harrison, Vanessa Cropley, Dennis Velakoulis. “Dopamine, fronto-subcortical circuits and risk for schizophrenia”. $828,633.

2013-2017 ID: 1048386. The neuroendocrinological stress response system and stress vulnerability in youth with first-presentation borderline personality disorder. CIs: Andrew Chanen, Rachael Brunner, Martina Jovev, Michael Kaess, Sarah Whittle. $873,689.

2013-2016 ID: 1048222. The Efficacy of Adjunctive S-Adenosyl Methionine (SAMe) versus a Combination Nutraceutical in Clinical Depression: A Double-Blind, Randomised, Placebo-Controlled Trial. CIs: Jerome Sarris, Issac Schweitzer, Con Stough, Chad Bousman. $774,264.

Research FundingSpanning 2012 to 2017


2011-2013 ID: 1004152. Role of Neurogenesis in Clinical Recovery from Depression during ECT: Application of a Novel in vivo Magnetic Resonance Spectroscopy Technology. CIs: Michael Valenzuela, Colleen Loo, Jesus Pujol, Peter Djuric, Dennis Velakoulis, Murat Yucel, Mike Dragunow. $505,312.

2012-2014 ID: 1025619. A brain-based measure of anxiety sensitivity. Ben Harrison, Murat Yucel, Chris Davey, Jesus Pujol, Nick Allen, Sarah Whittle, Alex Fornito. $265,000.

2012-16. ID: 1024570. First-line management of youth depression. Chris Davey, Patrick McGorry, Andrew Chanen, Sarah Hetrick, Kelly Yuen (CIs). Andrew McKinnon, Mark Phelan, Michael Berk, Nick Allen, John Koutsogiannis, Ben Harrison (AIs). $1,200,000.

2011-2014 ID: 1008921. Cognitive control and brain connectivity disturbances in schizophrenia and obsessive-compulsive disorder: CIs: Murat Yucel, Ben Harrison, Rob Hester, Jesus Pujol, Michael Bresakspear. $358,348.

2011-2013 ID: 1006077. Targeting tau phosphorylation to treat and prevent acquired epilepsy, neurodegeneration and neuropsychiatric disease following a brain injury. Terence O’Brien, Chris Hovens, Nigel Jones, Dennis Velakoulis. Total - $506,706

NHMRC Program Grants2009-2013 ID: 566529. “Emerging Mental Disorders in Young People: Using Clinical Staging for Prediction, Prevention and Early

Intervention” CIs: Patrick McGorry, Antony Jorm, Ian Hickie, Christos Pantelis, Alison Yung. Refunded in 2008 for further 5 years funding. $10,027,500.

NHMRC-European Union (EU) Collaborative Research Grants (FP7)

2014-2017 ID: 1075379. “PRONIA - Personalised Prognostic Tools for Early Psychosis Management”. Australian work-package CIs: Christos Pantelis, Patrick McGorry, Stan Skafidas, Dennis Velakoulis, Ian Everall. Total funding €6M [$7.6 M AUD]. NHMRC Co-fund: $386,686.

2012 –2015 Optimisation of treatment and management of schizophrenia in Europe (OPTiMiSE) consortium. Chris Pantelis, Marc Seal, Chad Bousman, Aswin Ratheesh, Patrick McGorry. $979,375.

NHMRC Centres for Research Excellence (CRE) 2011-2015 ID: 1001206. Centre for Translational Neuroscience: A modular platform for translating discovery into health

outcomes. Stephen Davis, Terence O’Brien, Trevor Kilpatrick, Colin Masters, Patricia Desmond, Helmut Butzkueven, Andrew Kaye, Geoffrey Donnan, Caroline Brand. A/I: Velakoulis D. $2,511,875.

Department of Industry Co-operative Research Centre (CRC) grants

2011-2018 ID: 20090064. CRC for Mental Health. To identify biomarkers and novel therapries for psychosis. $. Project Co-Leader – Psychosis. Ian Everall, Chris Pantelis. $23,000,000.

ARC Discovery Projects2016 -2018 ID: DP170101815 - Novel methods to study structural-functional connectivity in the brain. CI: Andrew Zalesky.

$410,500.00.

2013-2015 ID: DP130103551 - Do family environments influence children’s brain development during the transition to adolescence? CIs: Sarah Whittle, Marc Seal, Julian Simmons, Orli Schwartz, Marie Yap, Lisa Sheeber, Nick Allen. $623,000.

2012-2014 ID: DP120101402- Early puberty and brain development: exploring the neurobiology of adolescent mental health. CIs: N Allen; Sarah Whittle; G Patton; P Dudgeon; C Pantelis; C Olsson; S Wood. $280,000.

Other Funding2017-2019 Fullana MA, Soriano-Mas C, Harrison BJ. “Anticipation and uncertainty: Using brain imaging to predict anxiety

symptom trajectories and disorder” (PI16/00144). FIS Project Grant, Instituto de Salud Carlos III (Govt. Spain). €270,000.

2017 Society for Mental Health Research project grant. Characterising cross-diagnostic cognitive subgroups in schizophrenia and bipolar disorder. CI: Tamsyn Van Rheenen. $20,000.


Research Funding Spanning 2012 to 2017 continued...

2017-2019 FIS Project Grant, Instituto de Salud Carlos III (Govt. Spain). Anticipation and uncertainty: Using brain imaging to predict anxiety symptom trajectories and disorder. CIs: Fullana MA, Soriano-Mas C, Harrison BJ. (PI16/00144). €180.00.

2017-2018 Jack Brockhoff Foundation Medical Research Grant. Understanding cognitive variability in schizophrenia and bipolar disorder. CI: Tamsyn Van Rheenen. AIs: Christos Pantelis, Susan Rossell. $100,000

2016 The University of Melbourne, Faculty Research Fellowship to Chad Bousman. Investigating growth factors and related proteins as peripheral biomarkers of psychosis symptom severity. $130,000.

2016 Melbourne Health Research Funding Program (Royal Melbourne Hospital Home Lottery Research Grant) (ID: GIA- 030H2016), Royal Melbourne Hospital Grant in Aid - Investigating glutamate dysregulation in relation to brain structure and inflammation in schizophrenia. CIs: Pantelis C, Cropley, V., Moffatt, B., Laskaris, L., Di Biase, M., Desmond, P., Ordidge, R. $25,000

2016 The University of Melbourne Research Grant Support Scheme. Sarah Whittle. $44,542.

2015-2016 The University of Melbourne - Research Grant Support Scheme (ID: 1452755) – Neural Correlates of Childhood Schizotypal Personality Disorder Relative to Autism Spectrum Disorder and ‘Typically Developing’ Children. CIs: Pantelis C, Harding, I, Testa, R, Harrison B, Skafidas S. $41,000.

2015-2018 Deus J, Pujol J, Garcia Fontanals, Benito P, Gonzalez Ortiz S, Lopez-Sola, Harrison BJ. “Neural correlates of pain sensitization in knee osteoarthritis and its association with personality and psychopathology”. National Program for the Promotion of Scientific and Technical Research Excellence, Govt. of Spain (ID: PSI2014-53524-P). 92,700€.

2015-2020 The Pratt Foundation Project Grant, Building Early Attachment Resilience (BEAR) Program. Cis: Newman L, Burrows GD, Bousman CA (CoI), Crean C, Everall IP, Mercuri K, Sheehan P, Tonge B. $700,000.

2015 Faculty of Medicine Dentistry & Health Sciences Fellowship, to Dr Vanessa Cropley. Title: Investigation of immune dysregulation in schizophrenia. $130,000.

2015-2018 National Program for the Promotion of Scientific and Technical Research Excellence, Govt. of Spain (ID: PSI2014-53524-P). “Neural correlates of pain sensitization in knee osteoarthritis and its association with personality and psychopathology”. CIs: Deus J, Pujol J, Garcia Fontanals, Benito P, Gonzalez Ortiz S, Lopez-Sola, Harrison BJ. 92,700€

2015 Melbourne Health Research Funding Program (Royal Melbourne Hospital Home Lottery Research Grant) (ID: GIA-022-2015), Royal Melbourne Hospital Grant in Aid - Investigating immune dys-regulation in different stages of schizophrenia. CIs: Christos Pantelis, Vanessa Cropley, Gursharan Chana, Liliana Laskaris, Ian Everall. $25,000.

2015 The University of Melbourne Dyason Fellowship. Sarah Whittle. $5K.

2015 Western Health Research Grant - Pilot trial investigating the use of cannabidiol as an adjunctive treatment in patients with chronic psychotic disorder. CIs: Christos Pantelis, Mahesh Jayaram, Naveen Thomas, Michael McDonough, Nadia Solowij, Murat Yucel, Chad Bousman, B Roberg, Antonia Merritt. $10,000.

2014-2017 Australian Rotary Health Ian Scott PhD Scholarship in Mental Health to Maria di Biase. Fellowship title: Sensitivity to the environment: Risk and resilience for adolescent depression. $100,000.

2014-2016 Soriano-Mas C, Harrison BJ, Sato J, Morena L, Munuera P, Via E, Subira M, S . “Cortico-limbic connectivity in patients with emotion regulation alterations: modulating factors and development of personalised therapies based on functional neuroimaging” (ID: PI13/01958). FIS Project Grant, Instituto de Salud Carlos III (Govt. Spain). 57.475€.

2014–2017 Australian Rotary Health Ian Scott PhD Scholarship in Mental Health to Maria di Biase. Fellowship title: Sensitivity to the environment: Risk and resilience for adolescent depression. $100,000.

2014-2016 2013 NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation, to Chad Bousman. Title: Development of a gene-based classifier for the diagnosis of schizophrenia; co-investigators: Christos Pantelis, Stan Skafidas, Ian Everall. $53,680.


2014-2015 NARSAD Young Investigator Grant. Using a Novel Paradigm to Understand the Neural Mechanisms of Rejection Sensitivity in Adolescent Depression. Sarah Whittle. $59,898.

2014-2016 2013 NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation, to Vanessa Cropley. Title: Investigating the dopaminergic basis of dysregulated frontostriatal circuitry in psychosis: A PET [18F]FDOPA and resting-state functional imaging study; co-investigators: Alex Fornito, Christos Pantelis. Total: $60,000

2014-2017 University of Melbourne. International Research and Research Training Fund. Melbourne-Peking Joint Centre for Psychiatric Research and Training. Everall IP, Bousman CA (CoI), Ng C. $291,000.

2014-2015 Bio21, Melbourne, Australia. Seed Grant .Maternal anxiety and placental gene expression. Sheehan P, Judd F, Bousman CA (CoI), Pantelis C, Everall IP, Murthi P. $40,000.

2014 Murdoch Childrens Research Institute Population Health theme funding grant. Title: The role of maternal history of mental disorder in fetal brain development and infant emotional regulation. Craig Olsen, Sarah Whittle, Marc Seal. $37,204.

2013-16. Cardoner N, Fullana MA, Lopez-Sola C, Via E, Martinez I, Harrison BJ. “Extinction recall as a biomarker and predictor of treatment outcome in anxiety disorders (OCD & PD): a functional MRI study” (ID: PI12/01306). FIS Project Grant, Instituto de Salud Carlos III (Govt. Spain). 80.465,00€

2013-2014 University of Melbourne - Research Grant Support Scheme (ID: 1350815) - Investigation into Candidate Genes for Autism Spectrum Disorders. CI: Chana G, Everall I, Skafidas E, Pantelis C, Testa R, Zantomio. $48,000.

2012-14. Martinez-Santos R, Torrens M, Pujol J, Harrison BJ, Abanades S,. “Impact of early onset of chronic cannabis use on brain attention networks”. ID: 2011/050. Plan Nacional sobre Drogas (Govt. Spain). 106.785,00 €.

2012-14. Cardoner N, Harrison BJ, Fullana M, Soriano-Mas C, Pujol J. “Central autonomic network dysfunction in generalised anxiety and panic disorder”. Pfizer Neuroscience Research Grants: $125, 000

2012-2014 University of Melbourne 2012 Early Career Researcher (ECR) award (ID: 601253) to Vanessa Cropley (Mentor: Christos Pantelis). Neuroinflammation in schizophrenia relapse: a pilot PET study. $38,250

2012-2013 Melbourne Research Interdisciplinary Seed Funding Scheme – BIO21 - e Melbourne Birth Cohort; CIs: Fiona Judd, Ian Everall, David Castle, Penny Sheehan, Chad Bousman, Christos Pantelis. $40,000.

2012-2014 Australian Rotary Health Geoffrey Betts Postdoctoral Fellowship to Dr Sarah Whittle. Fellowship title: Sensitivity to the environment: Risk and resilience for adolescent depression. $225,000.

2012–2016 Abbott, Australia. Virology External Collaborations Grant). Efficacy of lithium as an adjunctive therapy to antiretroviral regimens in treating HIV associated Mild Neurocognitve Disorder. Everall IP, Bousman CA (CoI), Wright E, Brew B, Cysique L, Pantelis C, Schweitzer I, Chana G. $286,497.

2012-14. Fontenelle LF, Harrison BJ, Yucel M, Moll J. “Impulsivity in obsessive-compulsive disorder: neuroimage, neuropsychology, immunology, genetics and therapeutic response to an opioid antagonist”. Emerging Research Centres in the Rio de Janerio State (ID: 74903). $130,000.

2011-12. Faculty of Medicine, Dentistry and Health Sciences (MDHS) Research Grants Support Scheme (FRGSS) The University of Melbourne. “A novel neuroimaging phenotype for anxiety disorder research”. CI: Harrison BJ. $45,000.

2010-13. Dalrymple-Alford J, Anderson T, Watts R, Harrison BJ, Wilkinson T, Porter R. “Combating dementia by cognitive enrichment”. New Zealand Health Lottery Grants Board (ID: 280146). $113,868.

2011-2012 NARSAD Distinguished Investigator Grant from the Brain & Behavior Research Foundation in the US, to Christos Pantelis. (US; Grant ID: 18722) “Neuroimaging Biomarkers of Psychosis Onset” - PET study examining inflammatory markers (microglial activity) in the CNS of patients developing acute psychosis. $100,000.

2011-2012 Inaugural Melbourne Neuroscience Institute Fellow, University of Melbourne, to Andrew Zalesky. Title: Neurobiological markers for machine-guided diagnosis in psychiatry. $50,000.

2010-2014 AVEC (international grant) - Efficacy of Lithium as an adjunctive therapy to antiretroviral regimens in treating HIV associated Mild Neurocognitive Disorder (MND); CIs: Everall, I., Bousman, C., Chana, G., Wright, E., Brew, B., Cysique, L., Pantelis, C., Letendre, S., Atkinson, H., Cherner, M. & Grant, I. $78,365.


Research Publications Jan 2012-April 2017

20121. Abbs, B., Achalia, R.M., Adelufosi, A.O., Aktener, A.Y., Beveridge, N.J., Bhakta, S.G., Blackman, R.K., Bora, E., Byun, M.S., Cabanis, M.,

Carrion, R., Castellani, C.A., Chow, T.J., Dmitrzak-Weglarz, M., Gayer-Anderson, C., Gomes, F.V., Haut, K., Hori, H., Kantrowitz, J.T., Kishimoto, T., Lee, F.H., Lin, A., Palaniyappan, L., Quan, M., Rubio, M.D., Ruiz de Azua, S., Sahoo, S., Strauss, G.P., Szczepankiewicz, A., Thompson, A.D., Trotta, A., Tully, L.M., Uchida, H., Velthorst, E., Young, J.W., O’Shea, A., Delisi, L.E., 2012. The 3rd Schizophrenia International Research Society Conference, 14-18 April 2012, Florence, Italy: summaries of oral sessions. Schizophr Res 141, e1-e24.

2. Abel, L.A., Bowman, E.A., Velakoulis, D., Fahey, M.C., Desmond, P., Macfarlane, M.D., Looi, J.C., Adamson, C.L., Walterfang, M., 2012. Saccadic eye movement characteristics in adult Niemann-Pick Type C disease: relationships with disease severity and brain structural measures. PLoS One 7, e50947.

3. Adams, S.J., Velakoulis, D., Kaye, A.H., Corcoran, N.M., O’Brien, T.J., 2012. Psychiatric history does not predict seizure outcome following temporal lobectomy for mesial temporal sclerosis. Epilepsia 53, 1700-1704.

4. Bartholomeusz, C.F., Allott, K., 2012. Neurocognitive and social cognitive approaches for improving functional outcome in early psychosis: theoretical considerations and current state of evidence. Schizophr Res Treatment 2012, 815315.

5. Bechdolf, A., Wood, S.J., Nelson, B., Velakoulis, D., Yucel, M., Takahashi, T., Yung, A.R., Berk, M., Wong, M.T., Pantelis, C., McGorry, P.D., 2012. Amygdala and insula volumes prior to illness onset in bipolar disorder: a magnetic resonance imaging study. Psychiatry Res 201, 34-39.

6. Berger, G.E., Wood, S.J., Ross, M., Hamer, C.A., Wellard, R.M., Pell, G., Phillips, L., Nelson, B., Amminger, G.P., Yung, A.R., Jackson, G., Velakoulis, D., Pantelis, C., Manji, H., McGorry, P.D., 2012. Neuroprotective effects of low-dose lithium in individuals at ultra-high risk for psychosis. A longitudinal MRI/MRS study. Curr Pharm Des 18, 570-575.

7. Bora, E., Fornito, A., Pantelis, C., Yucel, M., 2012. Gray matter abnormalities in Major Depressive Disorder: a meta-analysis of voxel based morphometry studies. J Affect Disord 138, 9-18.

8. Bora, E., Fornito, A., Yucel, M., Pantelis, C., 2012. The effects of gender on grey matter abnormalities in major psychoses: a comparative voxelwise meta-analysis of schizophrenia and bipolar disorder. Psychol Med 42, 295-307.

9. Bora, E., Harrison, B.J., Davey, C.G., Yucel, M., Pantelis, C., 2012. Meta-analysis of volumetric abnormalities in cortico-striatal-pallidal-thalamic circuits in major depressive disorder. Psychol Med 42, 671-681.

10. Bora, E., Pantelis, C., 2012. Neurobiology of Bipolar II Disorder In: Parker, G. (Ed.), Bipolar II Disorder. Modelling, Measuring and Managing. Cambridge University Press, Cambridge, UK, pp. 89-99.

11. Bora, E., Yucel, M., Fornito, A., Pantelis, C., Harrison, B.J., Cocchi, L., Pell, G., Lubman, D.I., 2012. White matter microstructure in opiate addiction. Addict Biol 17, 141-148.

12. Bousman, C.A., Rivard, C., Haese, J.D., Ambrosone, C., Hyland, A., 2012. Alpha-5 and -3 nicotinic receptor gene variants predict nicotine dependence but not cessation: findings from the COMMIT cohort. Am J Med Genet B Neuropsychiatr Genet 159b, 227-235.

13. Bousman, C.A., Szoeke, C., Chen, K., Dennerstein, L., Henderson, V.W., Everall, I.P., 2012. Oestrogen alpha-receptor variant and two-year memory decline in midlife Australian women. Neuropsychobiology 66, 259-265.

14. Brewer, W.J., Lin, A., Moberg, P.J., Smutzer, G., Nelson, B., Yung, A.R., Pantelis, C., McGorry, P.D., Turetsky, B.I., Wood, S.J., 2012. Phenylthiocarbamide (PTC) perception in ultra-high risk for psychosis participants who develop schizophrenia: testing the evidence for an endophenotypic marker. Psychiatry Res 199, 8-11.

15. Cheetham, A., Allen, N.B., Whittle, S., Simmons, J.G., Yucel, M., Lubman, D.I., 2012. Orbitofrontal volumes in early adolescence predict initiation of cannabis use: a 4-year longitudinal and prospective study. Biol Psychiatry 71, 684-692.


16. Chesher, N.J., Bousman, C.A., Gale, M., Norman, S.B., Twamley, E.W., Heaton, R.K., Everall, I.P., Judd, P.A., 2012. Chronic illness histories of adults entering treatment for co-occurring substance abuse and other mental health disorders. Am J Addict 21, 1-4.

17. Cocchi, L., Bramati, I.E., Zalesky, A., Furukawa, E., Fontenelle, L.F., Moll, J., Tripp, G., Mattos, P., 2012. Altered functional brain connectivity in a non-clinical sample of young adults with attention-deficit/hyperactivity disorder. J Neurosci 32, 17753-17761.

18. Cocchi, L., Harrison, B.J., Pujol, J., Harding, I.H., Fornito, A., Pantelis, C., Yucel, M., 2012. Functional alterations of large-scale brain networks related to cognitive control in obsessive-compulsive disorder. Hum Brain Mapp 33, 1089-1106.

19. Cocchi, L., Zalesky, A., Fontenelle, L.F., 2012. How can connectomics advance our knowledge of psychiatric disorders? Rev Bras Psiquiatr 34, 131-132.

20. Cropley, V., Croft, R., Silber, B., Neale, C., Scholey, A., Stough, C., Schmitt, J., 2012. Does coffee enriched with chlorogenic acids improve mood and cognition after acute administration in healthy elderly? A pilot study. Psychopharmacology (Berl) 219, 737-749.

21. Davey, C.G., Harrison, B.J., Yucel, M., Allen, N.B., 2012. Regionally specific alterations in functional connectivity of the anterior cingulate cortex in major depressive disorder. Psychol Med 42, 2071-2081.

22. Davey, C.G., Yucel, M., Allen, N.B., Harrison, B.J., 2012. Task-related deactivation and functional connectivity of the subgenual cingulate cortex in major depressive disorder. Front Psychiatry 3, 14.

23. Dazzan, P., Soulsby, B., Mechelli, A., Wood, S.J., Velakoulis, D., Phillips, L.J., Yung, A.R., Chitnis, X., Lin, A., Murray, R.M., McGorry, P.D., McGuire, P.K., Pantelis, C., 2012. Volumetric abnormalities predating the onset of schizophrenia and affective psychoses: an MRI study in subjects at ultrahigh risk of psychosis. Schizophr Bull 38, 1083-1091.

24. Feiler, G., Chen, R.C., Pantelis, C., Lambert, T., 2012. Health behaviours of community-treated patients with psychosis. Australas Psychiatry 20, 208-213.

25. Fontenelle, L.F., Cocchi, L., Harrison, B.J., Shavitt, R.G., do Rosario, M.C., Ferrao, Y.A., de Mathis, M.A., Cordioli, A.V., Yucel, M., Pantelis, C., Mari Jde, J., Miguel, E.C., Torres, A.R., 2012. Towards a post-traumatic subtype of obsessive-compulsive disorder. J Anxiety Disord 26, 377-383.

26. Fontenelle, L.F., Harrison, B.J., Pujol, J., Davey, C.G., Fornito, A., Bora, E., Pantelis, C., Yucel, M., 2012. Brain functional connectivity during induced sadness in patients with obsessive-compulsive disorder. J Psychiatry Neurosci 37, 231-240.

27. Fontenelle, L.F., Lin, A., Pantelis, C., Wood, S.J., Nelson, B., Yung, A.R., 2012. Markers of vulnerability to obsessive-compulsive disorder in an ultra-high risk sample of patients who developed psychosis. Early Interv Psychiatry 6, 201-206.

28. Fornito, A., Bullmore, E.T., 2012. Connectomic intermediate phenotypes for psychiatric disorders. Front Psychiatry 3, 32.

29. Fornito, A., Harrison, B.J., 2012. Brain connectivity and mental illness. Front Psychiatry 3, 72.

30. Fornito, A., Harrison, B.J., Zalesky, A., Simons, J.S., 2012. Competitive and cooperative dynamics of large-scale brain functional networks supporting recollection. Proc Natl Acad Sci U S A 109, 12788-12793.

31. Fornito, A., Zalesky, A., Pantelis, C., Bullmore, E.T., 2012. Schizophrenia, neuroimaging and connectomics. Neuroimage 62, 2296-2314.

32. Hakami, T., Todaro, M., Petrovski, S., Macgregor, L., Velakoulis, D., Tan, M., Matkovic, Z., Gorelik, A., Liew, D., Yerra, R., O’Brien, T.J., 2012. Substitution Monotherapy With Levetiracetam vs Older Antiepileptic Drugs: A Randomized Comparative Trial. Arch Neurol 69, 1563-1571.

33. Harding, I.H., Solowij, N., Harrison, B.J., Takagi, M., Lorenzetti, V., Lubman, D.I., Seal, M.L., Pantelis, C., Yucel, M., 2012. Functional connectivity in brain networks underlying cognitive control in chronic cannabis users. Neuropsychopharmacology 37, 1923-1933.

34. Harrison, B.J., Pujol, J., Soriano-Mas, C., Hernandez-Ribas, R., Lopez-Sola, M., Ortiz, H., Alonso, P., Deus, J., Menchon, J.M., Real, E., Segalas, C., Contreras-Rodriguez, O., Blanco-Hinojo, L., Cardoner, N., 2012. Neural correlates of moral sensitivity in obsessive-compulsive disorder. Arch Gen Psychiatry 69, 741-749.

35. Jones, N.C., Nguyen, T., Corcoran, N.M., Velakoulis, D., Chen, T., Grundy, R., O’Brien, T.J., Hovens, C.M., 2012. Targeting hyperphosphorylated tau with sodium selenate suppresses seizures in rodent models. Neurobiol Dis 45, 897-901.

36. Kashyap, H., Fontenelle, L.F., Miguel, E.C., Ferrao, Y.A., Torres, A.R., Shavitt, R.G., Ferreira-Garcia, R., do Rosario, M.C., Yucel, M., 2012. ‘Impulsive compulsivity’ in obsessive-compulsive disorder: a phenotypic marker of patients with poor clinical outcome. J Psychiatr Res 46, 1146-1152.

37. Kuppens, P., Sheeber, L.B., Yap, M.B., Whittle, S., Simmons, J.G., Allen, N.B., 2012. Emotional inertia prospectively predicts the onset of depressive disorder in adolescence. Emotion 12, 283-289.


Research Publications Jan 2012-April 2017 continued...

38. Lavoie, S., Schafer, M.R., Whitford, T.J., Benninger, F., Feucht, M., Klier, C.M., Yuen, H.P., Pantelis, C., McGorry, P.D., Amminger, G.P., 2012. Frontal delta power associated with negative symptoms in ultra-high risk individuals who transitioned to psychosis. Schizophr Res 138, 206-211.

39. Liao, Y., Tang, J., Fornito, A., Liu, T., Chen, X., Chen, H., Xiang, X., Wang, X., Hao, W., 2012. Alterations in regional homogeneity of resting-state brain activity in ketamine addicts. Neurosci Lett 522, 36-40.

40. Lindberg, O., Walterfang, M., Looi, J.C., Malykhin, N., Ostberg, P., Zandbelt, B., Styner, M., Paniagua, B., Velakoulis, D., Orndahl, E., Wahlund, L.O., 2012. Hippocampal shape analysis in Alzheimer’s disease and frontotemporal lobar degeneration subtypes. J Alzheimers Dis 30, 355-365.

41. Looi, J.C., Rajagopalan, P., Walterfang, M., Madsen, S.K., Thompson, P.M., Macfarlane, M.D., Ching, C., Chua, P., Velakoulis, D., 2012. Differential putaminal morphology in Huntington’s disease, frontotemporal dementia and Alzheimer’s disease. Aust N Z J Psychiatry 46, 1145-1158.

42. Looi, J.C., Walterfang, M., Velakoulis, D., Macfarlane, M.D., Svensson, L.A., Wahlund, L.O., 2012. Frontotemporal dementia as a frontostriatal disorder: neostriatal morphology as a biomarker and structural basis for an endophenotype. Aust N Z J Psychiatry 46, 422-434.

43. Mathes, B., Schmiedt, J., Schmiedt-Fehr, C., Pantelis, C., Basar-Eroglu, C., 2012. New rather than old? For working memory tasks with abstract patterns the P3 and the single-trial delta response are larger for modified than identical probe stimuli. Psychophysiology 49, 920-932.

44. Meunier, D., Ersche, K.D., Craig, K.J., Fornito, A., Merlo-Pich, E., Fineberg, N.A., Shabbir, S.S., Robbins, T.W., Bullmore, E.T., 2012. Brain functional connectivity in stimulant drug dependence and obsessive-compulsive disorder. Neuroimage 59, 1461-1468.

45. O’Connor, D.A., Rossiter, S., Yucel, M., Lubman, D.I., Hester, R., 2012. Successful inhibitory control over an immediate reward is associated with attentional disengagement in visual processing areas. Neuroimage 62, 1841-1847.

46. Ong, D., Walterfang, M., Malhi, G.S., Styner, M., Velakoulis, D., Pantelis, C., 2012. Size and shape of the caudate nucleus in individuals with bipolar affective disorder. Aust N Z J Psychiatry 46, 340-351.

47. Passamonti, L., Fairchild, G., Fornito, A., Goodyer, I.M., Nimmo-Smith, I., Hagan, C.C., Calder, A.J., 2012. Abnormal anatomical connectivity between the amygdala and orbitofrontal cortex in conduct disorder. PLoS One 7, e48789.

48. Patterson, M.C., Hendriksz, C.J., Walterfang, M., Sedel, F., Vanier, M.T., Wijburg, F., 2012. Recommendations for the diagnosis and management of Niemann-Pick disease type C: an update. Mol Genet Metab 106, 330-344.

49. Paul, D., Henskens, F.A., Loughland, C.A., Bridge, J., McCabe, K., Carr, V.J., Catts, S.V., Jablensky, A., Michie, P.T., Mowry, B.J., Pantelis, C., Schall, U., Scott, R.J., 2012. IT Development and Management of a Live e- ‐Research System: Experiences with the Australian Schizophrenia Research Bank. Healthinf-12: Proceedings of the International Conference on Health Informatics. INSTICC, Portugal, pp. 125-130.

50. Pujol, J., Batalla, I., Contreras-Rodriguez, O., Harrison, B.J., Pera, V., Hernandez-Ribas, R., Real, E., Bosa, L., Soriano-Mas, C., Deus, J., Lopez-Sola, M., Pifarre, J., Menchon, J.M., Cardoner, N., 2012. Breakdown in the brain network subserving moral judgment in criminal psychopathy. Soc Cogn Affect Neurosci 7, 917-923.

51. Sarris, J., Scholey, A., Schweitzer, I., Bousman, C., Laporte, E., Ng, C., Murray, G., Stough, C., 2012. The acute effects of kava and oxazepam on anxiety, mood, neurocognition; and genetic correlates: a randomized, placebo-controlled, double-blind study. Hum Psychopharmacol 27, 262-269.

52. Scarr, E., Sundram, S., Deljo, A., Cowie, T.F., Gibbons, A.S., Juzva, S., Mackinnon, A., Wood, S.J., Testa, R., Pantelis, C., Dean, B., 2012. Muscarinic M1 receptor sequence: preliminary studies on its effects on cognition and expression. Schizophr Res 138, 94-98.

53. Schwartz, O.S., Dudgeon, P., Sheeber, L.B., Yap, M.B., Simmons, J.G., Allen, N.B., 2012. Parental behaviors during family interactions predict changes in depression and anxiety symptoms during adolescence. J Abnorm Child Psychol 40, 59-71.

54. Singh, A.B., Bousman, C.A., Ng, C.H., Byron, K., Berk, M., 2012. ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression. Transl Psychiatry 2, e198.


55. Solowij, N., Jones, K.A., Rozman, M.E., Davis, S.M., Ciarrochi, J., Heaven, P.C., Pesa, N., Lubman, D.I., Yucel, M., 2012. Reflection impulsivity in adolescent cannabis users: a comparison with alcohol-using and non-substance-using adolescents. Psychopharmacology (Berl) 219, 575-586.

56. Stough, C.K., Pase, M.P., Cropley, V., Myers, S., Nolidin, K., King, R., Camfield, D., Wesnes, K., Pipingas, A., Croft, K., Chang, D., Scholey, A.B., 2012. A randomized controlled trial investigating the effect of Pycnogenol and Bacopa CDRI08 herbal medicines on cognitive, cardiovascular, and biochemical functioning in cognitively healthy elderly people: the Australian Research Council Longevity Intervention (ARCLI) study protocol (ANZCTR12611000487910). Nutr J 11, 11.

57. Turetsky, B.I., Kamath, V., Calkins, M.E., Brewer, W.J., Wood, S.J., Pantelis, C., Seidman, L.J., Malaspina, D., Good, K.P., Kopala, L.C., Moberg, P.J., 2012. Olfaction and schizophrenia clinical risk status: just the facts. Schizophr Res 139, 260-261; author reply 262-263.

58. Verdejo-Garcia, A., Lubman, D.I., Schwerk, A., Roffel, K., Vilar-Lopez, R., Mackenzie, T., Yucel, M., 2012. Effect of craving induction on inhibitory control in opiate dependence. Psychopharmacology (Berl) 219, 519-526.

59. Walterfang, M., Chien, Y.H., Imrie, J., Rushton, D., Schubiger, D., Patterson, M.C., 2012. Dysphagia as a risk factor for mortality in Niemann-Pick disease type C: systematic literature review and evidence from studies with miglustat. Orphanet J Rare Dis 7, 76.

60. Walterfang, M., Goh, A., Mocellin, R., Evans, A., Velakoulis, D., 2012. Peduncular hallucinosis secondary to central pontine myelinolysis. Psychiatry Clin Neurosci 66, 618-621.

61. Walterfang, M., Macfarlane, M.D., Looi, J.C., Abel, L., Bowman, E., Fahey, M.C., Desmond, P., Velakoulis, D., 2012. Pontine-to-midbrain ratio indexes ocular-motor function and illness stage in adult Niemann-Pick disease type C. Eur J Neurol 19, 462-467.

62. Whitford, T.J., Wood, S.J., Yung, A., Cocchi, L., Berger, G., Shenton, M.E., Kubicki, M., Phillips, L., Velakoulis, D., Yolken, R.H., Pantelis, C., McGorry, P., Amminger, G.P., 2012. Structural abnormalities in the cuneus associated with Herpes Simplex Virus (type 1) infection in people at ultra high risk of developing psychosis. Schizophr Res 135, 175-180.

63. Whittle, S., Yucel, M., Forbes, E.E., Davey, C.G., Harding, I.H., Sheeber, L., Yap, M.B., Allen, N.B., 2012. Adolescents’ depressive symptoms moderate neural responses to their mothers’ positive behavior. Soc Cogn Affect Neurosci 7, 23-34.

64. Whittle, S., Yucel, M., Lorenzetti, V., Byrne, M.L., Simmons, J.G., Wood, S.J., Pantelis, C., Allen, N.B., 2012. Pituitary volume mediates the relationship between pubertal timing and depressive symptoms during adolescence. Psychoneuroendocrinology 37, 881-891.

65. Wijburg, F.A., Sedel, F., Pineda, M., Hendriksz, C.J., Fahey, M., Walterfang, M., Patterson, M.C., Wraith, J.E., Kolb, S.A., 2012. Development of a suspicion index to aid diagnosis of Niemann-Pick disease type C. Neurology 78, 1560-1567.

66. Yucel, M., Bora, E., Lubman, D.I., Solowij, N., Brewer, W.J., Cotton, S.M., Conus, P., Takagi, M.J., Fornito, A., Wood, S.J., McGorry, P.D., Pantelis, C., 2012. The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample. Schizophr Bull 38, 316-330.

67. Yucel, M., Fontenelle, L.F., 2012. Compulsivity as an endophenotype: the search for a hazy moving target. Addiction 107, 1735-1736.

68. Yucel, M., Fornito, A., Youssef, G., Dwyer, D., Whittle, S., Wood, S.J., Lubman, D.I., Simmons, J., Pantelis, C., Allen, N.B., 2012. Inhibitory control in young adolescents: the role of sex, intelligence, and temperament. Neuropsychology 26, 347-356.

69. Zalesky, A., Cocchi, L., Fornito, A., Murray, M.M., Bullmore, E., 2012. Connectivity differences in brain networks. Neuroimage 60, 1055-1062.

70. Zalesky, A., Fornito, A., Bullmore, E., 2012. On the use of correlation as a measure of network connectivity. Neuroimage 60, 2096-2106.

71. Zalesky, A., Fornito, A., Egan, G.F., Pantelis, C., Bullmore, E.T., 2012. The relationship between regional and inter-regional functional connectivity deficits in schizophrenia. Hum Brain Mapp 33, 2535-2549.

72. Zalesky, A., Solowij, N., Yucel, M., Lubman, D.I., Takagi, M., Harding, I.H., Lorenzetti, V., Wang, R., Searle, K., Pantelis, C., Seal, M., 2012. Effect of long-term cannabis use on axonal fibre connectivity. Brain 135, 2245-2255.

201373. Allott, K., Proffitt, T.M., McGorry, P.D., Pantelis, C., Wood, S.J., Cumner, M., Brewer, W.J., 2013. Clinical neuropsychology within

adolescent and young-adult psychiatry: conceptualizing theory and practice. Appl Neuropsychol Child 2, 47-63.

74. Alonso, P., Lopez-Sola, C., Gratacos, M., Fullana, M.A., Segalas, C., Real, E., Cardoner, N., Soriano-Mas, C., Harrison, B.J., Estivill, X., Menchon, J.M., 2013. The interaction between Comt and Bdnf variants influences obsessive-compulsive-related dysfunctional beliefs. J Anxiety Disord 27, 321-327.

75. Alonso, P., Orbegozo, A., Pujol, J., Lopez-Sola, C., Fullana, M.A., Segalas, C., Real, E., Subira, M., Martinez-Zalacain, I., Menchon, J.M., Harrison, B.J., Cardoner, N., Soriano-Mas, C., 2013. Neural correlates of obsessive-compulsive related dysfunctional beliefs. Prog Neuropsychopharmacol Biol Psychiatry 47, 25-32.



76. Andrewes, H.E., Drummond, K.J., Rosenthal, M., Bucknill, A., Andrewes, D.G., 2013. Awareness of psychological and relationship problems amongst brain tumour patients and its association with carer distress. Psychooncology 22, 2200-2205.

77. Baker, S.T., Yucel, M., Fornito, A., Allen, N.B., Lubman, D.I., 2013. A systematic review of diffusion weighted MRI studies of white matter microstructure in adolescent substance users. Neurosci Biobehav Rev 37, 1713-1723.

78. Bartholomeusz, C.F., Allott, K., Killackey, E., Liu, P., Wood, S.J., Thompson, A., 2013. Social cognition training as an intervention for improving functional outcome in first-episode psychosis: a feasibility study. Early Interv Psychiatry 7, 421-426.

79. Bartholomeusz, C.F., Whittle, S.L., Montague, A., Ansell, B., McGorry, P.D., Velakoulis, D., Pantelis, C., Wood, S.J., 2013. Sulcogyral patterns and morphological abnormalities of the orbitofrontal cortex in psychosis. Prog Neuropsychopharmacol Biol Psychiatry 44, 168-177.

80. Batalla, A., Bhattacharyya, S., Yucel, M., Fusar-Poli, P., Crippa, J.A., Nogue, S., Torrens, M., Pujol, J., Farre, M., Martin-Santos, R., 2013. Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings. PLoS One 8, e55821.

81. Batalla, A., Garcia-Rizo, C., Castellvi, P., Fernandez-Egea, E., Yucel, M., Parellada, E., Kirkpatrick, B., Martin-Santos, R., Bernardo, M., 2013. Screening for substance use disorders in first-episode psychosis: implications for readmission. Schizophr Res 146, 125-131.

82. Bora, E., Harrison, B.J., Yucel, M., Pantelis, C., 2013. Cognitive impairment in euthymic major depressive disorder: a meta-analysis. Psychol Med 43, 2017-2026.

83. Bora, E., Pantelis, C., 2013. Theory of mind impairments in first-episode psychosis, individuals at ultra-high risk for psychosis and in first-degree relatives of schizophrenia: systematic review and meta-analysis. Schizophr Res 144, 31-36.

84. Bourne, C., Aydemir, O., Balanza-Martinez, V., Bora, E., Brissos, S., Cavanagh, J.T., Clark, L., Cubukcuoglu, Z., Dias, V.V., Dittmann, S., Ferrier, I.N., Fleck, D.E., Frangou, S., Gallagher, P., Jones, L., Kieseppa, T., Martinez-Aran, A., Melle, I., Moore, P.B., Mur, M., Pfennig, A., Raust, A., Senturk, V., Simonsen, C., Smith, D.J., Bio, D.S., Soeiro-de-Souza, M.G., Stoddart, S.D., Sundet, K., Szoke, A., Thompson, J.M., Torrent, C., Zalla, T., Craddock, N., Andreassen, O.A., Leboyer, M., Vieta, E., Bauer, M., Worhunsky, P.D., Tzagarakis, C., Rogers, R.D., Geddes, J.R., Goodwin, G.M., 2013. Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis. Acta Psychiatr Scand 128, 149-162.

85. Bousman, C.A., Glatt, S.J., Chandler, S.D., Lohr, J., Kremen, W.S., Tsuang, M.T., Everall, I.P., 2013. Negative Symptoms of Psychosis Correlate with Gene Expression of the Wnt/beta-Catenin Signaling Pathway in Peripheral Blood. Psychiatry J 2013, 852930.

86. Bousman, C.A., Yung, A.R., Pantelis, C., Ellis, J.A., Chavez, R.A., Nelson, B., Lin, A., Wood, S.J., Amminger, G.P., Velakoulis, D., McGorry, P.D., Everall, I.P., Foley, D.L., 2013. Effects of NRG1 and DAOA genetic variation on transition to psychosis in individuals at ultra-high risk for psychosis. Transl Psychiatry 3, e251.

87. Breckel, T.P., Thiel, C.M., Bullmore, E.T., Zalesky, A., Patel, A.X., Giessing, C., 2013. Long-term effects of attentional performance on functional brain network topology. PLoS One 8, e74125.

88. Chana, G., Bousman, C.A., Money, T.T., Gibbons, A., Gillett, P., Dean, B., Everall, I.P., 2013. Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis. Front Cell Neurosci 7, 95.

89. Cocchi, L., Zalesky, A., Fornito, A., Mattingley, J.B., 2013. Dynamic cooperation and competition between brain systems during cognitive control. Trends Cogn Sci 17, 493-501.

90. Cropley, V., Wood, S.J., Pantelis, C., 2013. Brain structural, neurochemical and neuroinflammatory markers of psychosis onset and relapse: Is there evidence for a psychosis relapse signature? Int Clin Psychopharmacol.

91. Dennison, M., Whittle, S., Yucel, M., Vijayakumar, N., Kline, A., Simmons, J., Allen, N.B., 2013. Mapping subcortical brain maturation during adolescence: evidence of hemisphere- and sex-specific longitudinal changes. Dev Sci 16, 772-791.

92. Ferreira, G.M., Harrison, B.J., Fontenelle, L.F., 2013. Hatred of sounds: misophonic disorder or just an underreported psychiatric symptom? Ann Clin Psychiatry 25, 271-274.


93. Filippi, M., van den Heuvel, M.P., Fornito, A., He, Y., Hulshoff Pol, H.E., Agosta, F., Comi, G., Rocca, M.A., 2013. Assessment of system dysfunction in the brain through MRI-based connectomics. Lancet Neurol 12, 1189-1199.

94. Fontenelle, J.M., Harrison, B.J., Santana, L., Conceicao do Rosario, M., Versiani, M., Fontenelle, L.F., 2013. Correlates of insight into different symptom dimensions in obsessive-compulsive disorder. Ann Clin Psychiatry 25, 11-16.

95. Fornito, A., Harrison, B.J., Goodby, E., Dean, A., Ooi, C., Nathan, P.J., Lennox, B.R., Jones, P.B., Suckling, J., Bullmore, E.T., 2013. Functional dysconnectivity of corticostriatal circuitry as a risk phenotype for psychosis. JAMA Psychiatry 70, 1143-1151.

96. Fornito, A., Zalesky, A., Breakspear, M., 2013. Graph analysis of the human connectome: promise, progress, and pitfalls. Neuroimage 80, 426-444.

97. Gate, M.A., Watkins, E.R., Simmons, J.G., Byrne, M.L., Schwartz, O.S., Whittle, S., Sheeber, L.B., Allen, N.B., 2013. Maternal parenting behaviors and adolescent depression: the mediating role of rumination. J Clin Child Adolesc Psychol 42, 348-357.

98. Harrison, B.J., Pujol, J., Cardoner, N., Deus, J., Alonso, P., Lopez-Sola, M., Contreras-Rodriguez, O., Real, E., Segalas, C., Blanco-Hinojo, L., Menchon, J.M., Soriano-Mas, C., 2013. Brain corticostriatal systems and the major clinical symptom dimensions of obsessive-compulsive disorder. Biol Psychiatry 73, 321-328.

99. Hassan, I., Shing, C., Bajraszewski, C.E., Gleason, A., Hayhow, B.D., Velakoulis, D., 2013. Osmotic demyelination syndrome: An under-recognised cause of delirium? Aust N Z J Psychiatry 47, 287-288.

100. Hayhow, B.D., Hassan, I., Looi, J.C., Gaillard, F., Velakoulis, D., Walterfang, M., 2013. The neuropsychiatry of hyperkinetic movement disorders: insights from neuroimaging into the neural circuit bases of dysfunction. Tremor Other Hyperkinet Mov (N Y) 3.

101. Hickie, I.B., Scott, E.M., Hermens, D.F., Naismith, S.L., Guastella, A.J., Kaur, M., Sidis, A., Whitwell, B., Glozier, N., Davenport, T., Pantelis, C., Wood, S.J., McGorry, P.D., 2013. Applying clinical staging to young people who present for mental health care. Early Interv Psychiatry 7, 31-43.

102. Hong, S.B., Kim, J.W., Choi, E.J., Kim, H.H., Suh, J.E., Kim, C.D., Klauser, P., Whittle, S., Yucel, M., Pantelis, C., Yi, S.H., 2013. Reduced orbitofrontal cortical thickness in male adolescents with internet addiction. Behav Brain Funct 9, 11.

103. Hong, S.B., Zalesky, A., Cocchi, L., Fornito, A., Choi, E.J., Kim, H.H., Suh, J.E., Kim, C.D., Kim, J.W., Yi, S.H., 2013. Decreased functional brain connectivity in adolescents with internet addiction. PLoS One 8, e57831.

104. Jovev, M., McKenzie, T., Whittle, S., Simmons, J.G., Allen, N.B., Chanen, A.M., 2013. Temperament and Maltreatment in the Emergence of Borderline and Antisocial Personality Pathology during Early Adolescence. J Can Acad Child Adolesc Psychiatry 22, 220-229.

105. Kaess, M., Simmons, J.G., Whittle, S., Jovev, M., Chanen, A.M., Yucel, M., Pantelis, C., Allen, N.B., 2013. Sex-specific prediction of hypothalamic-pituitary-adrenal axis activity by pituitary volume during adolescence: a longitudinal study from 12 to 17 years of age. Psychoneuroendocrinology 38, 2694-2704.

106. Lim, C.S., Baldessarini, R.J., Vieta, E., Yucel, M., Bora, E., Sim, K., 2013. Longitudinal neuroimaging and neuropsychological changes in bipolar disorder patients: review of the evidence. Neurosci Biobehav Rev 37, 418-435.

107. Lin, A., Yung, A.R., Nelson, B., Brewer, W.J., Riley, R., Simmons, M., Pantelis, C., Wood, S.J., 2013. Neurocognitive predictors of transition to psychosis: medium- to long-term findings from a sample at ultra-high risk for psychosis. Psychol Med 43, 2349-2360.

108. Looi, J.C., Walterfang, M., 2013. Striatal morphology as a biomarker in neurodegenerative disease. Mol Psychiatry 18, 417-424.

109. Macfarlane, M.D., Looi, J.C., Walterfang, M., Spulber, G., Velakoulis, D., Crisby, M., Orndahl, E., Erkinjuntti, T., Garde, E., Waldemar, G., Wallin, A., Wahlund, L.O., 2013. Executive dysfunction correlates with caudate nucleus atrophy in patients with white matter changes on MRI: a subset of LADIS. Psychiatry Res 214, 16-23.

110. Masaoka, Y., Pantelis, C., Phillips, A., Kawamura, M., Mimura, M., Minegishi, G., Homma, I., 2013. Markers of brain illness may be hidden in your olfactory ability: a Japanese perspective. Neurosci Lett 549, 182-185.

111. Melca, I.A., Rodrigues, C.L., Serra-Pinheiro, M.A., Pantelis, C., Velakoulis, D., Mendlowicz, M.V., Fontenelle, L.F., 2013. Delusional misidentification syndromes in obsessive-compulsive disorder. Psychiatr Q 84, 175-181.

112. Mengel, E., Klunemann, H.H., Lourenco, C.M., Hendriksz, C.J., Sedel, F., Walterfang, M., Kolb, S.A., 2013. Niemann-Pick disease type C symptomatology: an expert-based clinical description. Orphanet J Rare Dis 8, 166.

113. Mundy, L.K., Simmons, J.G., Allen, N.B., Viner, R.M., Bayer, J.K., Olds, T., Williams, J., Olsson, C., Romaniuk, H., Mensah, F., Sawyer, S.M., Degenhardt, L., Alati, R., Wake, M., Jacka, F., Patton, G.C., 2013. Study protocol: the Childhood to Adolescence Transition Study (CATS). BMC Pediatr 13, 160.

114. Nelson, M.T., Seal, M.L., Pantelis, C., Phillips, L.J., 2013. Evidence of a dimensional relationship between schizotypy and schizophrenia: a systematic review. Neurosci Biobehav Rev 37, 317-327.



115. Ng, C., Sarris, J., Singh, A., Bousman, C., Byron, K., Peh, L.H., Smith, D.J., Tan, C.H., Schweitzer, I., 2013. Pharmacogenetic polymorphisms and response to escitalopram and venlafaxine over 8 weeks in major depression. Hum Psychopharmacol 28, 516-522.

116. Pujol, J., Gimenez, M., Ortiz, H., Soriano-Mas, C., Lopez-Sola, M., Farre, M., Deus, J., Merlo-Pich, E., Harrison, B.J., Cardoner, N., Navines, R., Martin-Santos, R., 2013. Neural response to the observable self in social anxiety disorder. Psychol Med 43, 721-731.

117. Rossell, S.L., Van Rheenen, T.E., 2013. Theory of mind performance using a story comprehension task in bipolar mania compared to schizophrenia and healthy controls. Cogn Neuropsychiatry 18, 409-421.

118. Rossell, S.L., Van Rheenen, T.E., Groot, C., Gogos, A., O’Regan, A., Joshua, N.R., 2013. Investigating affective prosody in psychosis: a study using the Comprehensive Affective Testing System. Psychiatry Res 210, 896-900.

119. Santana, L., Fontenelle, J.M., Yucel, M., Fontenelle, L.F., 2013. Rates and correlates of nonadherence to treatment in obsessive-compulsive disorder. J Psychiatr Pract 19, 42-53.

120. Sarris, J., Stough, C., Bousman, C.A., Wahid, Z.T., Murray, G., Teschke, R., Savage, K.M., Dowell, A., Ng, C., Schweitzer, I., 2013. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study. J Clin Psychopharmacol 33, 643-648.

121. Sarris, J., Stough, C., Teschke, R., Wahid, Z.T., Bousman, C.A., Murray, G., Savage, K.M., Mouatt, P., Ng, C., Schweitzer, I., 2013. Kava for the treatment of generalized anxiety disorder RCT: analysis of adverse reactions, liver function, addiction, and sexual effects. Phytother Res 27, 1723-1728.

122. Schork, A.J., Thompson, W.K., Pham, P., Torkamani, A., Roddey, J.C., Sullivan, P.F., Kelsoe, J.R., O’Donovan, M.C., Furberg, H., Schork, N.J., Andreassen, O.A., Dale, A.M., 2013. All SNPs are not created equal: genome-wide association studies reveal a consistent pattern of enrichment among functionally annotated SNPs. PLoS Genet 9, e1003449.

123. Singam, C., Walterfang, M., Mocellin, R., Evans, A., Velakoulis, D., 2013. Topiramate for abnormal eating behaviour in frontotemporal dementia. Behav Neurol 27, 285-286.

124. Singh, A.B., Bousman, C.A., Ng, C.H., Berk, M., 2013. High impact child abuse may predict risk of elevated suicidality during antidepressant initiation. Aust N Z J Psychiatry 47, 1191-1195.

125. Singh, A.B., Bousman, C.A., Ng, C.H., Byron, K., Berk, M., 2013. Psychomotor depressive symptoms may differentially respond to venlafaxine. Int Clin Psychopharmacol 28, 121-126.

126. Solowij, N., Walterfang, M., Lubman, D.I., Whittle, S., Lorenzetti, V., Styner, M., Velakoulis, D., Pantelis, C., Yucel, M., 2013. Alteration to hippocampal shape in cannabis users with and without schizophrenia. Schizophr Res 143, 179-184.

127. Soriano-Mas, C., Harrison, B.J., Pujol, J., Lopez-Sola, M., Hernandez-Ribas, R., Alonso, P., Contreras-Rodriguez, O., Gimenez, M., Blanco-Hinojo, L., Ortiz, H., Deus, J., Menchon, J.M., Cardoner, N., 2013. Structural covariance of the neostriatum with regional gray matter volumes. Brain Struct Funct 218, 697-709.

128. Stjepanovic, D., Lorenzetti, V., Yucel, M., Hawi, Z., Bellgrove, M.A., 2013. Human amygdala volume is predicted by common DNA variation in the stathmin and serotonin transporter genes. Transl Psychiatry 3, e283.

129. Stough, C., Scholey, A., Cropley, V., Wesnes, K., Zangara, A., Pase, M., Savage, K., Nolidin, K., Lomas, J., Downey, L., 2013. Examining the cognitive effects of a special extract of Bacopa monniera (CDRI08: Keenmnd): a review of ten years of research at Swinburne University. J Pharm Pharm Sci 16, 254-258.

130. Subira, M., Alonso, P., Segalas, C., Real, E., Lopez-Sola, C., Pujol, J., Martinez-Zalacain, I., Harrison, B.J., Menchon, J.M., Cardoner, N., Soriano-Mas, C., 2013. Brain structural alterations in obsessive-compulsive disorder patients with autogenous and reactive obsessions. PLoS One 8, e75273.

131. Takagi, M., Lubman, D.I., Walterfang, M., Barton, S., Reutens, D., Wood, A., Yucel, M., 2013. Corpus callosum size and shape alterations in adolescent inhalant users. Addict Biol 18, 851-854.

132. Terwisscha van Scheltinga, A.F., Bakker, S.C., van Haren, N.E., Derks, E.M., Buizer-Voskamp, J.E., Boos, H.B., Cahn, W., Hulshoff Pol, H.E., Ripke, S., Ophoff, R.A., Kahn, R.S., 2013. Genetic schizophrenia risk variants jointly modulate total brain and white matter volume. Biol Psychiatry 73, 525-531.


133. Valenzuela, M., Bartres-Faz, D., Bullmore, E., Fjell, A., Maletic-Savetic, M., Martins, R., Solowij, N., Yucel, M., 2013. More thinking about less data: a perspective from the 2nd Provence Summer Workshop. Mol Psychiatry 18, 524-525.

134. Van Rheenen, T.E., Rossell, S.L., 2013. Auditory-prosodic processing in bipolar disorder; from sensory perception to emotion. J Affect Disord 151, 1102-1107.

135. Van Rheenen, T.E., Rossell, S.L., 2013. Picture sequencing task performance indicates theory of mind deficit in bipolar disorder. J Affect Disord 151, 1132-1134.

136. Van Rheenen, T.E., Rossell, S.L., 2013. Is the non-verbal behavioural emotion-processing profile of bipolar disorder impaired? A critical review. Acta Psychiatr Scand 128, 163-178.

137. Van Rheenen, T.E., Rossell, S.L., 2013. Genetic and neurocognitive foundations of emotion abnormalities in bipolar disorder. Cogn Neuropsychiatry 18, 168-207.

138. van Scheltinga, A.F., Bakker, S.C., van Haren, N.E., Derks, E.M., Buizer-Voskamp, J.E., Cahn, W., Ripke, S., Ophoff, R.A., Kahn, R.S., 2013. Schizophrenia genetic variants are not associated with intelligence. Psychol Med 43, 2563-2570.

139. Vassilopoulou, K., Papathanasiou, M., Michopoulos, I., Boufidou, F., Oulis, P., Kelekis, N., Rizos, E., Nikolaou, C., Pantelis, C., Velakoulis, D., Lykouras, L., 2013. A magnetic resonance imaging study of hippocampal, amygdala and subgenual prefrontal cortex volumes in major depression subtypes: melancholic versus psychotic depression. J Affect Disord 146, 197-204.

140. Verdejo-Garcia, A., Lubman, D.I., Roffel, K., Vilar-Lopez, R., Bora, E., MacKenzie, T., Yucel, M., 2013. Cingulate biochemistry in heroin users on substitution pharmacotherapy. Aust N Z J Psychiatry 47, 244-249.

141. Vigne, P., de Menezes, G.B., Yucel, M., Fontenelle, L.F., 2013. Can hoarding be a symptom of social anxiety disorder? A case study. Int J Psychiatry Med 46, 315-323.

142. Vilar-Lopez, R., Takagi, M., Lubman, D.I., Cotton, S.M., Bora, E., Verdejo-Garcia, A., Yucel, M., 2013. The effects of inhalant misuse on attentional networks. Dev Neuropsychol 38, 126-136.

143. Walterfang, M., Abel, L.A., Desmond, P., Fahey, M.C., Bowman, E.A., Velakoulis, D., 2013. Cerebellar volume correlates with saccadic gain and ataxia in adult Niemann-Pick type C. Mol Genet Metab 108, 85-89.

144. Walterfang, M., Bonnot, O., Mocellin, R., Velakoulis, D., 2013. The neuropsychiatry of inborn errors of metabolism. J Inherit Metab Dis 36, 687-702.

145. Walterfang, M., Patenaude, B., Abel, L.A., Kluenemann, H., Bowman, E.A., Fahey, M.C., Desmond, P., Kelso, W., Velakoulis, D., 2013. Subcortical volumetric reductions in adult Niemann-Pick disease type C: a cross-sectional study. AJNR Am J Neuroradiol 34, 1334-1340.

146. Whittle, S., Dennison, M., Vijayakumar, N., Simmons, J.G., Yucel, M., Lubman, D.I., Pantelis, C., Allen, N.B., 2013. Childhood maltreatment and psychopathology affect brain development during adolescence. J Am Acad Child Adolesc Psychiatry 52, 940-952.e941.

147. Wood, S.J., Yung, A.R., Pantelis, C., 2013. Cognitive precursors of severe mental disorders. Cogn Neuropsychiatry 18, 1-8.

148. Zhong, M., Evans, A., Peppard, R., Velakoulis, D., 2013. Validity and reliability of the PDCB: a tool for the assessment of caregiver burden in Parkinson’s disease. Int Psychogeriatr 25, 1437-1441.

2014149. 2014. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421-427.

150. Adamson, C., Beare, R., Walterfang, M., Seal, M., 2014. Software pipeline for midsagittal corpus callosum thickness profile processing: automated segmentation, manual editor, thickness profile generator, group-wise statistical comparison and results display. Neuroinformatics 12, 595-614.

151. Allott, K.A., Schafer, M.R., Thompson, A., Nelson, B., Bendall, S., Bartholomeusz, C.F., Yuen, H.P., McGorry, P.D., Schlogelhofer, M., Bechdolf, A., Amminger, G.P., 2014. Emotion recognition as a predictor of transition to a psychotic disorder in ultra-high risk participants. Schizophr Res 153, 25-31.

152. Barekatain, M., Askarpour, H., Zahedian, F., Walterfang, M., Velakoulis, D., Maracy, M.R., Jazi, M.H., 2014. The relationship between regional brain volumes and the extent of coronary artery disease in mild cognitive impairment. J Res Med Sci 19, 739-745.

153. Bartholomeusz, C.F., Whittle, S.L., Pilioussis, E., Allott, K., Rice, S., Schafer, M.R., Pantelis, C., Amminger, G.P., 2014. Relationship between amygdala volume and emotion recognition in adolescents at ultra-high risk for psychosis. Psychiatry Res 224, 159-167.

154. Batalla, A., Soriano-Mas, C., Lopez-Sola, M., Torrens, M., Crippa, J.A., Bhattacharyya, S., Blanco-Hinojo, L., Fagundo, A.B., Harrison, B.J., Nogue, S., de la Torre, R., Farre, M., Pujol, J., Martin-Santos, R., 2014. Modulation of brain structure by catechol-O-methyltransferase Val(158) Met polymorphism in chronic cannabis users. Addict Biol 19, 722-732.



155. Bonnot, O., Klunemann, H.H., Sedel, F., Tordjman, S., Cohen, D., Walterfang, M., 2014. Diagnostic and treatment implications of psychosis secondary to treatable metabolic disorders in adults: a systematic review. Orphanet J Rare Dis 9, 65.

156. Bora, E., 2014. Developmental lag and course of cognitive deficits from the premorbid to postonset period in schizophrenia. Am J Psychiatry 171, 369.

157. Bora, E., Lin, A., Wood, S.J., Yung, A.R., McGorry, P.D., Pantelis, C., 2014. Cognitive deficits in youth with familial and clinical high risk to psychosis: a systematic review and meta-analysis. Acta Psychiatr Scand 130, 1-15.

158. Bora, E., Murray, R.M., 2014. Meta-analysis of cognitive deficits in ultra-high risk to psychosis and first-episode psychosis: do the cognitive deficits progress over, or after, the onset of psychosis? Schizophr Bull 40, 744-755.

159. Bousman, C.A., Potiriadis, M., Everall, I.P., Gunn, J.M., 2014. G-protein beta3 subunit genetic variation moderates five-year depressive symptom trajectories of primary care attendees. J Affect Disord 165, 64-68.

160. Bousman, C.A., Potiriadis, M., Everall, I.P., Gunn, J.M., 2014. Methylenetetrahydrofolate reductase (MTHFR) genetic variation and major depressive disorder prognosis: A five-year prospective cohort study of primary care attendees. Am J Med Genet B Neuropsychiatr Genet 165b, 68-76.

161. Bousman, C.A., Potiriadis, M., Everall, I.P., Gunn, J.M., 2014. Effects of neuregulin-1 genetic variation and depression symptom severity on longitudinal patterns of psychotic symptoms in primary care attendees. Am J Med Genet B Neuropsychiatr Genet 165b, 62-67.

162. Bousman, C.A., Sarris, J., Won, E.S., Chang, H.S., Singh, A., Lee, H.Y., Ham, B.J., Tan, C.H., Lee, M.S., Ng, C.H., 2014. Escitalopram efficacy in depression: a cross-ethnicity examination of the serotonin transporter promoter polymorphism. J Clin Psychopharmacol 34, 645-648.

163. Calvo, A., Moreno, M., Ruiz-Sancho, A., Rapado-Castro, M., Moreno, C., Sanchez-Gutierrez, T., Arango, C., Mayoral, M., 2014. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial. J Am Acad Child Adolesc Psychiatry 53, 688-696.

164. Chan, H.M., Stolwyk, R., Kelso, W., Neath, J., Walterfang, M., Mocellin, R., Pavlis, A., Velakoulis, D., 2014. Comparing neurocognition in severe chronic schizophrenia and frontotemporal dementia. Aust N Z J Psychiatry 48, 828-837.

165. Chana, G., Bousman, C.A., Everall, I.P., 2014. Pathogenesis of Mental Health Disorders in HIV. Hiv and Psychiatry, 61-81.

166. Chana, G., Testa, R., Gillett, P., Williams, D., Bousman, C.A., Zantomio, D., Everall, I.P., Pantelis, C., Skafidas, E., 2014. Construction of a Genetic Classifier for ASD using Gene Pathway Analysis. In: Hu, V.W. (Ed.), Frontiers in Autism Research, Diagnosis, and Treatment. World Scientific Publishing Company, NJ, USA, pp. 119-143.

167. Cheetham, A., Allen, N.B., Whittle, S., Simmons, J., Yucel, M., Lubman, D.I., 2014. Volumetric differences in the anterior cingulate cortex prospectively predict alcohol-related problems in adolescence. Psychopharmacology (Berl) 231, 1731-1742.

168. Cocchi, L., Halford, G.S., Zalesky, A., Harding, I.H., Ramm, B.J., Cutmore, T., Shum, D.H., Mattingley, J.B., 2014. Complexity in relational processing predicts changes in functional brain network dynamics. Cereb Cortex 24, 2283-2296.

169. Cocchi, L., Harding, I.H., Lord, A., Pantelis, C., Yucel, M., Zalesky, A., 2014. Disruption of structure-function coupling in the schizophrenia connectome. Neuroimage Clin 4, 779-787.

170. Contreras-Rodriguez, O., Pujol, J., Batalla, I., Harrison, B.J., Bosque, J., Ibern-Regas, I., Hernandez-Ribas, R., Soriano-Mas, C., Deus, J., Lopez-Sola, M., Pifarre, J., Menchon, J.M., Cardoner, N., 2014. Disrupted neural processing of emotional faces in psychopathy. Soc Cogn Affect Neurosci 9, 505-512.

171. Cropley, V.L., Pantelis, C., 2014. Using longitudinal imaging to map the ‘relapse signature’ of schizophrenia and other psychoses. Epidemiol Psychiatr Sci 23, 219-225.

172. Dandash, O., Fornito, A., Lee, J., Keefe, R.S., Chee, M.W., Adcock, R.A., Pantelis, C., Wood, S.J., Harrison, B.J., 2014. Altered striatal functional connectivity in subjects with an at-risk mental state for psychosis. Schizophr Bull 40, 904-913.


173. Davey, C.G., Chanen, A.M., Cotton, S.M., Hetrick, S.E., Kerr, M.J., Berk, M., Dean, O.M., Yuen, K., Phelan, M., Ratheesh, A., Schafer, M.R., Amminger, G.P., Parker, A.G., Piskulic, D., Harrigan, S., Mackinnon, A.J., Harrison, B.J., McGorry, P.D., 2014. The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial. Trials 15, 425.

174. Dwyer, D.B., Harrison, B.J., Yucel, M., Whittle, S., Zalesky, A., Pantelis, C., Allen, N.B., Fornito, A., 2014. Large-scale brain network dynamics supporting adolescent cognitive control. J Neurosci 34, 14096-14107.

175. Fernandez-Enright, F., Andrews, J.L., Newell, K.A., Pantelis, C., Huang, X.F., 2014. Novel implications of Lingo-1 and its signaling partners in schizophrenia. Transl Psychiatry 4, e348.

176. Fontenelle, L.F., Lins-Martins, N.M., Melca, I.A., Lima, A.L., de Menezes, G.B., Torres, A.R., Yucel, M., Miguel, E.C., Mendlowicz, M.V., 2014. Exaggerating, mislabeling or simulating obsessive-compulsive symptoms: case reports of patients claiming to have obsessive-compulsive disorder. Compr Psychiatry 55, 1188-1194.

177. Fraguas, D., Merchan-Naranjo, J., del Rey-Mejias, A., Castro-Fornieles, J., Gonzalez-Pinto, A., Rapado-Castro, M., Pina-Camacho, L., Diaz-Caneja, C.M., Graell, M., Otero, S., Baeza, I., Moreno, C., Martinez-Cengotitabengoa, M., Rodriguez-Toscano, E., Arango, C., Parellada, M., 2014. A longitudinal study on the relationship between duration of untreated psychosis and executive function in early-onset first-episode psychosis. Schizophr Res 158, 126-133.

178. Gao, L., Li, S.C., Xia, L., Pan, S., Velakoulis, D., Walterfang, M., 2014. Validation of the Chinese version of the NUCOG cognitive screening tool in patients with epilepsy, dementia and other neurological disorders. J Clin Neurosci 21, 980-987.

179. Garfield, J.B., Lubman, D.I., Yucel, M., 2014. Anhedonia in substance use disorders: a systematic review of its nature, course and clinical correlates. Aust N Z J Psychiatry 48, 36-51.

180. Gleason, A., Hayhow, B., Emmanuel, J., Gaillard, F., 2014. Cerebral amyloid angiopathy presenting with neuropsychiatric symptoms. Aust N Z J Psychiatry 48, 779-780.

181. Gleason, A., Hayhow, B., Walterfang, M., Evans, A., Mocellin, R., Gates, P., Velakoulis, D., 2014. Neuropsychiatric symptoms as the presenting feature of acquired hepatocerebral degeneration. Aust N Z J Psychiatry 48, 959-960.

182. Glozier, N., O’Dea, B., McGorry, P.D., Pantelis, C., Amminger, G.P., Hermens, D.F., Purcell, R., Scott, E., Hickie, I.B., 2014. Delayed sleep onset in depressed young people. BMC Psychiatry 14, 33.

183. Goudriaan, A.E., Yucel, M., van Holst, R.J., 2014. Getting a grip on problem gambling: what can neuroscience tell us? Front Behav Neurosci 8, 141.

184. Gusev, A., Lee, S.H., Trynka, G., Finucane, H., Vilhjalmsson, B.J., Xu, H., Zang, C., Ripke, S., Bulik-Sullivan, B., Stahl, E., Kahler, A.K., Hultman, C.M., Purcell, S.M., McCarroll, S.A., Daly, M., Pasaniuc, B., Sullivan, P.F., Neale, B.M., Wray, N.R., Raychaudhuri, S., Price, A.L., 2014. Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases. Am J Hum Genet 95, 535-552.

185. Harrison, B.J., Pantelis, C., 2014. Magnetic Resonance Imaging (Functional). In: Stolerman, I.P., Price, L.H. (Eds.), Encyclopedia of Psychopharmacology. Springer-Verlag, Berlin, Heidelberg.

186. Hassan, I.K., Looi, J.C., Velakoulis, D., Gaillard, F., Lui, E.H., O’Brien, T.J., French, C., Le Heron, C., Adams, S.J., 2014. Psychosis with obsessive-compulsive symptoms in tuberous sclerosis. J Clin Neurosci 21, 867-869.

187. Hayhow, B., Begic, F., Evans, A., Velakoulis, D., Gaillard, F., 2014. Communicating hydrocephalus with reversible cognitive impairment. Aust N Z J Psychiatry 48, 379-380.

188. Hong, S.B., Choi, E.J., Kim, H.H., Suh, J.E., Takagi, M.J., Lubman, D.I., Kim, J.W., Kim, C.D., Yi, S.H., Yucel, M., 2014. Decreased thalamic volumes in adolescent inhalant users from Korea and Australia. World J Biol Psychiatry 15, 636-640.

189. Hong, S.B., Dwyer, D., Kim, J.W., Park, E.J., Shin, M.S., Kim, B.N., Yoo, H.J., Cho, I.H., Bhang, S.Y., Hong, Y.C., Pantelis, C., Cho, S.C., 2014. Subthreshold attention-deficit/hyperactivity disorder is associated with functional impairments across domains: a comprehensive analysis in a large-scale community study. Eur Child Adolesc Psychiatry 23, 627-636.

190. Hong, S.B., Youssef, G.J., Song, S.H., Choi, N.H., Ryu, J., McDermott, B., Cobham, V., Park, S., Kim, J.W., Shin, M.S., Yoo, H.J., Cho, S.C., Kim, B.N., 2014. Different clinical courses of children exposed to a single incident of psychological trauma: a 30-month prospective follow-up study. J Child Psychol Psychiatry 55, 1226-1233.

191. Hong, S.B., Zalesky, A., Fornito, A., Park, S., Yang, Y.H., Park, M.H., Song, I.C., Sohn, C.H., Shin, M.S., Kim, B.N., Cho, S.C., Han, D.H., Cheong, J.H., Kim, J.W., 2014. Connectomic disturbances in attention-deficit/hyperactivity disorder: a whole-brain tractography analysis. Biol Psychiatry 76, 656-663.

192. Hung, Y.H., Faux, N.G., Killilea, D.W., Yanjanin, N., Firnkes, S., Volitakis, I., Ganio, G., Walterfang, M., Hastings, C., Porter, F.D., Ory, D.S., Bush, A.I., 2014. Altered transition metal homeostasis in Niemann-Pick disease, type C1. Metallomics 6, 542-553.



193. Jenkins, L.M., Andrewes, D.G., Nicholas, C.L., Drummond, K.J., Moffat, B.A., Phal, P., Desmond, P., Kessels, R.P., 2014. Social cognition in patients following surgery to the prefrontal cortex. Psychiatry Res 224, 192-203.

194. Johnson, J., Jones, C., Lin, A., Wood, S., Heinze, K., Jackson, C., 2014. Shame amplifies the association between stressful life events and paranoia amongst young adults using mental health services: Implications for understanding risk and psychological resilience. Psychiatry Res 220, 217-225.

195. Jovev, M., Whittle, S., Yucel, M., Simmons, J.G., Allen, N.B., Chanen, A.M., 2014. The relationship between hippocampal asymmetry and temperament in adolescent borderline and antisocial personality pathology. Dev Psychopathol 26, 275-285.

196. Kerestes, R., Davey, C.G., Stephanou, K., Whittle, S., Harrison, B.J., 2014. Functional brain imaging studies of youth depression: a systematic review. Neuroimage Clin 4, 209-231.

197. Kim, S.W., Schafer, M.R., Klier, C.M., Berk, M., Rice, S., Allott, K., Bartholomeusz, C.F., Whittle, S.L., Pilioussis, E., Pantelis, C., McGorry, P.D., Amminger, G.P., 2014. Relationship between membrane fatty acids and cognitive symptoms and information processing in individuals at ultra-high risk for psychosis. Schizophr Res 158, 39-44.

198. Korgaonkar, M.S., Fornito, A., Williams, L.M., Grieve, S.M., 2014. Abnormal structural networks characterize major depressive disorder: a connectome analysis. Biol Psychiatry 76, 567-574.

199. Koutsouleris, N., Davatzikos, C., Borgwardt, S., Gaser, C., Bottlender, R., Frodl, T., Falkai, P., Riecher-Rossler, A., Moller, H.J., Reiser, M., Pantelis, C., Meisenzahl, E., 2014. Accelerated brain aging in schizophrenia and beyond: a neuroanatomical marker of psychiatric disorders. Schizophr Bull 40, 1140-1153.

200. Lavoie, S., Bartholomeuz, C.F., Nelson, B., Lin, A., McGorry, P.D., Velakoulis, D., Whittle, S.L., Yung, A.R., Pantelis, C., Wood, S.J., 2014. Sulcogyral pattern and sulcal count of the orbitofrontal cortex in individuals at ultra high risk for psychosis. Schizophr Res 154, 93-99.

201. Lessa Lda, R., Luz, F.B., De Rezende, R.M., Duraes, S.M., Harrison, B.J., De Menezes, G.B., Fontenelle, L.F., 2014. The psychiatric facet of hyperhidrosis: demographics, disability, quality of life, and associated psychopathology. J Psychiatr Pract 20, 316-323.

202. Liberg, B., Klauser, P., Harding, I.H., Adler, M., Rahm, C., Lundberg, J., Masterman, T., Wachtler, C., Jonsson, T., Kristoffersen-Wiberg, M., Pantelis, C., Wahlund, B., 2014. Functional and structural alterations in the cingulate motor area relate to decreased fronto-striatal coupling in major depressive disorder with psychomotor disturbances. Front Psychiatry 5, 176.

203. Little, K., Olsson, C.A., Whittle, S., Youssef, G.J., Byrne, M.L., Simmons, J.G., Yucel, M., Foley, D.L., Allen, N.B., 2014. Association between serotonin transporter genotype, brain structure and adolescent-onset major depressive disorder: a longitudinal prospective study. Transl Psychiatry 4, e445.

204. Looi, J.C., Velakoulis, D., 2014. Major and minor neurocognitive disorders in DSM-5: the difference between the map and the terrain. Aust N Z J Psychiatry 48, 284-286.

205. Looi, J.C., Velakoulis, D., Walterfang, M., Georgiou-Karistianis, N., Macfarlane, M.D., Power, B.D., Nilsson, C., Styner, M., Thompson, P.M., Van Westen, D., Wilkes, F.A., Wahlund, L.O., 2014. The Australian, US, Scandinavian Imaging Exchange (AUSSIE): an innovative, virtually-integrated health research network embedded in health care. Australas Psychiatry 22, 260-265.

206. Looi, J.C., Walterfang, M., Nilsson, C., Power, B.D., van Westen, D., Velakoulis, D., Wahlund, L.O., Thompson, P.M., 2014. The subcortical connectome: hubs, spokes and the space between - a vision for further research in neurodegenerative disease. Aust N Z J Psychiatry 48, 306-309.

207. Lopez-Sola, C., Fontenelle, L.F., Alonso, P., Cuadras, D., Foley, D.L., Pantelis, C., Pujol, J., Yucel, M., Cardoner, N., Soriano-Mas, C., Menchon, J.M., Harrison, B.J., 2014. Prevalence and heritability of obsessive-compulsive spectrum and anxiety disorder symptoms: A survey of the Australian Twin Registry. Am J Med Genet B Neuropsychiatr Genet 165b, 314-325.

208. Lopez-Sola, M., Pujol, J., Wager, T.D., Garcia-Fontanals, A., Blanco-Hinojo, L., Garcia-Blanco, S., Poca-Dias, V., Harrison, B.J., Contreras-Rodriguez, O., Monfort, J., Garcia-Fructuoso, F., Deus, J., 2014. Altered functional magnetic resonance imaging responses to nonpainful sensory stimulation in fibromyalgia patients. Arthritis Rheumatol 66, 3200-3209.

209. Lorenzetti, V., Solowij, N., Fornito, A., Lubman, D.I., Yucel, M., 2014. The association between regular cannabis exposure and alterations of human brain morphology: an updated review of the literature. Curr Pharm Des 20, 2138-2167.


210. Makary, A.T., Testa, R., Einfeld, S.L., Tonge, B.J., Mohr, C., Gray, K.M., 2014. The association between behavioural and emotional problems and age in adults with Down syndrome without dementia: Examining a wide spectrum of behavioural and emotional problems. Res Dev Disabil 35, 1868-1877.

211. Masaoka, Y., Harding, I.H., Koiwa, N., Yoshida, M., Harrison, B.J., Lorenzetti, V., Ida, M., Izumizaki, M., Pantelis, C., Homma, I., 2014. The neural cascade of olfactory processing: a combined fMRI-EEG study. Respir Physiol Neurobiol 204, 71-77.

212. McGorry, P., Keshavan, M., Goldstone, S., Amminger, P., Allott, K., Berk, M., Lavoie, S., Pantelis, C., Yung, A., Wood, S., Hickie, I., 2014. Biomarkers and clinical staging in psychiatry. World Psychiatry 13, 211-223.

213. Nair, G., Evans, A., Bear, R.E., Velakoulis, D., Bittar, R.G., 2014. The anteromedial GPi as a new target for deep brain stimulation in obsessive compulsive disorder. J Clin Neurosci 21, 815-821.

214. Nicodemus, K.K., Hargreaves, A., Morris, D., Anney, R., Gill, M., Corvin, A., Donohoe, G., 2014. Variability in working memory performance explained by epistasis vs polygenic scores in the ZNF804A pathway. JAMA Psychiatry 71, 778-785.

215. Pantelis, C., Bartholomeusz, C.F., 2014. Social neuroscience in psychiatry: pathways to discovering neurobiological risk and resilience. World Psychiatry 13, 146-147.

216. Pizarro, M., Fontenelle, L.F., Paravidino, D.C., Yucel, M., Miguel, E.C., de Menezes, G.B., 2014. An updated review of antidepressants with marked serotonergic effects in obsessive-compulsive disorder. Expert Opin Pharmacother 15, 1391-1401.

217. Pujol, J., Blanco-Hinojo, L., Batalla, A., Lopez-Sola, M., Harrison, B.J., Soriano-Mas, C., Crippa, J.A., Fagundo, A.B., Deus, J., de la Torre, R., Nogue, S., Farre, M., Torrens, M., Martin-Santos, R., 2014. Functional connectivity alterations in brain networks relevant to self-awareness in chronic cannabis users. J Psychiatr Res 51, 68-78.

218. Pujol, J., Macia, D., Blanco-Hinojo, L., Martinez-Vilavella, G., Sunyer, J., de la Torre, R., Caixas, A., Martin-Santos, R., Deus, J., Harrison, B.J., 2014. Does motion-related brain functional connectivity reflect both artifacts and genuine neural activity? Neuroimage 101, 87-95.

219. Pujol, J., Macia, D., Garcia-Fontanals, A., Blanco-Hinojo, L., Lopez-Sola, M., Garcia-Blanco, S., Poca-Dias, V., Harrison, B.J., Contreras-Rodriguez, O., Monfort, J., Garcia-Fructuoso, F., Deus, J., 2014. The contribution of sensory system functional connectivity reduction to clinical pain in fibromyalgia. Pain 155, 1492-1503.

220. Reynolds, M.T., Van Rheenen, T.E., Rossell, S.L., 2014. Theory of mind in first degree relatives of individuals with bipolar disorder. Psychiatry Res 219, 400-402.

221. Rossell, S.L., Van Rheenen, T.E., Joshua, N.R., O’Regan, A., Gogos, A., 2014. Investigating facial affect processing in psychosis: a study using the Comprehensive Affective Testing System. Schizophr Res 157, 55-59.

222. Schwartz, O.S., Byrne, M.L., Simmons, J.G., Whittle, S., Dudgeon, P., Yap, M.B., Sheeber, L.B., Allen, N.B., 2014. Parenting during early adolescence and adolescent-onset major depression: A 6-year prospective longitudinal study. Clinical Psychological Science 2, 272-286.

223. Segalas, C., Alonso, P., Orbegozo, A., Real, E., Subira, M., Lopez-Sola, C., Martinez-Zalacain, I., Labad, J., Harrison, B.J., Pujol, J., Menchon, J.M., Cardoner, N., Soriano-Mas, C., 2014. Brain structural imaging correlates of olfactory dysfunction in obsessive-compulsive disorder. Eur Arch Psychiatry Clin Neurosci 264, 225-233.

224. Simmons, J.G., Whittle, S.L., Patton, G.C., Dudgeon, P., Olsson, C., Byrne, M.L., Mundy, L.K., Seal, M.L., Allen, N.B., 2014. Study protocol: imaging brain development in the Childhood to Adolescence Transition Study (iCATS). BMC Pediatr 14, 115.

225. Singh, A.B., Bousman, C.A., Ng, C., Berk, M., 2014. Antidepressant pharmacogenetics. Curr Opin Psychiatry 27, 43-51.

226. Sjoerds, Z., Luigjes, J., van den Brink, W., Denys, D., Yucel, M., 2014. The role of habits and motivation in human drug addiction: a reflection. Front Psychiatry 5, 8.

227. Skafidas, E., Testa, R., Zantomio, D., Chana, G., Everall, I.P., Pantelis, C., 2014. Response to Belgard et al. Mol Psychiatry 19, 407-409.

228. Skafidas, E., Testa, R., Zantomio, D., Chana, G., Everall, I.P., Pantelis, C., 2014. Predicting the diagnosis of autism spectrum disorder using gene pathway analysis. Mol Psychiatry 19, 504-510.

229. Takagi, M.J., Lubman, D.I., Cotton, S.M., Verdejo-Garcia, A., Vilar-Lopez, R., Yucel, M., 2014. A signal detection analysis of executive control performance among adolescent inhalant and cannabis users. Subst Use Misuse 49, 1920-1927.

230. Takahashi, T., Malhi, G.S., Nakamura, Y., Suzuki, M., Pantelis, C., 2014. Olfactory sulcus morphology in established bipolar affective disorder. Psychiatry Res 222, 114-117.

231. Takahashi, T., Wood, S.J., Yung, A.R., Nelson, B., Lin, A., Yucel, M., Phillips, L.J., Nakamura, Y., Suzuki, M., Brewer, W.J., Proffitt, T.M., McGorry, P.D., Velakoulis, D., Pantelis, C., 2014. Altered depth of the olfactory sulcus in ultra high-risk individuals and patients with psychotic disorders. Schizophr Res 153, 18-24.



232. Tognin, S., Riecher-Rossler, A., Meisenzahl, E.M., Wood, S.J., Hutton, C., Borgwardt, S.J., Koutsouleris, N., Yung, A.R., Allen, P., Phillips, L.J., McGorry, P.D., Valli, I., Velakoulis, D., Nelson, B., Woolley, J., Pantelis, C., McGuire, P., Mechelli, A., 2014. Reduced parahippocampal cortical thickness in subjects at ultra-high risk for psychosis. Psychol Med 44, 489-498.

233. van den Heuvel, M.P., Fornito, A., 2014. Brain networks in schizophrenia. Neuropsychol Rev 24, 32-48.

234. van Os, J., Rutten, B.P., Myin-Germeys, I., Delespaul, P., Viechtbauer, W., van Zelst, C., Bruggeman, R., Reininghaus, U., Morgan, C., Murray, R.M., Di Forti, M., McGuire, P., Valmaggia, L.R., Kempton, M.J., Gayer-Anderson, C., Hubbard, K., Beards, S., Stilo, S.A., Onyejiaka, A., Bourque, F., Modinos, G., Tognin, S., Calem, M., O’Donovan, M.C., Owen, M.J., Holmans, P., Williams, N., Craddock, N., Richards, A., Humphreys, I., Meyer-Lindenberg, A., Leweke, F.M., Tost, H., Akdeniz, C., Rohleder, C., Bumb, J.M., Schwarz, E., Alptekin, K., Ucok, A., Saka, M.C., Atbasoglu, E.C., Guloksuz, S., Gumus-Akay, G., Cihan, B., Karadag, H., Soygur, H., Cankurtaran, E.S., Ulusoy, S., Akdede, B., Binbay, T., Ayer, A., Noyan, H., Karadayi, G., Akturan, E., Ulas, H., Arango, C., Parellada, M., Bernardo, M., Sanjuan, J., Bobes, J., Arrojo, M., Santos, J.L., Cuadrado, P., Rodriguez Solano, J.J., Carracedo, A., Garcia Bernardo, E., Roldan, L., Lopez, G., Cabrera, B., Cruz, S., Diaz Mesa, E.M., Pouso, M., Jimenez, E., Sanchez, T., Rapado, M., Gonzalez, E., Martinez, C., Sanchez, E., Olmeda, M.S., de Haan, L., Velthorst, E., van der Gaag, M., Selten, J.P., van Dam, D., van der Ven, E., van der Meer, F., Messchaert, E., Kraan, T., Burger, N., Leboyer, M., Szoke, A., Schurhoff, F., Llorca, P.M., Jamain, S., Tortelli, A., Frijda, F., Vilain, J., Galliot, A.M., Baudin, G., Ferchiou, A., Richard, J.R., Bulzacka, E., Charpeaud, T., Tronche, A.M., De Hert, M., van Winkel, R., Decoster, J., Derom, C., Thiery, E., Stefanis, N.C., Sachs, G., Aschauer, H., Lasser, I., Winklbaur, B., Schlogelhofer, M., Riecher-Rossler, A., Borgwardt, S., Walter, A., Harrisberger, F., Smieskova, R., Rapp, C., Ittig, S., Soguel-dit-Piquard, F., Studerus, E., Klosterkotter, J., Ruhrmann, S., Paruch, J., Julkowski, D., Hilboll, D., Sham, P.C., Cherny, S.S., Chen, E.Y., Campbell, D.D., Li, M., Romeo-Casabona, C.M., Emaldi Cirion, A., Urruela Mora, A., Jones, P., Kirkbride, J., Cannon, M., Rujescu, D., Tarricone, I., Berardi, D., Bonora, E., Seri, M., Marcacci, T., Chiri, L., Chierzi, F., Storbini, V., Braca, M., Minenna, M.G., Donegani, I., Fioritti, A., La Barbera, D., La Cascia, C.E., Mule, A., Sideli, L., Sartorio, R., Ferraro, L., Tripoli, G., Seminerio, F., Marinaro, A.M., McGorry, P., Nelson, B., Amminger, G.P., Pantelis, C., Menezes, P.R., Del-Ben, C.M., Gallo Tenan, S.H., Shuhama, R., Ruggeri, M., Tosato, S., Lasalvia, A., Bonetto, C., Ira, E., Nordentoft, M., Krebs, M.O., Barrantes-Vidal, N., Cristobal, P., Kwapil, T.R., Brietzke, E., Bressan, R.A., Gadelha, A., Maric, N.P., Andric, S., Mihaljevic, M., Mirjanic, T., 2014. Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. Schizophr Bull 40, 729-736.

235. Van Rheenen, T.E., Meyer, D., Rossell, S.L., 2014. Pathways between neurocognition, social cognition and emotion regulation in bipolar disorder. Acta Psychiatr Scand 130, 397-405.

236. Van Rheenen, T.E., Rossell, S.L., 2014. Investigation of the component processes involved in verbal declarative memory function in bipolar disorder: utility of the Hopkins Verbal Learning Test-Revised. J Int Neuropsychol Soc 20, 727-735.

237. Van Rheenen, T.E., Rossell, S.L., 2014. Objective and subjective psychosocial functioning in bipolar disorder: an investigation of the relative importance of neurocognition, social cognition and emotion regulation. J Affect Disord 162, 134-141.

238. Van Rheenen, T.E., Rossell, S.L., 2014. Multimodal emotion integration in bipolar disorder: an investigation of involuntary cross-modal influences between facial and prosodic channels. J Int Neuropsychol Soc 20, 525-533.

239. Van Rheenen, T.E., Rossell, S.L., 2014. Let’s face it: facial emotion processing is impaired in bipolar disorder. J Int Neuropsychol Soc 20, 200-208.

240. Van Rheenen, T.E., Rossell, S.L., 2014. Phenomenological predictors of psychosocial function in bipolar disorder: is there evidence that social cognitive and emotion regulation abnormalities contribute? Aust N Z J Psychiatry 48, 26-35.

241. Van Rheenen, T.E., Rossell, S.L., 2014. An empirical evaluation of the MATRICS Consensus Cognitive Battery in bipolar disorder. Bipolar Disord 16, 318-325.

242. Velakoulis, D., Gleason, A., Hayhow, B., McNeil, P., Gaillard, F., 2014. Frontal meningioma mimicking relapse of schizophrenia. Aust N Z J Psychiatry 48, 486-487.

243. Velakoulis, D., Ting, A., Winton-Brown, T., Walterfang, M., Gaillard, F., 2014. Metachromatic leukodystrophy presenting as bipolar disorder. Aust N Z J Psychiatry 48, 1171-1172.

244. Via, E., Cardoner, N., Pujol, J., Alonso, P., Lopez-Sola, M., Real, E., Contreras-Rodriguez, O., Deus, J., Segalas, C., Menchon, J.M., Soriano-Mas, C., Harrison, B.J., 2014. Amygdala activation and symptom dimensions in obsessive-compulsive disorder. Br J Psychiatry 204, 61-68.


245. Via, E., Zalesky, A., Sanchez, I., Forcano, L., Harrison, B.J., Pujol, J., Fernandez-Aranda, F., Menchon, J.M., Soriano-Mas, C., Cardoner, N., Fornito, A., 2014. Disruption of brain white matter microstructure in women with anorexia nervosa. J Psychiatry Neurosci 39, 367-375.

246. Vigne, P., de Menezes, G.B., Harrison, B.J., Fontenelle, L.F., 2014. A study of poor insight in social anxiety disorder. Psychiatry Res 219, 556-561.

247. Vijayakumar, N., Whittle, S., Dennison, M., Yucel, M., Simmons, J., Allen, N.B., 2014. Development of temperamental effortful control mediates the relationship between maturation of the prefrontal cortex and psychopathology during adolescence: a 4-year longitudinal study. Dev Cogn Neurosci 9, 30-43.

248. Vijayakumar, N., Whittle, S., Yucel, M., Dennison, M., Simmons, J., Allen, N.B., 2014. Thinning of the lateral prefrontal cortex during adolescence predicts emotion regulation in females. Soc Cogn Affect Neurosci 9, 1845-1854.

249. Vijayakumar, N., Whittle, S., Yucel, M., Dennison, M., Simmons, J., Allen, N.B., 2014. Prefrontal structural correlates of cognitive control during adolescent development: a 4-year longitudinal study. J Cogn Neurosci 26, 1118-1130.

250. Visser, T.A., Ohan, J.L., Whittle, S., Yucel, M., Simmons, J.G., Allen, N.B., 2014. Sex differences in structural brain asymmetry predict overt aggression in early adolescents. Soc Cogn Affect Neurosci 9, 553-560.

251. Walterfang, M., Luders, E., Looi, J.C., Rajagopalan, P., Velakoulis, D., Thompson, P.M., Lindberg, O., Ostberg, P., Nordin, L.E., Svensson, L., Wahlund, L.O., 2014. Shape analysis of the corpus callosum in Alzheimer’s disease and frontotemporal lobar degeneration subtypes. J Alzheimers Dis 40, 897-906.

252. Walterfang, M., van de Warrenburg, B.P., 2014. Cognitive impairment in “Other” movement disorders: hidden defects and valuable clues. Mov Disord 29, 694-703.

253. Walterfang, M., Velakoulis, D., 2014. Callosal morphology in schizophrenia: what can shape tell us about function and illness? Br J Psychiatry 204, 9-11.

254. Whittle, S., Bartholomeusz, C., Yucel, M., Dennison, M., Vijayakumar, N., Allen, N.B., 2014. Orbitofrontal sulcogyral patterns are related to temperamental risk for psychopathology. Soc Cogn Affect Neurosci 9, 232-239.

255. Whittle, S., Lichter, R., Dennison, M., Vijayakumar, N., Schwartz, O., Byrne, M.L., Simmons, J.G., Yucel, M., Pantelis, C., McGorry, P., Allen, N.B., 2014. Structural brain development and depression onset during adolescence: a prospective longitudinal study. Am J Psychiatry 171, 564-571.

256. Whittle, S., Simmons, J.G., Dennison, M., Vijayakumar, N., Schwartz, O., Yap, M.B., Sheeber, L., Allen, N.B., 2014. Positive parenting predicts the development of adolescent brain structure: a longitudinal study. Dev Cogn Neurosci 8, 7-17.

257. Wraith, J.E., Sedel, F., Pineda, M., Wijburg, F.A., Hendriksz, C.J., Fahey, M., Walterfang, M., Patterson, M.C., Chadha-Boreham, H., Kolb, S.A., 2014. Niemann-Pick type C Suspicion Index tool: analyses by age and association of manifestations. J Inherit Metab Dis 37, 93-101.

258. Zalesky, A., Akhlaghi, H., Corben, L.A., Bradshaw, J.L., Delatycki, M.B., Storey, E., Georgiou-Karistianis, N., Egan, G.F., 2014. Cerebello-cerebral connectivity deficits in Friedreich ataxia. Brain Struct Funct 219, 969-981.

259. Zalesky, A., Fornito, A., Cocchi, L., Gollo, L.L., Breakspear, M., 2014. Time-resolved resting-state brain networks. Proc Natl Acad Sci U S A 111, 10341-10346.

260. Zhao, Q., Li, Z., Huang, J., Yan, C., Dazzan, P., Pantelis, C., Cheung, E.F., Lui, S.S., Chan, R.C., 2014. Neurological soft signs are not “soft” in brain structure and functional networks: evidence from ALE meta-analysis. Schizophr Bull 40, 626-641.

261. Zheng, P., Shultz, S.R., Hovens, C.M., Velakoulis, D., Jones, N.C., O’Brien, T.J., 2014. Hyperphosphorylated tau is implicated in acquired epilepsy and neuropsychiatric comorbidities. Mol Neurobiol 49, 1532-1539.

2015262. Abel, L.A., Walterfang, M., Stainer, M.J., Bowman, E.A., Velakoulis, D., 2015. Longitudinal assessment of reflexive and volitional

saccades in Niemann-Pick Type C disease during treatment with miglustat. Orphanet J Rare Dis 10, 160.

263. Abu-Akel, A.M., Wood, S.J., Hansen, P.C., Apperly, I.A., 2015. Perspective-taking abilities in the balance between autism tendencies and psychosis proneness. Proc Biol Sci 282, 20150563.

264. Allott, K.A., Rapado-Castro, M., Proffitt, T.M., Bendall, S., Garner, B., Butselaar, F., Markulev, C., Phassouliotis, C., McGorry, P.D., Wood, S.J., Cotton, S.M., Phillips, L.J., 2015. The impact of neuropsychological functioning and coping style on perceived stress in individuals with first-episode psychosis and healthy controls. Psychiatry Res 226, 128-135.

265. Allott, K.A., Rice, S., Bartholomeusz, C.F., Klier, C., Schlogelhofer, M., Schafer, M.R., Amminger, G.P., 2015. Emotion recognition in unaffected first-degree relatives of individuals with first-episode schizophrenia. Schizophr Res 161, 322-328.



266. Ansell, B.R., Dwyer, D.B., Wood, S.J., Bora, E., Brewer, W.J., Proffitt, T.M., Velakoulis, D., McGorry, P.D., Pantelis, C., 2015. Divergent effects of first-generation and second-generation antipsychotics on cortical thickness in first-episode psychosis. Psychol Med 45, 515-527.

267. Baker, S.T., Lubman, D.I., Yucel, M., Allen, N.B., Whittle, S., Fulcher, B.D., Zalesky, A., Fornito, A., 2015. Developmental Changes in Brain Network Hub Connectivity in Late Adolescence. J Neurosci 35, 9078-9087.

268. Bartholomeusz, C.F., Ganella, E.P., Labuschagne, I., Bousman, C., Pantelis, C., 2015. Effects of oxytocin and genetic variants on brain and behaviour: Implications for treatment in schizophrenia. Schizophr Res 168, 614-627.

269. Bartholomeusz, C.F., Pantelis, C., 2015. Neuroimaging and Staging: Do disparate mental illnesses have distinct neurobiological trajectories? In: McGorry, P.D., Hickie, I.B. (Eds.), Clinical Staging In Psychiatry. Cambridge University Press, UK.

270. Bonnot, O., Herrera, P.M., Tordjman, S., Walterfang, M., 2015. Secondary psychosis induced by metabolic disorders. Front Neurosci 9, 177.

271. Bora, E., 2015. Developmental trajectory of cognitive impairment in bipolar disorder: comparison with schizophrenia. Eur Neuropsychopharmacol 25, 158-168.

272. Bora, E., 2015. Neurodevelopmental origin of cognitive impairment in schizophrenia. Psychol Med 45, 1-9.

273. Bora, E., Pantelis, C., 2015. Meta-analysis of Cognitive Impairment in First-Episode Bipolar Disorder: Comparison With First-Episode Schizophrenia and Healthy Controls. Schizophr Bull 41, 1095-1104.

274. Bora, E., Walterfang, M., Velakoulis, D., 2015. Theory of mind in Parkinson’s disease: A meta-analysis. Behav Brain Res 292, 515-520.

275. Bora, E., Walterfang, M., Velakoulis, D., 2015. Theory of mind in behavioural-variant frontotemporal dementia and Alzheimer’s disease: a meta-analysis. J Neurol Neurosurg Psychiatry 86, 714-719.

276. Bousman, C.A., Katalinic, N., Martin, D.M., Smith, D.J., Ingram, A., Dowling, N., Ng, C., Loo, C.K., 2015. Effects of COMT, DRD2, BDNF, and APOE Genotypic Variation on Treatment Efficacy and Cognitive Side Effects of Electroconvulsive Therapy. J ect 31, 129-135.

277. Bousman, C.A., McKetin, R., Burns, R., Woods, S.P., Morgan, E.E., Atkinson, J.H., Everall, I.P., Grant, I., 2015. Typologies of positive psychotic symptoms in methamphetamine dependence. Am J Addict 24, 94-97.

278. Bowman, E.A., Walterfang, M., Abel, L., Desmond, P., Fahey, M., Velakoulis, D., 2015. Longitudinal changes in cerebellar and subcortical volumes in adult-onset Niemann-Pick disease type C patients treated with miglustat. J Neurol 262, 2106-2114.

279. Bulik-Sullivan, B.K., Loh, P.R., Finucane, H.K., Ripke, S., Yang, J., Patterson, N., Daly, M.J., Price, A.L., Neale, B.M., 2015. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat Genet 47, 291-295.

280. Calvo, A., Moreno, M., Ruiz-Sancho, A., Rapado-Castro, M., Moreno, C., Sanchez-Gutierrez, T., Arango, C., Mayoral, M., 2015. Psychoeducational Group Intervention for Adolescents With Psychosis and Their Families: A Two-Year Follow-Up. J Am Acad Child Adolesc Psychiatry 54, 984-990.

281. Campos-Lima, A.L., Torres, A.R., Yucel, M., Harrison, B.J., Moll, J., Ferreira, G.M., Fontenelle, L.F., 2015. Hoarding pet animals in obsessive-compulsive disorder. Acta Neuropsychiatr 27, 8-13.

282. Chan, H.M., Stolwyk, R., Neath, J., Kelso, W., Walterfang, M., Mocellin, R., Pantelis, C., Velakoulis, D., 2015. Neurocognitive similarities between severe chronic schizophrenia and behavioural variant frontotemporal dementia. Psychiatry Res 225, 658-666.

283. Chana, G., Laskaris, L., Pantelis, C., Gillett, P., Testa, R., Zantomio, D., Burrows, E.L., Hannan, A.J., Everall, I.P., Skafidas, E., 2015. Decreased expression of mGluR5 within the dorsolateral prefrontal cortex in autism and increased microglial number in mGluR5 knockout mice: Pathophysiological and neurobehavioral implications. Brain Behav Immun 49, 197-205.

284. Cheetham, A., Allen, N.B., Schwartz, O., Simmons, J.G., Whittle, S., Byrne, M.L., Sheeber, L., Lubman, D.I., 2015. Affective behavior and temperament predict the onset of smoking in adolescence. Psychol Addict Behav 29, 347-354.

285. Chisholm, K., Lin, A., Abu-Akel, A., Wood, S.J., 2015. The association between autism and schizophrenia spectrum disorders: A review of eight alternate models of co-occurrence. Neurosci Biobehav Rev 55, 173-183.


286. Cleland, N., Lieblich, S., Schalling, M., Rahm, C., 2015. A 16-year-old girl with anti-NMDA-receptor encephalitis and family history of psychotic disorders. Acta Neuropsychiatr 27, 375-379.

287. Cocchi, L., Sale, M.V., Lord, A., Zalesky, A., Breakspear, M., Mattingley, J.B., 2015. Dissociable effects of local inhibitory and excitatory theta-burst stimulation on large-scale brain dynamics. J Neurophysiol 113, 3375-3385.

288. Contreras-Rodriguez, O., Pujol, J., Batalla, I., Harrison, B.J., Soriano-Mas, C., Deus, J., Lopez-Sola, M., Macia, D., Pera, V., Hernandez-Ribas, R., Pifarre, J., Menchon, J.M., Cardoner, N., 2015. Functional Connectivity Bias in the Prefrontal Cortex of Psychopaths. Biol Psychiatry 78, 647-655.

289. Cropley, V.L., Bartholomeusz, C.F., Wu, P., Wood, S.J., Proffitt, T., Brewer, W.J., Desmond, P.M., Velakoulis, D., Pantelis, C., 2015. Investigation of orbitofrontal sulcogyral pattern in chronic schizophrenia. Psychiatry Res 234, 280-283.

290. Cropley, V.L., Scarr, E., Fornito, A., Klauser, P., Bousman, C.A., Scott, R., Cairns, M.J., Tooney, P.A., Pantelis, C., Dean, B., 2015. The effect of a muscarinic receptor 1 gene variant on grey matter volume in schizophrenia. Psychiatry Res 234, 182-187.

291. Daglas, R., Yucel, M., Cotton, S., Allott, K., Hetrick, S., Berk, M., 2015. Cognitive impairment in first-episode mania: a systematic review of the evidence in the acute and remission phases of the illness. Int J Bipolar Disord 3, 9.

292. Dandash, O., Harrison, B.J., Adapa, R., Gaillard, R., Giorlando, F., Wood, S.J., Fletcher, P.C., Fornito, A., 2015. Selective augmentation of striatal functional connectivity following NMDA receptor antagonism: implications for psychosis. Neuropsychopharmacology 40, 622-631.

293. Davey, C.G., Whittle, S., Harrison, B.J., Simmons, J.G., Byrne, M.L., Schwartz, O.S., Allen, N.B., 2015. Functional brain-imaging correlates of negative affectivity and the onset of first-episode depression. Psychol Med 45, 1001-1009.

294. Dennison, M., Whittle, S., Yucel, M., Byrne, M.L., Schwartz, O., Simmons, J.G., Allen, N.B., 2015. Trait positive affect is associated with hippocampal volume and change in caudate volume across adolescence. Cogn Affect Behav Neurosci 15, 80-94.

295. Dwyer, D., Harrison, B.J., Yücel , M., Whittle, S., Zalesky, A., Pantelis, C., Allen, N.B., Fornito, A., 2015. Adolescent Cognitive Control: Brain Network Dynamics. In: Fink, G. (Ed.), Stress Concepts And Cognition, Emotion, And Behavior. Elsevier / Academic Press, San Diego: US, p. in press.

296. Fontenelle, L.F., Coutinho, E.S., Lins-Martins, N.M., Fitzgerald, P.B., Fujiwara, H., Yucel, M., 2015. Electroconvulsive therapy for obsessive-compulsive disorder: a systematic review. J Clin Psychiatry 76, 949-957.

297. Fontenelle, L.F., Oostermeijer, S., Ferreira, G.M., Lorenzetti, V., Luigjes, J., Yucel, M., 2015. Anticipated reward in obsessive-compulsive disorder: are compulsions rewarding? J Clin Psychiatry 76, e1134-1135.

298. Fornito, A., Bullmore, E.T., 2015. Reconciling abnormalities of brain network structure and function in schizophrenia. Curr Opin Neurobiol 30, 44-50.

299. Fornito, A., Bullmore, E.T., 2015. Connectomics: a new paradigm for understanding brain disease. Eur Neuropsychopharmacol 25, 733-748.

300. Fornito, A., Zalesky, A., Breakspear, M., 2015. The connectomics of brain disorders. Nat Rev Neurosci 16, 159-172.

301. Friedel, S., Whittle, S.L., Vijayakumar, N., Simmons, J.G., Byrne, M.L., Schwartz, O.S., Allen, N.B., 2015. Dispositional mindfulness is predicted by structural development of the insula during late adolescence. Dev Cogn Neurosci 14, 62-70.

302. Ganella, D.E., Allen, N.B., Simmons, J.G., Schwartz, O., Kim, J.H., Sheeber, L., Whittle, S., 2015. Early life stress alters pituitary growth during adolescence-a longitudinal study. Psychoneuroendocrinology 53, 185-194.

303. Ganella, E.P., Burnett, A., Cheong, J., Thompson, D., Roberts, G., Wood, S., Lee, K., Duff, J., Anderson, P.J., Pantelis, C., Doyle, L.W., Bartholomeusz, C., 2015. Abnormalities in orbitofrontal cortex gyrification and mental health outcomes in adolescents born extremely preterm and/or at an extremely low birth weight. Hum Brain Mapp 36, 1138-1150.

304. Garfield, J.B., Allen, N.B., Cheetham, A., Simmons, J.G., Lubman, D.I., 2015. Attention to pleasant stimuli in early adolescence predicts alcohol-related problems in mid-adolescence. Biol Psychol 108, 43-50.

305. Garrison, J.R., Fernyhough, C., McCarthy-Jones, S., Haggard, M., Simons, J.S., 2015. Paracingulate sulcus morphology is associated with hallucinations in the human brain. Nat Commun 6, 8956.

306. Gollo, L.L., Zalesky, A., Hutchison, R.M., van den Heuvel, M., Breakspear, M., 2015. Dwelling quietly in the rich club: brain network determinants of slow cortical fluctuations. Philos Trans R Soc Lond B Biol Sci 370.

307. Harding, I.H., Yucel, M., Harrison, B.J., Pantelis, C., Breakspear, M., 2015. Effective connectivity within the frontoparietal control network differentiates cognitive control and working memory. Neuroimage 106, 144-153.



308. Harrison, B.J., Fullana, M.A., Soriano-Mas, C., Via, E., Pujol, J., Martinez-Zalacain, I., Tinoco-Gonzalez, D., Davey, C.G., Lopez-Sola, M., Perez Sola, V., Menchon, J.M., Cardoner, N., 2015. A neural mediator of human anxiety sensitivity. Hum Brain Mapp 36, 3950-3958.

309. Hayhow, B., Gaillard, F., Velakoulis, D., Walterfang, M., 2015. Delayed diagnosis of multiple sclerosis in a patient with schizoaffective disorder: a case of ‘diagnostic overshadowing’. Aust N Z J Psychiatry 49, 186-187.

310. Hayhow, B., Velakoulis, D., Dewhurst, R., Gaillard, F., 2015. Neuropsychiatric presentation following acute hypoxic-ischaemic encephalopathy. Aust N Z J Psychiatry 49, 188-189.

311. Hearne, L., Cocchi, L., Zalesky, A., Mattingley, J.B., 2015. Interactions between default mode and control networks as a function of increasing cognitive reasoning complexity. Hum Brain Mapp 36, 2719-2731.

312. Heinze, K., Reniers, R.L., Nelson, B., Yung, A.R., Lin, A., Harrison, B.J., Pantelis, C., Velakoulis, D., McGorry, P.D., Wood, S.J., 2015. Discrete alterations of brain network structural covariance in individuals at ultra-high risk for psychosis. Biol Psychiatry 77, 989-996.

313. Hong, S.B., Harrison, B.J., Dandash, O., Choi, E.J., Kim, S.C., Kim, H.H., Shim, D.H., Kim, C.D., Kim, J.W., Yi, S.H., 2015. A selective involvement of putamen functional connectivity in youth with internet gaming disorder. Brain Res 1602, 85-95.

314. Hong, S.B., Harrison, B.J., Fornito, A., Sohn, C.H., Song, I.C., Kim, J.W., 2015. Functional dysconnectivity of corticostriatal circuitry and differential response to methylphenidate in youth with attention-deficit/hyperactivity disorder. J Psychiatry Neurosci 40, 46-57.

315. Hong, S.B., Zalesky, A., Park, S., Yang, Y.H., Park, M.H., Kim, B., Song, I.C., Sohn, C.H., Shin, M.S., Kim, B.N., Cho, S.C., Kim, J.W., 2015. COMT genotype affects brain white matter pathways in attention-deficit/hyperactivity disorder. Hum Brain Mapp 36, 367-377.

316. Hyett, M.P., Parker, G.B., Guo, C.C., Zalesky, A., Nguyen, V.T., Yuen, T., Breakspear, M., 2015. Scene unseen: Disrupted neuronal adaptation in melancholia during emotional film viewing. Neuroimage Clin 9, 660-667.

317. Johnson, B.P., Pinar, A., Fornito, A., Nandam, L.S., Hester, R., Bellgrove, M.A., 2015. Left anterior cingulate activity predicts intra-individual reaction time variability in healthy adults. Neuropsychologia 72, 22-26.

318. Jones, H.P., Testa, R.R., Ross, N., Seal, M.L., Pantelis, C., Tonge, B., 2015. The Melbourne assessment of Schizotypy in kids: a useful measure of childhood schizotypal personality disorder. Biomed Res Int 2015, 635732.

319. Kalenitchenko, D., Fagervold, S.K., Pruski, A.M., Vetion, G., Yucel, M., Le Bris, N., Galand, P.E., 2015. Temporal and spatial constraints on community assembly during microbial colonization of wood in seawater. Isme j 9, 2657-2670.

320. Katagiri, N., Pantelis, C., Nemoto, T., Zalesky, A., Hori, M., Shimoji, K., Saito, J., Ito, S., Dwyer, D.B., Fukunaga, I., Morita, K., Tsujino, N., Yamaguchi, T., Shiraga, N., Aoki, S., Mizuno, M., 2015. A longitudinal study investigating sub-threshold symptoms and white matter changes in individuals with an ‘at risk mental state’ (ARMS). Schizophr Res 162, 7-13.

321. Kerestes, R., Harrison, B.J., Dandash, O., Stephanou, K., Whittle, S., Pujol, J., Davey, C.G., 2015. Specific functional connectivity alterations of the dorsal striatum in young people with depression. Neuroimage Clin 7, 266-272.

322. Klauser, P., Fornito, A., Lorenzetti, V., Davey, C.G., Dwyer, D.B., Allen, N.B., Yucel, M., 2015. Cortico-limbic network abnormalities in individuals with current and past major depressive disorder. J Affect Disord 173, 45-52.

323. Klauser, P., Whittle, S., Simmons, J.G., Byrne, M.L., Mundy, L.K., Patton, G.C., Fornito, A., Allen, N.B., 2015. Reduced frontal white matter volume in children with early onset of adrenarche. Psychoneuroendocrinology 52, 111-118.

324. Klauser, P., Zhou, J., Lim, J.K., Poh, J.S., Zheng, H., Tng, H.Y., Krishnan, R., Lee, J., Keefe, R.S., Adcock, R.A., Wood, S.J., Fornito, A., Chee, M.W., 2015. Lack of Evidence for Regional Brain Volume or Cortical Thickness Abnormalities in Youths at Clinical High Risk for Psychosis: Findings From the Longitudinal Youth at Risk Study. Schizophr Bull 41, 1285-1293.

325. Kulkarni, J., Gavrilidis, E., Wang, W., Worsley, R., Fitzgerald, P.B., Gurvich, C., Van Rheenen, T., Berk, M., Burger, H., 2015. Estradiol for treatment-resistant schizophrenia: a large-scale randomized-controlled trial in women of child-bearing age. Mol Psychiatry 20, 695-702.

326. Lee, T.T., Chana, G., Gorry, P.R., Ellett, A., Bousman, C.A., Churchill, M.J., Gray, L.R., Everall, I.P., 2015. Inhibition of catechol-O-methyl transferase (COMT) by tolcapone restores reductions in microtubule-associated protein 2 (MAP2) and synaptophysin (SYP) following exposure of neuronal cells to neurotropic HIV. J Neurovirol 21, 535-543.


327. Liberg, B., Rahm, C., 2015. The functional anatomy of psychomotor disturbances in major depressive disorder. Front Psychiatry 6, 34.

328. Lieblich, S.M., Castle, D.J., Pantelis, C., Hopwood, M., Young, A.H., Everall, I.P., 2015. High heterogeneity and low reliability in the diagnosis of major depression will impair the development of new drugs. BJPsych Open 1, e5-e7.

329. Lin, A., Brewer, W.J., Yung, A.R., Nelson, B., Pantelis, C., Wood, S.J., 2015. Olfactory identification deficits at identification as ultra-high risk for psychosis are associated with poor functional outcome. Schizophr Res 161, 156-162.

330. Lin, A., Wood, S.J., 2015. Understanding the course of cognitive deficits over the onset of psychosis. Evid Based Ment Health 18, 87.

331. Lin, A., Wood, S.J., Nelson, B., Beavan, A., McGorry, P., Yung, A.R., 2015. Outcomes of nontransitioned cases in a sample at ultra-high risk for psychosis. Am J Psychiatry 172, 249-258.

332. Lins-Martins, N.M., Yucel, M., Tovar-Moll, F., Rodrigues, E.C., Fontenelle, L.F., 2015. Electroconvulsive therapy in obsessive-compulsive disorder: a chart review and evaluation of its potential therapeutic effects. J Neuropsychiatry Clin Neurosci 27, 65-68.

333. Little, K., Olsson, C.A., Youssef, G.J., Whittle, S., Simmons, J.G., Yucel, M., Sheeber, L.B., Foley, D.L., Allen, N.B., 2015. Linking the serotonin transporter gene, family environments, hippocampal volume and depression onset: A prospective imaging gene x environment analysis. J Abnorm Psychol 124, 834-849.

334. Loh, P.R., Bhatia, G., Gusev, A., Finucane, H.K., Bulik-Sullivan, B.K., Pollack, S.J., de Candia, T.R., Lee, S.H., Wray, N.R., Kendler, K.S., O’Donovan, M.C., Neale, B.M., Patterson, N., Price, A.L., 2015. Contrasting genetic architectures of schizophrenia and other complex diseases using fast variance-components analysis. Nat Genet 47, 1385-1392.

335. Looi, J.C., Liberg, B., 2015. Advice for a young psychiatrist researcher. Aust N Z J Psychiatry 49, 683-685.

336. Looi, J.C., Liberg, B., 2015. Between Scylla and Charybdis: DSM-5/ICD-11 and RDoC in neuropsychiatry? Aust N Z J Psychiatry 49, 82-83.

337. Lorenzetti, V., Solowij, N., Whittle, S., Fornito, A., Lubman, D.I., Pantelis, C., Yucel, M., 2015. Gross morphological brain changes with chronic, heavy cannabis use. Br J Psychiatry 206, 77-78.

338. Louise, S., Gurvich, C., Neill, E., Tan, E.J., Van Rheenen, T.E., Rossell, S., 2015. Schizotypal Traits are Associated with Poorer Executive Functioning in Healthy Adults. Front Psychiatry 6, 79.

339. Lubman, D.I., Cheetham, A., Yucel, M., 2015. Cannabis and adolescent brain development. Pharmacol Ther 148, 1-16.

340. Macfarlane, M.D., Jakabek, D., Walterfang, M., Vestberg, S., Velakoulis, D., Wilkes, F.A., Nilsson, C., van Westen, D., Looi, J.C., Santillo, A.F., 2015. Striatal Atrophy in the Behavioural Variant of Frontotemporal Dementia: Correlation with Diagnosis, Negative Symptoms and Disease Severity. PLoS One 10, e0129692.

341. Macfarlane, M.D., Looi, J.C., Walterfang, M., Spulber, G., Velakoulis, D., Styner, M., Crisby, M., Orndahl, E., Erkinjuntti, T., Waldemar, G., Garde, E., Hennerici, M.G., Bazner, H., Blahak, C., Wallin, A., Wahlund, L.O., 2015. Shape abnormalities of the caudate nucleus correlate with poorer gait and balance: results from a subset of the LADIS study. Am J Geriatr Psychiatry 23, 59-71.e51.

342. Makary, A.T., Testa, R., Tonge, B.J., Einfeld, S.L., Mohr, C., Gray, K.M., 2015. Association between adaptive behaviour and age in adults with Down syndrome without dementia: examining the range and severity of adaptive behaviour problems. J Intellect Disabil Res 59, 689-702.

343. Malpas, C.B., Saling, M.M., Velakoulis, D., Desmond, P., Hicks, R.J., O’Brien, T.J., 2015. Longitudinal Partial Volume Correction in 2-[18F]-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Studies of Alzheimer Disease. J Comput Assist Tomogr 39, 559-564.

344. Malpas, C.B., Saling, M.M., Velakoulis, D., Desmond, P., O’Brien, T.J., 2015. Tau and Amyloid-beta Cerebrospinal Fluid Biomarkers have Differential Relationships with Cognition in Mild Cognitive Impairment. J Alzheimers Dis 47, 965-975.

345. Melca, I.A., Yucel, M., Mendlowicz, M.V., de Oliveira-Souza, R., Fontenelle, L.F., 2015. The correlates of obsessive-compulsive, schizotypal, and borderline personality disorders in obsessive-compulsive disorder. J Anxiety Disord 33, 15-24.

346. Mocellin, R., Scholes, A., Walterfang, M., Looi, J.C., Velakoulis, D., 2015. Clinical update on frontotemporal dementia: diagnosis and treatment. Australas Psychiatry 23, 481-487.

347. Mundy, L.K., Romaniuk, H., Canterford, L., Hearps, S., Viner, R.M., Bayer, J.K., Simmons, J.G., Carlin, J.B., Allen, N.B., Patton, G.C., 2015. Adrenarche and the Emotional and Behavioral Problems of Late Childhood. J Adolesc Health 57, 608-616.

348. Nguyen, T.B., Gunn, J.M., Potiriadis, M., Everall, I.P., Bousman, C.A., 2015. Serotonin transporter polymorphism (5HTTLPR), severe childhood abuse and depressive symptom trajectories in adulthood. BJPsych Open 1, 104-109.

349. O’Donoghue, B., Nelson, B., Yuen, H.P., Lane, A., Wood, S., Thompson, A., Lin, A., McGorry, P., Yung, A.R., 2015. Social environmental risk factors for transition to psychosis in an Ultra-High Risk population. Schizophr Res 161, 150-155.



350. O’Donoghue, B., Yung, A.R., Wood, S., Thompson, A., Lin, A., McGorry, P., Nelson, B., 2015. Neighbourhood characteristics and the rate of identification of young people at ultra-high risk for psychosis. Schizophr Res 169, 214-216.

351. Pantelis, C., Wannan, C., Bartholomeusz, C.F., Allott, K., McGorry, P.D., 2015. Cognitive Intervention in Early Psychosis – Preserving abilities versus remediating deficits. Current Opinion in Behavioural Sciences 4, 63-72.

352. Power, B.D., Wilkes, F.A., Hunter-Dickson, M., van Westen, D., Santillo, A.F., Walterfang, M., Nilsson, C., Velakoulis, D., Looi, J.C., 2015. Validation of a protocol for manual segmentation of the thalamus on magnetic resonance imaging scans. Psychiatry Res 232, 98-105.

353. Purcell, R., Jorm, A.F., Hickie, I.B., Yung, A.R., Pantelis, C., Amminger, G.P., Glozier, N., Killackey, E., Phillips, L., Wood, S.J., Mackinnon, A., Scott, E., Kenyon, A., Mundy, L., Nichles, A., Scaffidi, A., Spiliotacopoulos, D., Taylor, L., Tong, J.P., Wiltink, S., Zmicerevska, N., Hermens, D., Guastella, A., McGorry, P.D., 2015. Transitions Study of predictors of illness progression in young people with mental ill health: study methodology. Early Interv Psychiatry 9, 38-47.

354. Purcell, R., Jorm, A.F., Hickie, I.B., Yung, A.R., Pantelis, C., Amminger, G.P., Glozier, N., Killackey, E., Phillips, L.J., Wood, S.J., Harrigan, S., Mackinnon, A., Scott, E., Hermens, D.F., Guastella, A.J., Kenyon, A., Mundy, L., Nichles, A., Scaffidi, A., Spiliotacopoulos, D., Taylor, L., Tong, J.P., Wiltink, S., Zmicerevska, N., McGorry, P.D., 2015. Demographic and clinical characteristics of young people seeking help at youth mental health services: baseline findings of the Transitions Study. Early Interv Psychiatry 9, 487-497.

355. Rapado-Castro, M., Bartholomeusz, C.F., Castro-Fornieles, J., Gonzalez-Pinto, A., Otero, S., Baeza, I., Moreno, C., Graell, M., Janssen, J., Bargallo, N., Pantelis, C., Desco, M., Arango, C., 2015. Gender effects on brain changes in early-onset psychosis. Eur Child Adolesc Psychiatry 24, 1193-1205.

356. Rapado-Castro, M., Berk, M., Venugopal, K., Bush, A.I., Dodd, S., Dean, O.M., 2015. Towards stage specific treatments: effects of duration of illness on therapeutic response to adjunctive treatment with N-acetyl cysteine in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 57, 69-75.

357. Rapado-Castro, M., McGorry, P.D., Yung, A., Calvo, A., Nelson, B., 2015. Sources of clinical distress in young people at ultra high risk of psychosis. Schizophr Res 165, 15-21.

358. Rapado-Castro, M., Pazos, A., Fananas, L., Bernardo, M., Ayuso-Mateos, J.L., Leza, J.C., Berrocoso, E., de Arriba, J., Roldan, L., Sanjuan, J., Perez, V., Haro, J.M., Palomo, T., Valdizan, E.M., Mico, J.A., Sanchez, M., Arango, C., 2015. Building up careers in translational neuroscience and mental health research: Education and training in the Centre for Biomedical Research in Mental Health. Rev Psiquiatr Salud Ment 8, 65-74.

359. Reniers, R.L., Garner, B., Phassouliotis, C., Phillips, L.J., Markulev, C., Pantelis, C., Bendall, S., McGorry, P.D., Wood, S.J., 2015. The relationship between stress, HPA axis functioning and brain structure in first episode psychosis over the first 12 weeks of treatment. Psychiatry Res 231, 111-119.

360. Rossell, S.L., Harrison, B.J., Castle, D., 2015. Can understanding the neurobiology of body dysmorphic disorder (BDD) inform treatment? Australas Psychiatry 23, 361-364.

361. Sale, M.V., Mattingley, J.B., Zalesky, A., Cocchi, L., 2015. Imaging human brain networks to improve the clinical efficacy of non-invasive brain stimulation. Neurosci Biobehav Rev 57, 187-198.

362. Savage, K.M., Stough, C.K., Byrne, G.J., Scholey, A., Bousman, C., Murphy, J., Macdonald, P., Suo, C., Hughes, M., Thomas, S., Teschke, R., Xing, C., Sarris, J., 2015. Kava for the treatment of generalised anxiety disorder (K-GAD): study protocol for a randomised controlled trial. Trials 16, 493.

363. Shirtcliff, E.A., Dismukes, A.R., Marceau, K., Ruttle, P.L., Simmons, J.G., Han, G., 2015. A dual-axis approach to understanding neuroendocrine development. Dev Psychobiol 57, 643-653.

364. Simmons, J.G., Byrne, M.L., Schwartz, O.S., Whittle, S.L., Sheeber, L., Kaess, M., Youssef, G.J., Allen, N.B., 2015. Dual-axis hormonal covariation in adolescence and the moderating influence of prior trauma and aversive maternal parenting. Dev Psychobiol 57, 670-687.

365. Singh, A.B., Bousman, C.A., Ng, C.H., Byron, K., Berk, M., 2015. Effects of persisting emotional impact from child abuse and norepinephrine transporter genetic variation on antidepressant efficacy in major depression: a pilot study. Clin Psychopharmacol Neurosci 13, 53-61.


366. Skafidas, E., Testa, R., Zantomio, D., Chana, G., Everall, I.P., Pantelis, C., 2015. Response to Robinson et al. Mol Psychiatry 20, 794.

367. Strikwerda-Brown, C., Davey, C.G., Whittle, S., Allen, N.B., Byrne, M.L., Schwartz, O.S., Simmons, J.G., Dwyer, D., Harrison, B.J., 2015. Mapping the relationship between subgenual cingulate cortex functional connectivity and depressive symptoms across adolescence. Soc Cogn Affect Neurosci 10, 961-968.

368. Thomas, N., Pantelis, C., 2015. Psychotic Disorders. In: Cautin, R.L., Lilienfeld, S.O. (Eds.), The Encyclopedia of Clinical Psychology. John Wiley & Sons, Inc, NJ, USA, p. 16.

369. Thomson, D., Berk, M., Dodd, S., Rapado-Castro, M., Quirk, S.E., Ellegaard, P.K., Berk, L., Dean, O.M., 2015. Tobacco use in bipolar disorder. Clin Psychopharmacol Neurosci 13, 1-11.

370. Turner, L.M., Croft, R.J., Churchyard, A., Looi, J.C., Apthorp, D., Georgiou-Karistianis, N., 2015. Abnormal Electrophysiological Motor Responses in Huntington’s Disease: Evidence of Premanifest Compensation. PLoS One 10, e0138563.

371. Van Rheenen, T.E., Davidson, S.K., Giorlando, F., Gliddon, E., Dean, O.M., 2015. Fostering early and mid-career research in affective disorders. Aust N Z J Psychiatry 49, 387-388.

372. Van Rheenen, T.E., Murray, G., Rossell, S.L., 2015. Emotion regulation in bipolar disorder: profile and utility in predicting trait mania and depression propensity. Psychiatry Res 225, 425-432.

373. Via, E., Soriano-Mas, C., Sanchez, I., Forcano, L., Harrison, B.J., Davey, C.G., Pujol, J., Martinez-Zalacain, I., Menchon, J.M., Fernandez-Aranda, F., Cardoner, N., 2015. Abnormal Social Reward Responses in Anorexia Nervosa: An fMRI Study. PLoS One 10, e0133539.

374. Vilhjalmsson, B.J., Yang, J., Finucane, H.K., Gusev, A., Lindstrom, S., Ripke, S., Genovese, G., Loh, P.R., Bhatia, G., Do, R., Hayeck, T., Won, H.H., Kathiresan, S., Pato, M., Pato, C., Tamimi, R., Stahl, E., Zaitlen, N., Pasaniuc, B., Belbin, G., Kenny, E.E., Schierup, M.H., De Jager, P., Patsopoulos, N.A., McCarroll, S., Daly, M., Purcell, S., Chasman, D., Neale, B., Goddard, M., Visscher, P.M., Kraft, P., Patterson, N., Price, A.L., 2015. Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores. Am J Hum Genet 97, 576-592.

375. Waloszek, J.M., Schwartz, O., Simmons, J.G., Blake, M., Blake, L., Murray, G., Raniti, M., Dahl, R.E., O’Brien-Simpson, N., Dudgeon, P., Trinder, J., Allen, N.B., 2015. The SENSE Study (Sleep and Education: learning New Skills Early): a community cognitive-behavioural therapy and mindfulness-based sleep intervention to prevent depression and improve cardiac health in adolescence. BMC Psychol 3, 39.

376. Wang, Y., Yan, C., Yin, D.Z., Fan, M.X., Cheung, E.F., Pantelis, C., Chan, R.C., 2015. Neurobiological changes of schizotypy: evidence from both volume-based morphometric analysis and resting-state functional connectivity. Schizophr Bull 41 Suppl 2, S444-454.

377. Wells, R., Swaminathan, V., Sundram, S., Weinberg, D., Bruggemann, J., Jacomb, I., Cropley, V., Lenroot, R., Pereira, A.M., Zalesky, A., Bousman, C., Pantelis, C., Weickert, C.S., Weickert, T.W., 2015. The impact of premorbid and current intellect in schizophrenia: cognitive, symptom, and functional outcomes. NPJ Schizophr 1, 15043.

378. Whitford, T.J., Kubicki, M., Pelavin, P.E., Lucia, D., Schneiderman, J.S., Pantelis, C., McCarley, R.W., Shenton, M.E., 2015. Cingulum bundle integrity associated with delusions of control in schizophrenia: Preliminary evidence from diffusion-tensor tractography. Schizophr Res 161, 36-41.

379. Whittle, S., Simmons, J.G., Byrne, M.L., Strikwerda-Brown, C., Kerestes, R., Seal, M.L., Olsson, C.A., Dudgeon, P., Mundy, L.K., Patton, G.C., Allen, N.B., 2015. Associations between early adrenarche, affective brain function and mental health in children. Soc Cogn Affect Neurosci 10, 1282-1290.

380. Wood, S.J., Reniers, R.L., Pantelis, C., 2015. Adolescent brain development and implications for mental health. In: Yung, A., McGorry, P.D. (Eds.), Youth Mental Health.

381. Yücel, M., Whittle, S., Youssef, G.J., Kashyap, H., Simmons, J.G., Schwartz, O., Lubman, D.I., Allen, N.B., 2015. The influence of sex, temperament, risk-taking and mental health on the emergence of gambling: a longitudinal study of young people. International Gambling Studies 15, 108-123.

382. Zalesky, A., Breakspear, M., 2015. Towards a statistical test for functional connectivity dynamics. Neuroimage 114, 466-470.

383. Zalesky, A., Pantelis, C., Cropley, V., Fornito, A., Cocchi, L., McAdams, H., Clasen, L., Greenstein, D., Rapoport, J.L., Gogtay, N., 2015. Delayed Development of Brain Connectivity in Adolescents With Schizophrenia and Their Unaffected Siblings. JAMA Psychiatry 72, 900-908.

384. Zantomio, D., Chana, G., Laskaris, L., Testa, R., Everall, I., Pantelis, C., Skafidas, E., 2015. Convergent evidence for mGluR5 in synaptic and neuroinflammatory pathways implicated in ASD. Neurosci Biobehav Rev 52, 172-177.

385. Zhang, R., Wei, Q., Kang, Z., Zalesky, A., Li, M., Xu, Y., Li, L., Wang, J., Zheng, L., Wang, B., Zhao, J., Zhang, J., Huang, R., 2015. Disrupted brain anatomical connectivity in medication-naive patients with first-episode schizophrenia. Brain Struct Funct 220, 1145-1159.



2016386. 2016. Australian Brain Alliance. Neuron 92, 597-600.

387. Abu-Akel, A., Reniers, R.L., Wood, S.J., 2016. Visual-spatial processing and working-memory load as a function of negative and positive psychotic-like experiences. Cogn Neuropsychiatry 21, 402-411.

388. Abu-Akel, A.M., Apperly, I.A., Wood, S.J., Hansen, P.C., 2016. Autism and psychosis expressions diametrically modulate the right temporoparietal junction. Soc Neurosci, 1-13.

389. Adams, C.E., Jayaram, M., Bodart, A.Y., Sampson, S., Zhao, S., Montgomery, A.A., 2016. Tweeting links to Cochrane Schizophrenia Group reviews: a randomised controlled trial. BMJ Open 6, e010509.

390. Bartholomeusz, C., Pantelis, C., 2016. Neuroimaging and staging: Do disparate mental illnesses have distinct neurobiological trajectories? In: McGorry, P.D., Hickie, I.B. (Eds.), Clinical Staging in Psychiatry: Making Diagnosis Meaningful for Clinical Care and Research. Cambridge University Press, Cambridge, UK.

391. Bastin, C., Harrison, B.J., Davey, C.G., Moll, J., Whittle, S., 2016. Feelings of shame, embarrassment and guilt and their neural correlates: A systematic review. Neurosci Biobehav Rev 71, 455-471.

392. Bigdeli, T.B., Ripke, S., Bacanu, S.A., Lee, S.H., Wray, N.R., Gejman, P.V., Rietschel, M., Cichon, S., St Clair, D., Corvin, A., Kirov, G., McQuillin, A., Gurling, H., Rujescu, D., Andreassen, O.A., Werge, T., Blackwood, D.H., Pato, C.N., Pato, M.T., Malhotra, A.K., O’Donovan, M.C., Kendler, K.S., Fanous, A.H., 2016. Genome-wide association study reveals greater polygenic loading for schizophrenia in cases with a family history of illness. Am J Med Genet B Neuropsychiatr Genet 171b, 276-289.

393. Blake, M., Waloszek, J.M., Schwartz, O., Raniti, M., Simmons, J.G., Blake, L., Murray, G., Dahl, R.E., Bootzin, R., Dudgeon, P., Trinder, J., Allen, N.B., 2016. The SENSE study: Post intervention effects of a randomized controlled trial of a cognitive-behavioral and mindfulness-based group sleep improvement intervention among at-risk adolescents. J Consult Clin Psychol 84, 1039-1051.

394. Blanco-Hinojo, L., Pujol, J., Harrison, B.J., Macia, D., Batalla, A., Nogue, S., Torrens, M., Farre, M., Deus, J., Martin-Santos, R., 2016. Attenuated frontal and sensory inputs to the basal ganglia in cannabis users. Addict Biol.

395. Bora, E., 2016. Differences in cognitive impairment between schizophrenia and bipolar disorder: Considering the role of heterogeneity. Psychiatry Clin Neurosci 70, 424-433.

396. Bora, E., Bartholomeusz, C., Pantelis, C., 2016. Meta-analysis of Theory of Mind (ToM) impairment in bipolar disorder. Psychol Med 46, 253-264.

397. Bora, E., Berk, M., 2016. Theory of mind in major depressive disorder: A meta-analysis. J Affect Disord 191, 49-55.

398. Bora, E., Hidiroglu, C., Ozerdem, A., Kacar, O.F., Sarisoy, G., Civil Arslan, F., Aydemir, O., Cubukcuoglu Tas, Z., Vahip, S., Atalay, A., Atasoy, N., Atesci, F., Tumkaya, S., 2016. Executive dysfunction and cognitive subgroups in a large sample of euthymic patients with bipolar disorder. Eur Neuropsychopharmacol 26, 1338-1347.

399. Bora, E., Kose, S., 2016. Meta-analysis of theory of mind in anorexia nervosa and bulimia nervosa: A specific Impairment of cognitive perspective taking in anorexia nervosa? Int J Eat Disord 49, 739-740.

400. Bora, E., Meletti, S., 2016. Social cognition in temporal lobe epilepsy: A systematic review and meta-analysis. Epilepsy Behav 60, 50-57.

401. Bora, E., Ozakbas, S., Velakoulis, D., Walterfang, M., 2016. Social Cognition in Multiple Sclerosis: a Meta-Analysis. Neuropsychol Rev 26, 160-172.

402. Bora, E., Pantelis, C., 2016. Social cognition in schizophrenia in comparison to bipolar disorder: A meta-analysis. Schizophr Res 175, 72-78.

403. Bora, E., Pantelis, C., 2016. Meta-analysis of social cognition in attention-deficit/hyperactivity disorder (ADHD): comparison with healthy controls and autistic spectrum disorder. Psychol Med 46, 699-716.


404. Bora, E., Velakoulis, D., Walterfang, M., 2016. Meta-Analysis of Facial Emotion Recognition in Behavioral Variant Frontotemporal Dementia: Comparison With Alzheimer Disease and Healthy Controls. J Geriatr Psychiatry Neurol 29, 205-211.

405. Bora, E., Velakoulis, D., Walterfang, M., 2016. Social cognition in Huntington’s disease: A meta-analysis. Behav Brain Res 297, 131-140.

406. Bora, E., Veznedaroglu, B., Vahip, S., 2016. Theory of mind and executive functions in schizophrenia and bipolar disorder: A cross-diagnostic latent class analysis for identification of neuropsychological subtypes. Schizophr Res 176, 500-505.

407. Bousman, C.A., Hopwood, M., 2016. Commercial pharmacogenetic-based decision-support tools in psychiatry. Lancet Psychiatry 3, 585-590.

408. Broyd, S.J., van Hell, H.H., Beale, C., Yucel, M., Solowij, N., 2016. Acute and Chronic Effects of Cannabinoids on Human Cognition-A Systematic Review. Biol Psychiatry 79, 557-567.

409. Byrne, M.L., Whittle, S., Allen, N.B., 2016. The Role of Brain Structure and Function in the Association Between Inflammation and Depressive Symptoms: A Systematic Review. Psychosom Med 78, 389-400.

410. Byrne, M.L., Whittle, S., Vijayakumar, N., Dennison, M., Simmons, J.G., Allen, N.B., 2016. A systematic review of adrenarche as a sensitive period in neurobiological development and mental health. Dev Cogn Neurosci.

411. Carter, A., Hendrikse, J., Lee, N., Yucel, M., Verdejo-Garcia, A., Andrews, Z., Hall, W., 2016. The Neurobiology of “Food Addiction” and Its Implications for Obesity Treatment and Policy. Annu Rev Nutr 36, 105-128.

412. Chee, K.Y., Evans, A.H., Velakoulis, D., 2016. Skin Picking Heralding Parkinson’s Disease. J Neuropsychiatry Clin Neurosci 28, e23-24.

413. Chen, Z., Lusicic, A., O’Brien, T.J., Velakoulis, D., Adams, S.J., Kwan, P., 2016. Psychotic disorders induced by antiepileptic drugs in people with epilepsy. Brain 139, 2668-2678.

414. Cheong, J.L., Bainbridge, A., Anderson, P.J., Lee, K.J., Burnett, A.C., Thompson, D.K., Roberts, G., Wood, S.J., Doyle, L.W., Robertson, N.J., 2016. Altered posterior cingulate brain metabolites and cognitive dysfunction in preterm adolescents. Pediatr Res 79, 716-722.

415. Choy, K.H., Shackleford, D.M., Malone, D.T., Mistry, S.N., Patil, R.T., Scammells, P.J., Langmead, C.J., Pantelis, C., Sexton, P.M., Lane, J.R., Christopoulos, A., 2016. Positive Allosteric Modulation of the Muscarinic M1 Receptor Improves Efficacy of Antipsychotics in Mouse Glutamatergic Deficit Models of Behavior. J Pharmacol Exp Ther 359, 354-365.

416. Cocchi, L., Sale, M.V., L, L.G., Bell, P.T., Nguyen, V.T., Zalesky, A., Breakspear, M., Mattingley, J.B., 2016. A hierarchy of timescales explains distinct effects of local inhibition of primary visual cortex and frontal eye fields. Elife 5.

417. Cropley, V.L., Lin, A., Nelson, B., Reniers, R.L., Yung, A.R., Bartholomeusz, C.F., Klauser, P., Velakoulis, D., McGorry, P., Wood, S.J., Pantelis, C., 2016. Baseline grey matter volume of non-transitioned “ultra high risk” for psychosis individuals with and without attenuated psychotic symptoms at long-term follow-up. Schizophr Res 173, 152-158.

418. Daglas, R., Allott, K., Yucel, M., Pantelis, C., Macneil, C.A., Berk, M., Cotton, S.M., 2016. The trajectory of cognitive functioning following first episode mania: A 12-month follow-up study. Aust N Z J Psychiatry 50, 1186-1197.

419. Daglas, R., Cotton, S.M., Allott, K., Yucel, M., Macneil, C.A., Hasty, M.K., Murphy, B., Pantelis, C., Hallam, K.T., Henry, L.P., Conus, P., Ratheesh, A., Kader, L., Wong, M.T., McGorry, P.D., Berk, M., 2016. A single-blind, randomised controlled trial on the effects of lithium and quetiapine monotherapy on the trajectory of cognitive functioning in first episode mania: A 12-month follow-up study. Eur Psychiatry 31, 20-28.

420. Davey, C.G., Lopez-Sola, C., Bui, M., Hopper, J.L., Pantelis, C., Fontenelle, L.F., Harrison, B.J., 2016. The effects of stress-tension on depression and anxiety symptoms: evidence from a novel twin modelling analysis. Psychol Med 46, 3213-3218.

421. Davey, C.G., Pujol, J., Harrison, B.J., 2016. Mapping the self in the brain’s default mode network. Neuroimage 132, 390-397.

422. Davis, J., Eyre, H., Jacka, F.N., Dodd, S., Dean, O., McEwen, S., Debnath, M., McGrath, J., Maes, M., Amminger, P., McGorry, P.D., Pantelis, C., Berk, M., 2016. A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis. Neurosci Biobehav Rev 65, 185-194.

423. Delany, F.M., Byrne, M.L., Whittle, S., Simmons, J.G., Olsson, C., Mundy, L.K., Patton, G.C., Allen, N.B., 2016. Depression, immune function, and early adrenarche in children. Psychoneuroendocrinology 63, 228-234.

424. Dileo, J.F., Brewer, W., Northam, E., Yucel, M., Anderson, V., 2016. Investigating the neurodevelopmental mediators of aggression in children with a history of child maltreatment: An exploratory field study. Child Neuropsychol, 1-23.

425. Dixon, R.W., Youssef, G.J., Hasking, P., Yucel, M., Jackson, A.C., Dowling, N.A., 2016. The relationship between gambling attitudes, involvement, and problems in adolescence: Examining the moderating role of coping strategies and parenting styles. Addict Behav 58, 42-46.



426. Dos Santos-Ribeiro, S., Lins-Martins, N.M., Frydman, I., Conceicao do Rosario, M., Ferrao, Y.A., Shavitt, R.G., Yucel, M., Miguel, E.C., Fontenelle, L.F., 2016. Prevalence and correlates of electroconvulsive therapy delivery in 1001 obsessive-compulsive disorder outpatients. Psychiatry Res 239, 145-148.

427. Ellis, R.E., Seal, M.L., Simmons, J.G., Whittle, S., Schwartz, O.S., Byrne, M.L., Allen, N.B., 2016. Longitudinal Trajectories of Depression Symptoms in Adolescence: Psychosocial Risk Factors and Outcomes. Child Psychiatry Hum Dev.

428. Ferrazzoli, D., Carter, A., Ustun, F.S., Palamara, G., Ortelli, P., Maestri, R., Yucel, M., Frazzitta, G., 2016. Dopamine Replacement Therapy, Learning and Reward Prediction in Parkinson’s Disease: Implications for Rehabilitation. Front Behav Neurosci 10, 121.

429. Fitzgibbon, B.M., Kirkovski, M., Fornito, A., Paton, B., Fitzgerald, P.B., Enticott, P.G., 2016. Emotion processing fails to modulate putative mirror neuron response to trained visuomotor associations. Neuropsychologia 84, 7-13.

430. Franke, B., Stein, J.L., Ripke, S., Anttila, V., Hibar, D.P., van Hulzen, K.J., Arias-Vasquez, A., Smoller, J.W., Nichols, T.E., Neale, M.C., McIntosh, A.M., Lee, P., McMahon, F.J., Meyer-Lindenberg, A., Mattheisen, M., Andreassen, O.A., Gruber, O., Sachdev, P.S., Roiz-Santianez, R., Saykin, A.J., Ehrlich, S., Mather, K.A., Turner, J.A., Schwarz, E., Thalamuthu, A., Yao, Y., Ho, Y.Y., Martin, N.G., Wright, M.J., O’Donovan, M.C., Thompson, P.M., Neale, B.M., Medland, S.E., Sullivan, P.F., 2016. Genetic influences on schizophrenia and subcortical brain volumes: large-scale proof of concept. Nat Neurosci 19, 420-431.

431. Fulcher, B.D., Fornito, A., 2016. A transcriptional signature of hub connectivity in the mouse connectome. Proc Natl Acad Sci U S A 113, 1435-1440.

432. Fullana, M.A., Harrison, B.J., Soriano-Mas, C., Vervliet, B., Cardoner, N., Avila-Parcet, A., Radua, J., 2016. Neural signatures of human fear conditioning: an updated and extended meta-analysis of fMRI studies. Mol Psychiatry 21, 500-508.

433. Ganella, E.P., Bartholomeusz, C.F., Seguin, C., Whittle, S., Bousman, C., Phassouliotis, C., Everall, I., Pantelis, C., Zalesky, A., 2016. Functional brain networks in treatment-resistant schizophrenia. Schizophr Res.

434. Genc, S., Steward, C.E., Malpas, C.B., Velakoulis, D., O’Brien, T.J., Desmond, P.M., 2016. Short-term white matter alterations in Alzheimer’s disease characterized by diffusion tensor imaging. J Magn Reson Imaging 43, 627-634.

435. Gimenez, M., Guinea-Izquierdo, A., Villalta-Gil, V., Martinez-Zalacain, I., Segalas, C., Subira, M., Real, E., Pujol, J., Harrison, B.J., Haro, J.M., Sato, J.R., Hoexter, M.Q., Cardoner, N., Alonso, P., Menchon, J.M., Soriano-Mas, C., 2016. Brain alterations in low-frequency fluctuations across multiple bands in obsessive compulsive disorder. Brain Imaging Behav.

436. Goh, A.M., Westphal, A., Daws, T., Gascoigne-Cohen, S., Hamilton, B., Lautenschlager, N.T., 2016. A retrospective study of medical comorbidities in psychogeriatric patients. Psychogeriatrics 16, 12-19.

437. Gurvich, C., Bozaoglu, K., Neill, E., Van Rheenen, T.E., Tan, E.J., Louise, S., Rossell, S.L., 2016. The dopamine D1 receptor gene is associated with negative schizotypy in a non-clinical sample. Psychiatry Res 235, 213-214.

438. Harding, I.H., Harrison, B.J., Breakspear, M., Pantelis, C., Yucel, M., 2016. Cortical Representations of Cognitive Control and Working Memory Are Dependent Yet Non-Interacting. Cereb Cortex 26, 557-565.

439. Hartmann, J.A., Yuen, H.P., McGorry, P.D., Yung, A.R., Lin, A., Wood, S.J., Lavoie, S., Nelson, B., 2016. Declining transition rates to psychotic disorder in “ultra-high risk” clients: Investigation of a dilution effect. Schizophr Res 170, 130-136.

440. Heinze, K., Lin, A., Reniers, R.L., Wood, S.J., 2016. Longer-term increased cortisol levels in young people with mental health problems. Psychiatry Res 236, 98-104.

441. Hung, Y.H., Walterfang, M., Churilov, L., Bray, L., Jacobson, L.H., Barnham, K.J., Jones, N.C., O’Brien, T.J., Velakoulis, D., Bush, A.I., 2016. Neurological Dysfunction in Early Maturity of a Model for Niemann-Pick C1 Carrier Status. Neurotherapeutics 13, 614-622.

442. Jakabek, D., Yucel, M., Lorenzetti, V., Solowij, N., 2016. An MRI study of white matter tract integrity in regular cannabis users: effects of cannabis use and age. Psychopharmacology (Berl) 233, 3627-3637.

443. Jenkins, L.M., Andrewes, D.G., Nicholas, C.L., Drummond, K.J., Moffat, B.A., Phal, P.M., Desmond, P., 2016. Emotional reactivity following surgery to the prefrontal cortex. J Neuropsychol.


444. Johnson, K.A., Macfarlane, M.D., Looi, J.C., 2016. Affective disorders and functional (non-epileptic) seizures in persons with epilepsy. Australas Psychiatry 24, 526-528.

445. Johnstone, B., Velakoulis, D., Yuan, C.Y., Ang, A., Steward, C., Desmond, P., O’Brien, T.J., 2016. Early childhood trauma and hippocampal volumes in patients with epileptic and psychogenic seizures. Epilepsy Behav 64, 180-185.

446. Joshua, N., Van Rheenen, T.E., Castle, D.J., Rossell, S.L., 2016. Taking It at “Face Value”: The Use of Face Processing Strategies in Bipolar Disorder and Schizophrenia. J Int Neuropsychol Soc 22, 652-661.

447. Kandola, A., Hendrikse, J., Lucassen, P.J., Yucel, M., 2016. Aerobic Exercise as a Tool to Improve Hippocampal Plasticity and Function in Humans: Practical Implications for Mental Health Treatment. Front Hum Neurosci 10, 373.

448. Kaya, T., Yucel, M., Eraslan, O., Cinemre, H., Tamer, A., 2016. SEVERE HYPONATREMIA, EPISTAXIS, AND FLUOXETINE. J Ayub Med Coll Abbottabad 28, 204-205.

449. Kerestes, R., Segreti, A.M., Pan, L.A., Phillips, M.L., Birmaher, B., Brent, D.A., Ladouceur, C.D., 2016. Altered neural function to happy faces in adolescents with and at risk for depression. J Affect Disord 192, 143-152.

450. Laskaris, L.E., Di Biase, M.A., Everall, I., Chana, G., Christopoulos, A., Skafidas, E., Cropley, V.L., Pantelis, C., 2016. Microglial activation and progressive brain changes in schizophrenia. Br J Pharmacol 173, 666-680.

451. Liberg, B., Rahm, C., Panayiotou, A., Pantelis, C., 2016. Brain change trajectories that differentiate the major psychoses. Eur J Clin Invest 46, 658-674.

452. Lin, A., Wardenaar, K.J., Pontillo, M., De Crescenzo, F., Mazzone, L., Vicari, S., Wood, S.J., Beavan, A., Armando, M., 2016. Is it still correct to differentiate between early and very early onset psychosis? Schizophr Res 170, 211-216.

453. Looi, J.C., 2016. Neuropsychiatry: a synthesis of clinical and scientific fields for disorders of mind and body. Australas Psychiatry 24, 523-524.

454. López-Solà, C., Fontenelle, L., Bui, M., Hopper, J., Pantelis, C., Yücel, M., Menchón, J., Alonso, P., Harrison, B., 2016. Aetiological overlap between obsessive-compulsive related and anxiety disorder symptoms: multivariate twin study. Br J Psychiatry 208, 26-33.

455. Lopez-Sola, C., Fontenelle, L.F., Verhulst, B., Neale, M.C., Menchon, J.M., Alonso, P., Harrison, B.J., 2016. DISTINCT ETIOLOGICAL INFLUENCES ON OBSESSIVE-COMPULSIVE SYMPTOM DIMENSIONS: A MULTIVARIATE TWIN STUDY. Depress Anxiety 33, 179-191.

456. Lorenzetti, V., Alonso-Lana, S., Youssef, G.J., Verdejo-Garcia, A., Suo, C., Cousijn, J., Takagi, M., Yucel, M., Solowij, N., 2016. Adolescent Cannabis Use: What is the Evidence for Functional Brain Alteration? Curr Pharm Des 22, 6353-6365.

457. Lorenzetti, V., Cousijn, J., Solowij, N., Garavan, H., Suo, C., Yucel, M., Verdejo-Garcia, A., 2016. The Neurobiology of Cannabis Use Disorders: A Call for Evidence. Front Behav Neurosci 10, 86.

458. Lorenzetti, V., Solowij, N., Yucel, M., 2016. The Role of Cannabinoids in Neuroanatomic Alterations in Cannabis Users. Biol Psychiatry 79, e17-31.

459. Mackey, S., Kan, K.J., Chaarani, B., Alia-Klein, N., Batalla, A., Brooks, S., Cousijn, J., Dagher, A., de Ruiter, M., Desrivieres, S., Feldstein Ewing, S.W., Goldstein, R.Z., Goudriaan, A.E., Heitzeg, M.M., Hutchison, K., Li, C.S., London, E.D., Lorenzetti, V., Luijten, M., Martin-Santos, R., Morales, A.M., Paulus, M.P., Paus, T., Pearlson, G., Schluter, R., Momenan, R., Schmaal, L., Schumann, G., Sinha, R., Sjoerds, Z., Stein, D.J., Stein, E.A., Solowij, N., Tapert, S., Uhlmann, A., Veltman, D., van Holst, R., Walter, H., Wright, M.J., Yucel, M., Yurgelun-Todd, D., Hibar, D.P., Jahanshad, N., Thompson, P.M., Glahn, D.C., Garavan, H., Conrod, P., 2016. Genetic imaging consortium for addiction medicine: From neuroimaging to genes. Prog Brain Res 224, 203-223.

460. Malpas, C.B., Genc, S., Saling, M.M., Velakoulis, D., Desmond, P.M., O’Brien, T.J., 2016. MRI correlates of general intelligence in neurotypical adults. J Clin Neurosci 24, 128-134.

461. Malpas, C.B., Saling, M.M., Velakoulis, D., Desmond, P., O’Brien, T.J., 2016. Differential Functional Connectivity Correlates of Cerebrospinal Fluid Biomarkers in Dementia of the Alzheimer’s Type. Neurodegener Dis 16, 147-151.

462. Malpas, C.B., Vivash, L., Genc, S., Saling, M.M., Desmond, P., Steward, C., Hicks, R.J., Callahan, J., Brodtmann, A., Collins, S., Macfarlane, S., Corcoran, N.M., Hovens, C.M., Velakoulis, D., O’Brien, T.J., 2016. A Phase IIa Randomized Control Trial of VEL015 (Sodium Selenate) in Mild-Moderate Alzheimer’s Disease. J Alzheimers Dis 54, 223-232.

463. Mata, F., Verdejo-Roman, J., Soriano-Mas, C., Yucel, M., Verdejo-Garcia, A., 2016. Changes in choice evoked brain activations after a weight loss intervention in adolescents. Appetite 103, 113-117.

464. Mechelli, A., Lin, A., Wood, S., McGorry, P., Amminger, P., Tognin, S., McGuire, P., Young, J., Nelson, B., Yung, A., 2016. Using clinical information to make individualized prognostic predictions in people at ultra high risk for psychosis. Schizophr Res.



465. Mehta, D., Tropf, F.C., Gratten, J., Bakshi, A., Zhu, Z., Bacanu, S.A., Hemani, G., Magnusson, P.K., Barban, N., Esko, T., Metspalu, A., Snieder, H., Mowry, B.J., Kendler, K.S., Yang, J., Visscher, P.M., McGrath, J.J., Mills, M.C., Wray, N.R., Lee, S.H., Andreassen, O.A., Bramon, E., Bruggeman, R., Buxbaum, J.D., Cairns, M.J., Cantor, R.M., Cloninger, C.R., Cohen, D., Crespo-Facorro, B., Darvasi, A., DeLisi, L.E., Dinan, T., Djurovic, S., Donohoe, G., Drapeau, E., Escott-Price, V., Freimer, N.B., Georgieva, L., de Haan, L., Henskens, F.A., Joa, I., Julia, A., Khrunin, A., Lerer, B., Limborska, S., Loughland, C.M., Macek, M., Jr., Magnusson, P.K., Marsal, S., McCarley, R.W., McIntosh, A.M., McQuillin, A., Melegh, B., Michie, P.T., Morris, D.W., Murphy, K.C., Myin-Germeys, I., Olincy, A., Van Os, J., Pantelis, C., Posthuma, D., Quested, D., Schall, U., Scott, R.J., Seidman, L.J., Toncheva, D., Tooney, P.A., Waddington, J., Weinberger, D.R., Weiser, M., Wu, J.Q., 2016. Evidence for Genetic Overlap Between Schizophrenia and Age at First Birth in Women. JAMA Psychiatry 73, 497-505.

466. Molina Ruiz, R.M., Evans, A.H., Velakoulis, D., Looi, J.C., 2016. Neuropsychiatric manifestations of Parkinson’s disease. Australas Psychiatry 24, 529-533.

467. Molina Ruiz, R.M., Evans, A.H., Velakoulis, D., Looi, J.C., 2016. A guide to management of neuropsychiatric manifestations of Parkinson’s disease. Australas Psychiatry 24, 534-537.

468. Mostaid, M.S., Lloyd, D., Liberg, B., Sundram, S., Pereira, A., Pantelis, C., Karl, T., Weickert, C.S., Everall, I.P., Bousman, C.A., 2016. Neuregulin-1 and schizophrenia in the genome-wide association study era. Neurosci Biobehav Rev 68, 387-409.

469. Murray, C.R., Simmons, J.G., Allen, N.B., Byrne, M.L., Mundy, L.K., Seal, M.L., Patton, G.C., Olsson, C.A., Whittle, S., 2016. Associations between dehydroepiandrosterone (DHEA) levels, pituitary volume, and social anxiety in children. Psychoneuroendocrinology 64, 31-39.

470. Newman, L., Judd, F., Olsson, C.A., Castle, D., Bousman, C., Sheehan, P., Pantelis, C., Craig, J.M., Komiti, A., Everall, I., 2016. Early origins of mental disorder - risk factors in the perinatal and infant period. BMC Psychiatry 16, 270.

471. Ng, C.H., Bousman, C., Smith, D.J., Dowling, N., Byron, K., King, J., Sarris, J., 2016. A Prospective Study of Serotonin and Norepinephrine Transporter Genes and the Response to Desvenlafaxine Over 8 Weeks in Major Depressive Disorder. Pharmacopsychiatry 49, 210-212.

472. O’Connor, K., Nelson, B., Lin, A., Wood, S.J., Yung, A., Thompson, A., 2016. Are UHR patients who present with hallucinations alone at lower risk of transition to psychosis? Psychiatry Res 235, 177-196.

473. O’Dea, B., Lee, R.S., McGorry, P.D., Hickie, I.B., Scott, J., Hermens, D.F., Mykeltun, A., Purcell, R., Killackey, E., Pantelis, C., Amminger, G.P., Glozier, N., 2016. A prospective cohort study of depression course, functional disability, and NEET status in help-seeking young adults. Soc Psychiatry Psychiatr Epidemiol 51, 1395-1404.

474. Oostermeijer, S., Whittle, S., Suo, C., Allen, N.B., Simmons, J.G., Vijayakumar, N., van de Ven, P.M., Jansen, L.M., Yucel, M., Popma, A., 2016. Trajectories of adolescent conduct problems in relation to cortical thickness development: a longitudinal MRI study. Transl Psychiatry 6, e899.

475. Pujol, J., Blanco-Hinojo, L., Esteba-Castillo, S., Caixas, A., Harrison, B.J., Bueno, M., Deus, J., Rigla, M., Macia, D., Llorente-Onaindia, J., Novell-Alsina, R., 2016. Anomalous basal ganglia connectivity and obsessive-compulsive behaviour in patients with Prader Willi syndrome. J Psychiatry Neurosci 41, 261-271.

476. Pujol, J., Fenoll, R., Forns, J., Harrison, B.J., Martinez-Vilavella, G., Macia, D., Alvarez-Pedrerol, M., Blanco-Hinojo, L., Gonzalez-Ortiz, S., Deus, J., Sunyer, J., 2016. Video gaming in school children: How much is enough? Ann Neurol 80, 424-433.

477. Rattehalli, R.D., Zhao, S., Li, B.G., Jayaram, M.B., Xia, J., Sampson, S., 2016. Risperidone versus placebo for schizophrenia. Cochrane Database Syst Rev 12, Cd006918.

478. Reniers, R.L., Murphy, L., Lin, A., Bartolome, S.P., Wood, S.J., 2016. Risk Perception and Risk-Taking Behaviour during Adolescence: The Influence of Personality and Gender. PLoS One 11, e0153842.

479. Richmond, S., Johnson, K.A., Seal, M.L., Allen, N.B., Whittle, S., 2016. Development of brain networks and relevance of environmental and genetic factors: A systematic review. Neurosci Biobehav Rev 71, 215-239.


480. Schmaal, L., Hibar, D.P., Samann, P.G., Hall, G.B., Baune, B.T., Jahanshad, N., Cheung, J.W., van Erp, T.G., Bos, D., Ikram, M.A., Vernooij, M.W., Niessen, W.J., Tiemeier, H., Hofman, A., Wittfeld, K., Grabe, H.J., Janowitz, D., Bulow, R., Selonke, M., Volzke, H., Grotegerd, D., Dannlowski, U., Arolt, V., Opel, N., Heindel, W., Kugel, H., Hoehn, D., Czisch, M., Couvy-Duchesne, B., Renteria, M.E., Strike, L.T., Wright, M.J., Mills, N.T., de Zubicaray, G.I., McMahon, K.L., Medland, S.E., Martin, N.G., Gillespie, N.A., Goya-Maldonado, R., Gruber, O., Kramer, B., Hatton, S.N., Lagopoulos, J., Hickie, I.B., Frodl, T., Carballedo, A., Frey, E.M., van Velzen, L.S., Penninx, B.W., van Tol, M.J., van der Wee, N.J., Davey, C.G., Harrison, B.J., Mwangi, B., Cao, B., Soares, J.C., Veer, I.M., Walter, H., Schoepf, D., Zurowski, B., Konrad, C., Schramm, E., Normann, C., Schnell, K., Sacchet, M.D., Gotlib, I.H., MacQueen, G.M., Godlewska, B.R., Nickson, T., McIntosh, A.M., Papmeyer, M., Whalley, H.C., Hall, J., Sussmann, J.E., Li, M., Walter, M., Aftanas, L., Brack, I., Bokhan, N.A., Thompson, P.M., Veltman, D.J., 2016. Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group. Mol Psychiatry.

481. Sekar, A., Bialas, A.R., de Rivera, H., Davis, A., Hammond, T.R., Kamitaki, N., Tooley, K., Presumey, J., Baum, M., Van Doren, V., Genovese, G., Rose, S.A., Handsaker, R.E., Daly, M.J., Carroll, M.C., Stevens, B., McCarroll, S.A., 2016. Schizophrenia risk from complex variation of complement component 4. Nature 530, 177-183.

482. Simmons, J.G., Badcock, P.B., Whittle, S.L., Byrne, M.L., Mundy, L., Patton, G.C., Olsson, C.A., Allen, N.B., 2016. The lifetime experience of traumatic events is associated with hair cortisol concentrations in community-based children. Psychoneuroendocrinology 63, 276-281.

483. Solowij, N., Lorenzetti, V., Yucel, M., 2016. Effects of Cannabis Use on Human Behavior: A Call for Standardization of Cannabis Use Metrics. JAMA Psychiatry 73, 995-996.

484. Soriano-Mas, C., Harrison, B., 2016. Brain functional connectivity in obsessive-compulsive disorder. In: Pittenger, C. (Ed.), Obsessive-compulsive disorde: Phenomenology, Pathophysiology & Treatment.

485. Stafford, L., Komiti, A., Bousman, C., Judd, F., Gibson, P., Mann, G.B., Quinn, M., 2016. Predictors of depression and anxiety symptom trajectories in the 24 months following diagnosis of breast or gynaecologic cancer. Breast 26, 100-105.

486. Stephanou, K., Davey, C., Kerestes, R., Whittle, S., Pujol, J., Yücel, M., Fornito, A., López-Solà, M., Harrison, B., 2016. Brain functional correlates of emotion regulation across adolescence and young adulthood. Hum Brain Mapp 37, 7-19.

487. Steward, T., Pico-Perez, M., Mata, F., Martinez-Zalacain, I., Cano, M., Contreras-Rodriguez, O., Fernandez-Aranda, F., Yucel, M., Soriano-Mas, C., Verdejo-Garcia, A., 2016. Emotion Regulation and Excess Weight: Impaired Affective Processing Characterized by Dysfunctional Insula Activation and Connectivity. PLoS One 11, e0152150.

488. Su, Y.A., Li, J.T., Dai, W.J., Liao, X.M., Dong, L.C., Lu, T.L., Bousman, C., Si, T.M., 2016. Genetic variation in the tryptophan hydroxylase 2 gene moderates depressive symptom trajectories and remission over 8 weeks of escitalopram treatment. Int Clin Psychopharmacol 31, 127-133.

489. Takahashi, T., Nishikawa, Y., Yucel, M., Whittle, S., Lorenzetti, V., Walterfang, M., Sasabayashi, D., Suzuki, M., Pantelis, C., Allen, N.B., 2016. Olfactory sulcus morphology in patients with current and past major depression. Psychiatry Res 255, 60-65.

490. Thompson, D.K., Chen, J., Beare, R., Adamson, C.L., Ellis, R., Ahmadzai, Z.M., Kelly, C.E., Lee, K.J., Zalesky, A., Yang, J.Y., Hunt, R.W., Cheong, J.L., Inder, T.E., Doyle, L.W., Seal, M.L., Anderson, P.J., 2016. Structural connectivity relates to perinatal factors and functional impairment at 7years in children born very preterm. Neuroimage 134, 328-337.

491. Thong, K.S., Chee, K.Y., Ng, C.G., Walterfang, M., Velakoulis, D., 2016. Psychometric properties of Malay neuropsychiatry unit cognitive assessment tool among Alzheimer’s disease patients in comparison to Malay Montreal Cognitive Assessment. Asia Pac Psychiatry 8, 238-240.

492. Turner, L.M., Jakabek, D., Wilkes, F.A., Croft, R.J., Churchyard, A., Walterfang, M., Velakoulis, D., Looi, J.C., Georgiou-Karistianis, N., Apthorp, D., 2016. Striatal morphology correlates with frontostriatal electrophysiological motor processing in Huntington’s disease: an IMAGE-HD study. Brain Behav 6, e00511.

493. Upthegrove, R., Broome, M.R., Caldwell, K., Ives, J., Oyebode, F., Wood, S.J., 2016. Understanding auditory verbal hallucinations: a systematic review of current evidence. Acta Psychiatr Scand 133, 352-367.

494. Upthegrove, R., Ives, J., Broome, M.R., Caldwell, K., Wood, S.J., Oyebode, F., 2016. Auditory verbal hallucinations in first-episode psychosis: a phenomenological investigation. BJPsych Open 2, 88-95.

495. Van Rheenen, T., Rossell, S., 2016. Facial Emotion Recognition Impairments in Bipolar Disorder. A Cognitive Problem? J Int Neuropsychol Soc 22, 583-585.

496. Van Rheenen, T.E., Bryce, S., Tan, E.J., Neill, E., Gurvich, C., Louise, S., Rossell, S.L., 2016. Does cognitive performance map to categorical diagnoses of schizophrenia, schizoaffective disorder and bipolar disorder? A discriminant functions analysis. J Affect Disord 192, 109-115.



497. Via, E., Goldberg, X., Sánchez, I., Forcano, L., Harrison, B., Davey, C., Pujol, J., Martínez-Zalacaín, I., Fernández-Aranda, F., Soriano-Mas, C., Cardoner, N., Menchón, J., 2016. Self and other body perception in anorexia nervosa: The role of posterior DMN nodes. World J Biol Psychiatry, 1-15.

498. Vijayakumar, N., Allen, N.B., Youssef, G., Dennison, M., Yucel, M., Simmons, J.G., Whittle, S., 2016. Brain development during adolescence: A mixed-longitudinal investigation of cortical thickness, surface area, and volume. Hum Brain Mapp 37, 2027-2038.

499. Vijayakumar, N., Allen, N.B., Youssef, G.J., Simmons, J.G., Byrne, M.L., Whittle, S., 2016. Neurodevelopmental Trajectories Related to Attention Problems Predict Driving-Related Risk Behaviors. Journal of Attention Disorders, 1087054716682336.

500. Vijayakumar, N., Bartholomeusz, C., Whitford, T., Hermens, D.F., Nelson, B., Rice, S., Whittle, S., Pantelis, C., McGorry, P., Schafer, M.R., Amminger, G.P., 2016. White matter integrity in individuals at ultra-high risk for psychosis: a systematic review and discussion of the role of polyunsaturated fatty acids. BMC Psychiatry 16, 287.

501. Vijayakumar, N., Whittle, S., Yucel, M., Byrne, M.L., Schwartz, O., Simmons, J.G., Allen, N.B., 2016. Impaired Maturation of Cognitive Control in Adolescents Who Develop Major Depressive Disorder. J Clin Child Adolesc Psychol 45, 31-43.

502. Vinckier, F., Gaillard, R., Palminteri, S., Rigoux, L., Salvador, A., Fornito, A., Adapa, R., Krebs, M.O., Pessiglione, M., Fletcher, P.C., 2016. Confidence and psychosis: a neuro-computational account of contingency learning disruption by NMDA blockade. Mol Psychiatry 21, 946-955.

503. Wang, C., Ji, F., Hong, Z., Poh, J.S., Krishnan, R., Lee, J., Rekhi, G., Keefe, R.S., Adcock, R.A., Wood, S.J., Fornito, A., Pasternak, O., Chee, M.W., Zhou, J., 2016. Disrupted salience network functional connectivity and white-matter microstructure in persons at risk for psychosis: findings from the LYRIKS study. Psychol Med 46, 2771-2783.

504. Wang, Y., Liu, W.H., Li, Z., Wei, X.H., Jiang, X.Q., Geng, F.L., Zou, L.Q., Lui, S.S., Cheung, E.F., Pantelis, C., Chan, R.C., 2016. Altered corticostriatal functional connectivity in individuals with high social anhedonia. Psychol Med 46, 125-135.

505. Webb, C., Gunn, J.M., Potiriadis, M., Everall, I.P., Bousman, C.A., 2016. The Brain-Derived Neurotrophic Factor Val66Met Polymorphism Moderates the Effects of Childhood Abuse on Severity of Depressive Symptoms in a Time-Dependent Manner. Front Psychiatry 7, 151.

506. White, T.P., Wigton, R., Joyce, D.W., Collier, T., Fornito, A., Shergill, S.S., 2016. Dysfunctional Striatal Systems in Treatment-Resistant Schizophrenia. Neuropsychopharmacology 41, 1274-1285.

507. Whittle, S., Liu, K., Bastin, C., Harrison, B.J., Davey, C.G., 2016. Neurodevelopmental correlates of proneness to guilt and shame in adolescence and early adulthood. Dev Cogn Neurosci 19, 51-57.

508. Whittle, S., Vijayakumar, N., Dennison, M., Schwartz, O., Simmons, J.G., Sheeber, L., Allen, N.B., 2016. Observed Measures of Negative Parenting Predict Brain Development during Adolescence. PLoS One 11, e0147774.

509. Winton-Brown, T., Doti, I., Ting, A., Atherton, S., Mocellin, R., Loyal, S., Gaillard, F., Velakoulis, D., 2016. A Case of Creutzfeldt-Jakob Disease Presenting as Catatonia. J Clin Psychiatry 77, e900-901.

510. Winton-Brown, T.T., Ting, A., Mocellin, R., Velakoulis, D., Gaillard, F., 2016. Reply. AJNR Am J Neuroradiol.

511. Winton-Brown, T.T., Ting, A., Mocellin, R., Velakoulis, D., Gaillard, F., 2016. Distinguishing Neuroimaging Features in Patients Presenting with Visual Hallucinations. AJNR Am J Neuroradiol 37, 774-781.

512. Yalincetin, B., Bora, E., Binbay, T., Ulas, H., Akdede, B.B., Alptekin, K., 2016. Formal thought disorder in schizophrenia and bipolar disorder: A systematic review and meta-analysis. Schizophr Res.

513. Youssef, G.J., Whittle, S., Allen, N.B., Lubman, D.I., Simmons, J.G., Yucel, M., 2016. Cognitive Control as a Moderator of Temperamental Motivations Toward Adolescent Risk-Taking Behavior. Child Dev 87, 395-404.

514. Yucel, M., Lorenzetti, V., Suo, C., Zalesky, A., Fornito, A., Takagi, M.J., Lubman, D.I., Solowij, N., 2016. Hippocampal harms, protection and recovery following regular cannabis use. Transl Psychiatry 6, e710.

515. Zalesky, A., Fornito, A., Cocchi, L., Gollo, L.L., van den Heuvel, M.P., Breakspear, M., 2016. Connectome sensitivity or specificity: which is more important? Neuroimage 142, 407-420.


516. Zhang, R., Jiang, G., Tian, J., Qiu, Y., Wen, X., Zalesky, A., Li, M., Ma, X., Wang, J., Li, S., Wang, T., Li, C., Huang, R., 2016. Abnormal white matter structural networks characterize heroin-dependent individuals: a network analysis. Addict Biol 21, 667-678.

517. Zhong, M., Peppard, R., Velakoulis, D., Evans, A.H., 2016. The relationship between specific cognitive defects and burden of care in Parkinson’s disease. Int Psychogeriatr 28, 275-281.

518. Zorlu, N., Angelique Di Biase, M., Kalayci, C.C., Zalesky, A., Bagci, B., Oguz, N., Gelal, F., Besiroglu, L., Gulseren, S., Saricicek, A., Bora, E., Pantelis, C., 2016. Abnormal white matter integrity in synthetic cannabinoid users. Eur Neuropsychopharmacol 26, 1818-1825.

2017 (January to April)519. Abu-Akel, A., Apperly, I.A., Wood, S.J., Hansen, P.C., Mevorach, C., 2017. Autism Tendencies and Psychosis Proneness Interactively

Modulate Saliency Cost. Schizophr Bull 43, 142-151.

520. Abu-Akel, A., Clark, J., Perry, A., Wood, S.J., Forty, L., Craddock, N., Jones, I., Gordon-Smith, K., Jones, L., 2017. Autistic and schizotypal traits and global functioning in bipolar I disorder. J Affect Disord 207, 268-275.

521. Abu-Akel, A., Testa, R.R., Jones, H.P., Ross, N., Skafidas, E., Tonge, B., Pantelis, C., 2017. Attentional and socio-pragmatic abilities in children with schizotypal and comorbid autism spectrum disorders. Aust N Z J Psychiatry in press (13/04/2017).

522. Badcock, P.B., Davey, C.G., Whittle, S., Allen, N.B., Friston, K.J., 2017. The Depressed Brain: An Evolutionary Systems Theory. Trends Cogn Sci 21, 182-194.

523. Bartholomeusz, C.F., Cropley, V.L., Wannan, C., Di Biase, M., McGorry, P.D., Pantelis, C., 2017. Structural neuroimaging across early-stage psychosis: Aberrations in neurobiological trajectories and implications for the staging model. Aust N Z J Psychiatry 51, 455-476.

524. Berger, G.E., Bartholomeusz, C.F., Wood, S.J., Ang, A., Phillips, L.J., Proffitt, T., Brewer, W.J., Smith, D., Nelson, B., Lin, A., Borgwardt, S., Velakoulis, D., Yung, A.R., McGorry, P.D., Pantelis, C., 2017. Ventricular volumes in ultra high-risk for psychosis, first episode psychosis and chronic schizophrenia. Aust N Z J Psychiatry in press (26/04/2017).

525. Berk, M., Daglas, R., Dandash, O., Yucel, M., Henry, L., Hallam, K., Macneil, C., Hasty, M., Pantelis, C., Murphy, B.P., Kader, L., Damodaran, S., Wong, M.T., Conus, P., Ratheesh, A., McGorry, P.D., Cotton, S.M., 2017. Quetiapine v. lithium in the maintenance phase following a first episode of mania: randomised controlled trial. Br J Psychiatry.

526. Berk, M., Dandash, O., Daglas, R., Cotton, S.M., Allott, K., Fornito, A., Suo, C., Klauser, P., Liberg, B., Henry, L., Macneil, C., Hasty, M., McGorry, P., Pantelis, C., Yucel, M., 2017. Neuroprotection after a first episode of mania: a randomized controlled maintenance trial comparing the effects of lithium and quetiapine on grey and white matter volume. Transl Psychiatry 7, e1041.

527. Blake, M., Schwartz, O., Waloszek, J.M., Raniti, M., Simmons, J.G., Murray, G., Blake, L., Dahl, R.E., Bootzin, R., McMakin, D.L., Dudgeon, P., Trinder, J., Allen, N.B., 2017. The SENSE Study: Treatment mechanisms of a cognitive behavioral and mindfulness-based group sleep improvement intervention for at-risk adolescents. Sleep.

528. Bora, E., 2017. Relationship between insight and theory of mind in schizophrenia: A meta-analysis. Schizophr Res.

529. Bora, E., 2017. Meta-analysis of social cognition in amyotrophic lateral sclerosis. Cortex 88, 1-7.

530. Bora, E., Akdede, B.B., Alptekin, K., 2017. The relationship between cognitive impairment in schizophrenia and metabolic syndrome: a systematic review and meta-analysis. Psychol Med 47, 1030-1040.

531. Bora, E., Aydin, A., Sarac, T., Kadak, M.T., Kose, S., 2017. Heterogeneity of subclinical autistic traits among parents of children with autism spectrum disorder: Identifying the broader autism phenotype with a data-driven method. Autism Res 10, 321-326.

532. Bora, E., Binnur Akdede, B., Alptekin, K., 2017. Neurocognitive impairment in deficit and non-deficit schizophrenia: a meta-analysis. Psychol Med, 1-14.

533. Bora, E., Jayaram, M., Pantelis, C., 2017. Early intervention in psychotic disorders. In: Andreasen, N.C., Geddes, J., Goodwin, G. (Eds.), New Oxford Textbook of Psychiatry. Oxford University Press, Oxford, UK.

534. Bora, E., Ozerdem, A., 2017. Social cognition in first-degree relatives of patients with bipolar disorder: A meta-analysis. Eur Neuropsychopharmacol 27, 293-300.

535. Bora, E., Pantelis, C., 2017. Challenges facing the identification of distinctive cognitive and neurobiological features of schizophrenia and bipolar disorder and the need for a data-driven approach: Response to Dr. Martino. Schizophr Res 183, 163.

536. Bora, E., Zorlu, N., 2017. Social cognition in alcohol use disorder: a meta-analysis. Addiction 112, 40-48.

537. Bousman, C.A., Forbes, M., Jayaram, M., Eyre, H., Reynolds, C.F., Berk, M., Hopwood, M., Ng, C., 2017. Antidepressant prescribing in the precision medicine era: a prescriber’s primer on pharmacogenetic tools. BMC Psychiatry 17, 60.



538. Bousman, C.A., Gunn, J.M., Potiriadis, M., Everall, I.P., 2017. Polygenic phenotypic plasticity moderates the effects of severe childhood abuse on depressive symptom severity in adulthood: A 5-year prospective cohort study. World J Biol Psychiatry 18, 75-81.

539. Bousman, C.A., Muller, D.J., Ng, C.H., Byron, K., Berk, M., Singh, A.B., 2017. Concordance between actual and pharmacogenetic predicted desvenlafaxine dose needed to achieve remission in major depressive disorder: a 10-week open-label study. Pharmacogenet Genomics 27, 1-6.

540. Bulic, D., Bennett, M., Rodgers, H., Nourse, M., Rubie, P., Looi, J.C., Van Haren, F., 2017. Delirium After Mechanical Ventilation in Intensive Care Units: The Cognitive and Psychosocial Assessment (CAPA) Study Protocol. JMIR Res Protoc 6, e31.

541. Byrne, M.L., Badcock, P.B., Simmons, J.G., Whittle, S., Pettitt, A., Olsson, C.A., Mundy, L.K., Patton, G.C., Allen, N.B., 2017. Self-reported parenting style is associated with children’s inflammation and immune activation. J Fam Psychol 31, 374-380.

542. Calamante, F., Smith, R.E., Liang, X., Zalesky, A., Connelly, A., 2017. Track-weighted dynamic functional connectivity (TW-dFC): a new method to study time-resolved functional connectivity. Brain Struct Funct.

543. Carney, R., Yung, A.R., Amminger, G.P., Bradshaw, T., Glozier, N., Hermens, D.F., Hickie, I.B., Killackey, E., McGorry, P., Pantelis, C., Wood, S.J., Purcell, R., 2017. Substance use in youth at risk for psychosis. Schizophr Res 181, 23-29.

544. Chee, K.Y., Gaillard, F., Velakoulis, D., Ang, C.L., Chin, L.K., Ariffin, R., 2017. A case of TREM2 mutation presenting with features of progressive non-fluent aphasia and without bone involvement. Aust N Z J Psychiatry, 4867417707821.

545. Cheetham, A., Allen, N.B., Whittle, S., Simmons, J., Yucel, M., Lubman, D.I., 2017. Orbitofrontal Cortex Volume and Effortful Control as Prospective Risk Factors for Substance Use Disorder in Adolescence. Eur Addict Res 23, 37-44.

546. Chye, Y., Solowij, N., Suo, C., Batalla, A., Cousijn, J., Goudriaan, A.E., Martin-Santos, R., Whittle, S., Lorenzetti, V., Yucel, M., 2017. Orbitofrontal and caudate volumes in cannabis users: a multi-site mega-analysis comparing dependent versus non-dependent users. Psychopharmacology (Berl).

547. Chye, Y., Suo, C., Yucel, M., den Ouden, L., Solowij, N., Lorenzetti, V., 2017. Cannabis-related hippocampal volumetric abnormalities specific to subregions in dependent users. Psychopharmacology (Berl).

548. Cocchi, L., Yang, Z., Zalesky, A., Stelzer, J., Hearne, L.J., Gollo, L.L., Mattingley, J.B., 2017. Neural decoding of visual stimuli varies with fluctuations in global network efficiency. Hum Brain Mapp 38, 3069-3080.

549. Cropley, V.L., Klauser, P., Lenroot, R.K., Bruggemann, J., Sundram, S., Bousman, C., Pereira, A., Di Biase, M.A., Weickert, T.W., Weickert, C.S., Pantelis, C., Zalesky, A., 2017. Accelerated Gray and White Matter Deterioration With Age in Schizophrenia. Am J Psychiatry 174, 286-295.

550. Dandash, O., Pantelis, C., Fornito, A., 2017. Dopamine, fronto-striato-thalamic circuits and risk for psychosis. Schizophr Res 180, 48-57.

551. Davey, C., Pujol, J., Breakspear, M., Harrison, B., 2017. A brain model of disturbed self appraisal in depression. Am J Psychiatry.

552. Davey, C.G., Lopez-Sola, C., Bui, M., Hopper, J.L., Pantelis, C., Fontenelle, L.F., Harrison, B.J., 2017. The effects of stress-tension on depression and anxiety symptoms: evidence from a novel twin modelling analysis. Psychol Med, 1.

553. Di Biase, M.A., Cropley, V., Baune, B.T., Olver, J., Amminger, G.P., Phassouliotis, C., Bousman, C., McGorry, P.D., Everall, I., Pantelis, C., Zalesky, A., 2017. White matter connectivity disruptions in early and chronic schizophrenia. Psychol Med in press (21/04/17).

554. Du, M., Wang, X., Yin, S., Shu, W., Hao, R., Zhao, S., Rao, H., Yeung, W.L., Jayaram, M.B., Xia, J., 2017. De-escalation techniques for psychosis-induced aggression or agitation. Cochrane Database Syst Rev 4, Cd009922.

555. Ellis, R., Seal, M.L., Adamson, C., Beare, R., Simmons, J.G., Whittle, S., Allen, N.B., 2017. Brain connectivity networks and longitudinal trajectories of depression symptoms in adolescence. Psychiatry Res 260, 62-69.

556. Ferreira, G.M., Yucel, M., Dawson, A., Lorenzetti, V., Fontenelle, L.F., 2017. Investigating the role of anticipatory reward and habit strength in obsessive-compulsive disorder. CNS Spectr, 1-10.


557. Guo, K., Youssef, G.J., Dawson, A., Parkes, L., Oostermeijer, S., Lopez-Sola, C., Lorenzetti, V., Greenwood, C., Fontenelle, L.F., Yucel, M., 2017. A psychometric validation study of the Impulsive-Compulsive Behaviours Checklist: A transdiagnostic tool for addictive and compulsive behaviours. Addict Behav 67, 26-33.

558. Harrison, B.J., Fullana, M.A., Via, E., Soriano-Mas, C., Vervliet, B., Martinez-Zalacain, I., Pujol, J., Davey, C.G., Kircher, T., Straube, B., Cardoner, N., 2017. Human ventromedial prefrontal cortex and the positive affective processing of safety signals. Neuroimage 152, 12-18.

559. Hendriksz, C.J., Anheim, M., Bauer, P., Bonnot, O., Chakrapani, A., Corvol, J.C., de Koning, T.J., Degtyareva, A., Dionisi-Vici, C., Doss, S., Duning, T., Giunti, P., Iodice, R., Johnston, T., Kelly, D., Klunemann, H.H., Lorenzl, S., Padovani, A., Pocovi, M., Synofzik, M., Terblanche, A., Then Bergh, F., Topcu, M., Tranchant, C., Walterfang, M., Velten, C., Kolb, S.A., 2017. The hidden Niemann-Pick type C patient: clinical niches for a rare inherited metabolic disease. Curr Med Res Opin 33, 877-890.

560. Howes, O.D., McCutcheon, R., Agid, O., de Bartolomeis, A., van Beveren, N.J., Birnbaum, M.L., Bloomfield, M.A., Bressan, R.A., Buchanan, R.W., Carpenter, W.T., Castle, D.J., Citrome, L., Daskalakis, Z.J., Davidson, M., Drake, R.J., Dursun, S., Ebdrup, B.H., Elkis, H., Falkai, P., Fleischacker, W.W., Gadelha, A., Gaughran, F., Glenthoj, B.Y., Graff-Guerrero, A., Hallak, J.E., Honer, W.G., Kennedy, J., Kinon, B.J., Lawrie, S.M., Lee, J., Leweke, F.M., MacCabe, J.H., McNabb, C.B., Meltzer, H., Moller, H.J., Nakajima, S., Pantelis, C., Reis Marques, T., Remington, G., Rossell, S.L., Russell, B.R., Siu, C.O., Suzuki, T., Sommer, I.E., Taylor, D., Thomas, N., Ucok, A., Umbricht, D., Walters, J.T., Kane, J., Correll, C.U., 2017. Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology. Am J Psychiatry 174, 216-229.

561. Jayaram, M., Hopwood, M., Pantelis, C., 2017. Can we raise the standard of care in treating schizophrenia: A cautionary note! [invited commentary]. Aust N Z J Psychiatry in press (12/16).

562. Jayaram, M., Moran, L., Adams, C., 2017. Twittering on about mental health: is it worth the effort? Evid Based Ment Health 20, 1-3.

563. Jung, W.H., Yucel, M., Yun, J.Y., Yoon, Y.B., Cho, K.I., Parkes, L., Kim, S.N., Kwon, J.S., 2017. Altered functional network architecture in orbitofronto-striato-thalamic circuit of unmedicated patients with obsessive-compulsive disorder. Hum Brain Mapp 38, 109-119.

564. Kaess, M., Whittle, S., Simmons, J.G., Jovev, M., Allen, N.B., Chanen, A.M., 2017. The Interaction of Childhood Maltreatment, Sex, and Borderline Personality Features in the Prediction of the Cortisol Awakening Response in Adolescents. Psychopathology.

565. Kamagata, K., Zalesky, A., Hatano, T., Ueda, R., Di Biase, M.A., Okuzumi, A., Shimoji, K., Hori, M., Caeyenberghs, K., Pantelis, C., Hattori, N., Aoki, S., 2017. Gray Matter Abnormalities in Idiopathic Parkinson’s Disease: Evaluation by Diffusional Kurtosis Imaging and Neurite Orientation Dispersion and Density Imaging. Hum Brain Mapp.

566. Klauser, P., Baker, S.T., Cropley, V.L., Bousman, C., Fornito, A., Cocchi, L., Fullerton, J.M., Rasser, P., Schall, U., Henskens, F., Michie, P.T., Loughland, C., Catts, S.V., Mowry, B., Weickert, T.W., Shannon Weickert, C., Carr, V., Lenroot, R., Pantelis, C., Zalesky, A., 2017. White Matter Disruptions in Schizophrenia Are Spatially Widespread and Topologically Converge on Brain Network Hubs. Schizophr Bull 43, 425-435.

567. Lei, P., Ayton, S., Appukuttan, A.T., Moon, S., Duce, J.A., Volitakis, I., Cherny, R., Wood, S.J., Greenough, M., Berger, G., Pantelis, C., McGorry, P., Yung, A., Finkelstein, D.I., Bush, A.I., 2017. Lithium suppression of tau induces brain iron accumulation and neurodegeneration. Mol Psychiatry 22, 396-406.

568. Liu, C., Bousman, C.A., Pantelis, C., Skafidas, E., Zhang, D., Yue, W., Everall, I.P., 2017. Pathway-wide association study identifies five shared pathways associated with schizophrenia in three ancestral distinct populations. Transl Psychiatry 7, e1037.

569. Looi, J.C., Santillo, A.F., 2017. Time and relative dimensions in syndromology: Towards endophenotypes in neurology, psychiatry and in-between. Aust N Z J Psychiatry, 4867417707059.

570. Lopez-Sola, M., Woo, C.W., Pujol, J., Deus, J., Harrison, B.J., Monfort, J., Wager, T.D., 2017. Towards a neurophysiological signature for fibromyalgia. Pain 158, 34-47.

571. Matta, G., Velakoulis, D., Gaillard, F., McLean, C.A., Yerra, R., 2017. Creutzfeldt-Jakob disease, cerebral amyloid angiopathy and Abeta-related angiitis with neuropsychiatric manifestations. Aust N Z J Psychiatry, 4867416686695.

572. McLaughlin, R.L., Schijven, D., van Rheenen, W., van Eijk, K.R., O’Brien, M., Kahn, R.S., Ophoff, R.A., Goris, A., Bradley, D.G., Al-Chalabi, A., van den Berg, L.H., Luykx, J.J., Hardiman, O., Veldink, J.H., 2017. Genetic correlation between amyotrophic lateral sclerosis and schizophrenia. Nat Commun 8, 14774.

573. Mengel, E., Pineda, M., Hendriksz, C.J., Walterfang, M., Torres, J.V., Kolb, S.A., 2017. Differences in Niemann-Pick disease Type C symptomatology observed in patients of different ages. Mol Genet Metab 120, 180-189.

574. Mostaid, M.S., Mancuso, S.G., Liu, C., Sundram, S., Pantelis, C., Everall, I.P., Bousman, C.A., 2017. Meta-analysis reveals associations between genetic variation in the 5’ and 3’ regions of Neuregulin-1 and schizophrenia. Transl Psychiatry 7, e1004.



575. Nieuwenhuis, M., Schnack, H.G., van Haren, N.E., Lappin, J., Morgan, C., Reinders, A.A., Gutierrez-Tordesillas, D., Roiz-Santianez, R., Schaufelberger, M.S., Rosa, P.G., Zanetti, M.V., Busatto, G.F., Crespo-Facorro, B., McGorry, P.D., Velakoulis, D., Pantelis, C., Wood, S.J., Kahn, R.S., Mourao-Miranda, J., Dazzan, P., 2017. Multi-center MRI prediction models: Predicting sex and illness course in first episode psychosis patients. Neuroimage 145, 246-253.

576. O’Dea, B., Lee, R.S., McGorry, P.D., Hickie, I.B., Scott, J., Hermens, D.F., Mykletun, A., Purcell, R., Killackey, E., Pantelis, C., Amminger, G.P., Glozier, N., 2017. Erratum to: A prospective cohort study of depression course, functional disability, and NEET status in help-seeking young adults. Soc Psychiatry Psychiatr Epidemiol 52, 503.

577. Pantelis, C., Cropley, V., Zalesky, A., 2017. Brain imaging biomarkers of psychosis. In: Tamminga, C., van Os, J., Ivleva, E.I., Reininghaus, U. (Eds.), Psychosis. Oxford University Press, Oxford, UK.

578. Parkes, L., Fulcher, B.D., Yucel, M., Fornito, A., 2017. Transcriptional signatures of connectomic subregions of the human striatum. Genes Brain Behav.

579. Prochazkova, L., Parkes, L., Dawson, A., Youssef, G., Ferreira, G.M., Lorenzetti, V., Segrave, R.A., Fontenelle, L.F., Yucel, M., 2017. Unpacking the role of self-reported compulsivity and impulsivity in obsessive-compulsive disorder. CNS Spectr, 1-8.

580. Reniers, R.L., Beavan, A., Keogan, L., Furneaux, A., Mayhew, S., Wood, S.J., 2017. Is it all in the reward? Peers influence risk-taking behaviour in young adulthood. Br J Psychol 108, 276-295.

581. Reniers, R.L., Lin, A., Yung, A.R., Koutsouleris, N., Nelson, B., Cropley, V.L., Velakoulis, D., McGorry, P.D., Pantelis, C., Wood, S.J., 2017. Neuroanatomical Predictors of Functional Outcome in Individuals at Ultra-High Risk for Psychosis. Schizophr Bull 43, 449-458.

582. Sethi, S.S., Zerbi, V., Wenderoth, N., Fornito, A., Fulcher, B.D., 2017. Structural connectome topology relates to regional BOLD signal dynamics in the mouse brain. Chaos 27, 047405.

583. Singh, A.B., Bousman, C.A., 2017. Antidepressant Pharmacogenetics. Am J Psychiatry 174, 417-418.

584. Stephanou, K., Davey, C.G., Kerestes, R., Whittle, S., Harrison, B.J., 2017. Hard to look on the bright side: Neural correlates of impaired emotion regulation in depressed youth. Soc Cogn Affect Neurosci.

585. Tezcan, D., Tumkaya, S., Bora, E., 2017. Reversal learning in patients with obsessive-compulsive disorder (OCD) and their unaffected relatives: Is orbitofrontal dysfunction an endophenotype of OCD? Psychiatry Res 252, 231-233.

586. Trakadis, Y.J., Fulginiti, V., Walterfang, M., 2017. Inborn errors of metabolism associated with psychosis: literature review and case-control study using exome data from 5090 adult individuals. J Inherit Metab Dis.

587. van den Heuvel, M.P., de Lange, S.C., Zalesky, A., Seguin, C., Yeo, B.T.T., Schmidt, R., 2017. Proportional thresholding in resting-state fMRI functional connectivity networks and consequences for patient-control connectome studies: Issues and recommendations. Neuroimage 152, 437-449.

588. Van Rheenen, T.E., Joshua, N., Castle, D.J., Rossell, S.L., 2017. Configural and Featural Face Processing Influences on Emotion Recognition in Schizophrenia and Bipolar Disorder. J Int Neuropsychol Soc 23, 287-291.

589. Van Rheenen, T.E., Lewandowski, K.E., Tan, E.J., Ospina, L.H., Ongur, D., Neill, E., Gurvich, C., Pantelis, C., Malhotra, A.K., Rossell, S.L., Burdick, K.E., 2017. Characterizing cognitive heterogeneity on the schizophrenia-bipolar disorder spectrum. Psychol Med, 1-17.

590. Verdejo-Garcia, A., Chong, T.T., Stout, J.C., Yucel, M., London, E.D., 2017. Stages of dysfunctional decision-making in addiction. Pharmacol Biochem Behav.

591. Verdejo-Roman, J., Fornito, A., Soriano-Mas, C., Vilar-Lopez, R., Verdejo-Garcia, A., 2017. Independent functional connectivity networks underpin food and monetary reward sensitivity in excess weight. Neuroimage 146, 293-300.

592. Wannan, C., Bartholomeusz, C.F., Cropley, V.L., Van Rheenen, T.E., Panayiotou, A., Brewer, W.J., Proffitt, T.M., Henry, L.P., Harris, M.G., Velakoulis, D., McGorry, P.D., Pantelis, C., Wood, S.J., 2017. Deterioration of Visuospatial Associative Memory Following a First Psychotic Episode: A Long-term Follow-up Study. Psychol Med in press (17/05/2017).


593. Whittle, S., Simmons, J.G., Hendriksma, S., Vijayakumar, N., Byrne, M.L., Dennison, M., Allen, N.B., 2017. Childhood maltreatment, psychopathology, and the development of hippocampal subregions during adolescence. Brain Behav 7, e00607.

594. Yucel, M., Carter, A., Allen, A.R., Balleine, B., Clark, L., Dowling, N.A., Gainsbury, S.M., Goudriaan, A.E., Grant, J., Hayes, A., Hodgins, D., van Holst, R., Lattimore, R., Livingstone, C., Lorenzetti, V., Lubman, D., Murawski, C., Parkes, L., Petry, N., Room, R., Singh, B., Thomas, A., Townshend, P., Youssef, G., Hall, W., 2017. Neuroscience in gambling policy and treatment: an interdisciplinary perspective. Lancet Psychiatry.

595. Zorlu, N., Cropley, V.L., Zorlu, P.K., Delibas, D.H., Adibelli, Z.H., Baskin, E.P., Esen, O.S., Bora, E., Pantelis, C., 2017. Effects of cigarette smoking on cortical thickness in major depressive disorder. J Psychiatr Res 84, 1-8.

596. Byrne, M.L., Horne, S., O’Brien-Simpson, N.M., Walsh, K.A., Reynolds, E.C., Schwartz, O.S., Whittle, S., Simmons, J.G., Sheeber, L., Allen, N.B., 2017. Associations between observed parenting behavior and adolescent inflammation two and a half years later in a community sample. Health Psychology.

597. Schmaal, L., Yucel, M., Ellis, R., Vijayakumar, N., Simmons, J.G., Allen, N.B., Whittle, S., 2017. Brain structural signatures of adolescent depressive symptom trajectories: A longitudinal MRI study. Journal of the American Academy of Child & Adolescent Psychiatry.

598. Whittle, S., Vijayakumar, N., Simmons, J.G., Dennison, M., Schwartz, O., Pantelis, C., Sheeber, L., Byrne, M.L., Allen, N.B., 2017. Impact of Positive Parenting on Associations between Neighborhood Social Disadvantage and Brain Development Across Adolescence. JAMA Psychiatry.

Disclaimer Copyright in this publication is owned by the University and no part of it may be reproduced without the permission of the University.

For further information, refer to: www.psychiatry.unimelb.edu.au/mnc/

CRICOS Provider Code: 00116K

Production details: June 2017 Authorised by: Faculty of Medicine, Dentistry and Health Sciences

Contact us

mdhs.unimelb.edu.au

www.psychiatry.unimelb.edu.au/mnc/

13MELB (6352)

facebook.com/MDHS.UniMelb

@UniMelbMDHS

@MNC_Psychiatry

mdhs.unimelb.edu.au

Want to find out more?

2017 Centre Overview · 2018-08-28 · Deputy: A/Prof Mark Walterfang DEPRESSION AND ANXIETY NEUROSCIENCE A/Prof. Ben Harrison Deputy: A/Prof Chris Davey SOCIAL AFFECTIVE NEURODEVELOPMENT

Documents